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Abstract 
Glutamate uptake by high-affinity plasma membrane transporters is essential for 
maintaining a low ambient level of glutamate and avoiding neurotoxicity. At 
excitatory synapses, glutamate transporters help to terminate glutamate transients 
following release, restrict diffusion of glutamate between synapses, recycle glutamate 
for subsequent release, as well as provide glutamate for metabolic purposes. Five 
different glutamate transporters have been identified in the mammalian central 
nervous system (CNS); GLAST (EAAT1) and GLT-1 (EAAT2) are found 
predominantly in glial cells, and EAAC1 (EAAT3) and EAAT4 are expressed by 
neurons. Despite our knowledge about the localization and density of these 
transporters, their relative contribution to uptake of synaptic glutamate and their 
differential impact on transmission are poorly understood. This is mainly because 
antagonists selective for each type of glutamate transporter have not yet been 
developed. In this study, we performed electrophysiological recordings in wild-type 
and genetically modified mice defective in selective glutamate transporters to address 
the following questions: (1) What are the relative contributions of neuronal and glial 
glutamate transporters to glutamate uptake at excitatory synapses and (2) how do 
different types of glutamate transporters influence transmission at excitatory synapses? 
We examined synaptic clearance of glutamate at two representative excitatory 
synapses in the rodent brain: climbing fiber-Purkinje neuron synapses in the 
cerebellum, where neuronal glutamate uptake can be directly measured; and 
oriens-lacunosum moleculare interneuron synapses in the hippocampus, where  iii
glutamate clearance at perisynaptic locations can be monitored. We found that at 
climbing fiber-Purkinje neuron synapses, neuronal transporter EAAT4 but not 
EAAC1 contributes to the clearance of glutamate, and astroglial transporters remove 
the majority of synaptic glutamate; at the hippocampal interneuron synapse, astroglial 
but not neuronal transporters regulate the occupancy of perisynaptic metabotropic 
glutamate receptors during transmission. We also observed that GLT-1, the 
predominant astroglial glutamate transporter, is expressed by a selective population of 
neurons, the hippocampal CA3 pyramidal neurons. The potential function of GLT-1 in 
these neurons is discussed. 
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Chapter I 
Introduction 
 
Importance of clearance of extracellular glutamate 
The amino acid L-glutamate is the major excitatory neurotransmitter in the 
mammalian central nervous system (CNS). Proper handling of this neural currency is 
required for most aspects of brain function including cognition, learning and memory, 
as well as development of the CNS (for review, see Danbolt, 2001). Glutamate is also 
a potent neurotoxin, whose accumulation in the extracellular space causes extensive 
activation of glutamate receptors located on neuronal and glial cell membranes, which 
can lead to excitotoxic damage to cells. Glutamate is synthesized and stored in high 
concentrations in glutamatergic neurons (~ 10 mM, see Ottersen et al., 1996), and is 
released upon specific stimuli (e.g. action potential firing) into extracellular space. It 
is critical to constrain the movement and lifetime of extracellular glutamate not only 
to prevent excitotoxicity, but to create a low-noise background for effective and 
sustained glutamate transmission. 
 
Glutamate transporters represent the main mechanism to remove extracellular 
glutamate 
The identification of mechanisms for clearance of extracellular glutamate was a 
critical step in the final establishment of glutamate as a neurotransmitter. More than 
20 years after the initial discovery of potent glutamate uptake capacity in brain tissues  2
(Balcar and Johnston, 1972; Johnston, 1981; Logan and Snyder, 1972), five different 
plasma membrane glutamate transporters were cloned (Saier, 1999; Slotboom et al., 
1999). Human isoforms (and their rodent homologs) are named EAAT1 (GLAST), 
EAAT2 (GLT-1), EAAT3 (EAAC1), EAAT4 (rEAAT4), and EAAT5 (rEAAT5). 
Splice variants for GLT-1 in rodents (named GLT-1a, -1b, -1c, and -1v) have been 
further identified (for review, see Grewer and Rauen, 2005). GLT-1 and GLAST are 
present at very high densities in brain tissue, and all five transporters exhibit high 
capacities for glutamate transport (see below, or review by Danbolt, 2001). The 
transport capacity is determined by the following stoichiometry (based on 
measurements of EAAC1 and GLT-1): each glutamate molecule is taken up together 
with 3Na
+ and 1H
+ in exchange for 1K
+ (Levy et al., 1998; Zerangue and Kavanaugh, 
1996). This coupling predicts a transport capacity that can reach a concentration 
gradient greater than 1x10
6, lowering ambient glutamate concentration to a few 
nanomolar at equilibrium (Zerangue and Kavanaugh, 1996). Disrupting the 
expression or activity of these transporters results in excessive activation of glutamate 
receptors, abnormal neuronal activity, and eventual excitotoxic degeneration 
(Rothstein et al., 1996; Tanaka et al., 1997). Considerable effort is being expended to 
understand the mechanisms responsible for transporter dysfunction in diseases 
(Cleveland and Rothstein, 2001), including the contribution of reverse transport – the 
inappropriate transport of glutamate out of the cell – to glutamate release during acute 
ischemic episodes (Rossi et al., 2000). In brief, glutamate transporters play a crucial 
role in preventing the accumulation of extracellular glutamate, which, apart from  3
passive diffusion, represents the primary mechanism for glutamate clearance in the 
CNS. 
 
Glutamate transporters are a key component for excitatory synapses 
When the glutamate uptake mechanism was initially discovered, it was speculated that 
the uptake machinery was present at the glutamate-releasing nerve terminals to 
conveniently recycle glutamate for continuous release. However, subsequent studies 
using immunohistochemistry and electron microscopy revealed that glutamate 
transporters are distributed on post- but not pre-synaptic neuronal membranes, and on 
glial cell membranes surrounding synapses (free review, see Danbolt, 2001). 
Electrophysiological recordings have also shown that glutamate transporter activity 
can be detected in postsynaptic neurons and adjacent glial cells 0.1-1 ms following 
presynaptic release (Bergles et al., 1997; Bergles and Jahr, 1997; Otis et al., 1997), 
suggesting that functional glutamate transporters are indeed present close to the 
release sites. These transporters prevent accumulation of glutamate in the synaptic 
cleft so as to reduce background noise for transmission. Transporters also set up 
diffusion barriers to prevent glutamate “spillover” to neighboring synapses to ensure 
transmission fidelity (Arnth-Jensen et al., 2002; Asztely et al., 1997; Diamond, 2001; 
Tsvetkov et al., 2004). Importantly, because presynaptic nerve terminals are largely 
devoid of transporters, glutamate is recycled via a detour through glial cells to 
replenish the releasable pool: glutamate is taken up into glial cells by transporters, 
converted to glutamine through glutamine synthetase, and recycled back to neurons in  4
the form of glutamine (the “glutamate-glutamine cycle”), before eventually converted 
to glutamate through glutaminase (for review, see Danbolt, 2001). Glutamate taken up 
by neurons can also enter metabolic pathways to synthesize other molecules including 
the inhibitory neurotransmitter GABA (for review, see Danbolt, 2001); and glutamate 
uptake by astroglial cells can even stimulate glycolysis and lactate production in 
astrocytes, providing readily consumable energy sources for adjacent neurons 
(Voutsinos-Porche et al., 2003). In summary, glutamate transporters extend their 
homeostatic maintenance operations to excitatory synapses: they remove glutamate to 
maintain low background noise for transmission; they restrict diffusion of glutamate 
between synapses to ensure the fidelity of transmission; and they recycle glutamate 
for sustained release and energy production. 
 
Glutamate transporters can influence receptor occupancy at excitatory synapses   
The function of glutamate transporters at excitatory synapses goes beyond the 
extension of their homeostatic maintenance operations. Accumulating evidence now 
suggests that glutamate transporters are able to impact transmission by competing 
with receptors for glutamate binding and thus regulate receptor activation (for review, 
see Huang and Bergles, 2004). This has been studied using electrophysiological 
recordings of glutamate receptor-mediated EPSCs, and analyzing the change in EPSC 
size and duration upon application of transporter inhibitors. These studies have shown 
that glutamate transporters are able to restrict the size and duration of EPSCs at a 
number of CNS synapses (Arnth-Jensen et al., 2002; Barbour et al., 1994; Brasnjo and  5
Otis, 2001; Diamond, 2001; Otis et al., 1996; Tong and Jahr, 1994). The reasons for 
their ability to regulate receptor occupancy during transmission are as follows. (1) 
The density of glutamate transporters in brain tissue is very high; it has been 
estimated in the stratum radiatum of hippocampal CA1 region that the concentration 
of glial transporters alone (about 8,500 molecules per µm
2 astroglial cell membrane, 
(Lehre and Danbolt, 1998)) is significant compared to the synaptic release capacity 
(Danbolt, 2001). Within 1 ms of release, the 4,000 glutamate molecules in a vesicle 
will encounter ~8,000-12,000 transporters, many more than the 15-50 AMPA 
receptors that they activate (for review, see Attwell and Gibb, 2005). In addition, 
studies on the subcellular distribution of glial glutamate transporters have shown that 
the densities of transporters are higher on the astroglial membranes facing neuropil, 
nerve terminals, axons and dendritic spines, than those facing other astrocytes, cell 
bodies, pia mater or the basement membrane of capillary endothelium (Chaudhry et 
al., 1995), suggesting that glutamate transporters are more heavily involved in 
synaptic function. (2) The affinity of glutamate transporters is comparable to that of 
glutamate receptors; the EC50 for glutamate transporters is 3 – 97 µM (Arriza et al., 
1997; Arriza et al., 1994; Fairman et al., 1995); the EC50 values for AMPA and 
NMDA receptors are 46 µM and 0.6 µM respectively (Attwell and Gibb, 2005), and 
for mGluRs are 4 – 60 µM (Pin and Duvoisin, 1995). (3) Glutamate transporters bind 
glutamate rapidly. The rise times of glutamate-evoked transporter currents in 
outside-out patches of astroglial cell membranes (Bergles and Jahr, 1997; Wadiche et 
al., 1995) and in whole-cell recordings in response to photolysis (Grewer et al., 2000)  6
indicate that they bind glutamate as rapidly as ionotropic glutamate receptors (Jonas 
and Sakmann, 1992). Therefore, although the entire transport cycle takes a longer 
time to complete (see below), the initial fast binding of transporters may be sufficient 
to rapidly buffer glutamate and win the race against receptors. (4) All five types of 
glutamate transporters exhibit a high capacity for transport, as determined by the 
shared stoichiometry (see above). However, the transport efficiency for many 
transporters is close to 50% (Bergles et al., 2002; Otis and Kavanaugh, 2000), 
meaning that glutamate, once bound, is as likely to unbind as it is to be translocated. 
Therefore, although the initial fast binding of transporters can effectively reduce 
glutamate concentration from its maximum value, subsequent dissociation of 
glutamate from transporters can slow down the decay of glutamate transient at low 
concentrations and prolong activation of receptors (for review, see Grewer and Rauen, 
2005). In summary, the high affinity, high density, rapid binding, high capacity and 
low efficiency of glutamate transporters enable them to regulate the spatial and 
temporal concentration profile of glutamate in the extracellular space, and therefore 
regulate receptor occupancy at individual synapses, as well as to regulate the 
cross-activation of receptors at neighboring synapses (see Figure I-1). 
 
Other factors contribute to the regulation of receptor occupancy by glutamate 
transporters 
In addition to the intrinsic properties of glutamate transporters, the potential impact of 
transporters on excitatory transmission is further determined by additional parameters  7
at each individual synapses, including (1) the probability and frequency of release, (2) 
the structure of synaptic compartment, (3) the kinetic properties of glutamate 
receptors, (4) and the localization of transporters in relation to synaptic receptor 
molecules. (1) Glutamate transporters exhibit slow turn-over rates (10 ~75 ms, 
depending on the particular transporter (Bergles and Jahr, 1997; Bergles and Jahr, 
1998; Otis and Jahr, 1998; Wadiche and Kavanaugh, 1998)), which predicts that their 
availability for glutamate binding decreases as the release frequency increases. Once 
the release interval is shorter than the turn-over time, glutamate transporters will not 
have had sufficient time to complete the transport cycle before the next round of 
release occurs. Therefore glutamate transporters can, if the density is relatively low in 
vicinity of receptors, serve as a high-pass filter for receptor activation, particularly for 
extrasynaptic receptors whose activation requires diffusion of glutamate out of the 
synaptic cleft. This may in part explain why activation of mGluRs and extrasynaptic 
NMDA receptors typically requires high frequency stimulation (Clark and Cull-Candy, 
2002; Tempia et al., 1998). Similarly, in cerebellar Purkinje neurons where 
high-frequency stimulation of parallel fibers leads to activation of extrasynaptic 
mGluRs, inhibition of glutamate transporters reduces the number of stimuli necessary 
for mGluR activation at a given frequency (Reichelt and Knopfel, 2002). (2) CNS 
synapses are ensheathed by glial cell processes to different extents, which is predicted 
to lead to differences in local concentration and accessibility of transporters to 
glutamate. One dramatic example is demonstrated in the hypothalamus. During 
lactation dramatic structural rearrangements occur when astrocytes retract their  8
processes from excitatory synapses (Theodosis and Poulain, 1993). Following these 
morphological changes, activation of presynaptic mGluRs is enhanced because of a 
lack of proximal glutamate transporters (Oliet et al., 2001). A similar phenomenon has 
been observed in the cerebellum. Viral mediated expression of GluR2 selectively in 
Bergmann glia, an astrocyte-like cell, renders their AMPA receptors impermeable to 
calcium and causes these cells to retract their processes (Iino et al., 2001). An analysis 
of parallel fiber and climbing fiber mediated excitatory postsynaptic currents (EPSCs) 
in Purkinje neurons under these conditions of reduced ensheathment revealed that 
glutamate clearance from synapses was dramatically impaired (Iino et al., 2001). (3-4) 
For receptors located directly opposite release sites, such as the ionotropic glutamate 
receptors, their initial occupancy by glutamate is rarely altered by perisynaptically 
localized transporters (but see Diamond and Jahr, 1997; Tong and Jahr, 1994). 
However, blocking transporters may prolong the glutamate transient in the synaptic 
cleft, which either prolongs activation (Barbour et al., 1994; Kinney et al., 1997; Otis 
et al., 1996; Takahashi et al., 1995; Takahashi et al., 1996), or facilitates 
desensitization (Otis et al., 1996; Renden et al., 2005) of the postsynaptic receptors, 
depending on the local concentration of glutamate achieved and the kinetic properties 
of receptors. In contrast, mGluRs are typically located on peri- or extra-synaptic 
membranes; activation of these receptors therefore requires diffusion of glutamate 
away from the synaptic cleft. At cerebellar parallel fiber-Purkinje neuron synapses, 
inhibition of glutamate transporters facilitates diffusion and potentiates mGluR 
activation (Reichelt and Knopfel, 2002). Recent studies by Wadiche and Jahr  9
(Wadiche and Jahr, 2005) also revealed an inverse correlation at this synapse between 
the density of EAAT4 transporters and synaptic activation of mGluRs. In contrast, 
AMPA receptor-mediated transmission at the same synapse was not affected by 
changes in EAAT4 transporter density. These studies suggest that the impact of 
glutamate transport on synaptic transmission may be generalized only with caution, 
considering the diversity of synaptic structures and the expression profiles of 
transporters and receptors.   
 
Understanding the differential contributions of transporters to synaptic 
clearance 
To fully understand the function of glutamate transporters in excitatory transmission, 
it is necessary to recognize the individual contributions of different types of glutamate 
transporters. Compared to other neurotransmitters, the clearance pathway for 
glutamate is much more elaborate, as there are more than five types of transporters for 
glutamate, but only two types for GABA (GAT-1,2), and one for each of the 
monoamines, norepinephrine (NET), dopamine (DAT), and serotonin (SERT). Finer 
control over extracellular glutamate dynamics may be achieved by spreading the task 
of glutamate uptake among different transporters, as they are expressed by distinct 
populations of cells (for review, see Danbolt, 2001). GLAST and GLT-1 are primarily 
expressed in astroglial cells throughout the CNS, and their expression varies between 
different brain regions and during development. GLT-1 is the quantitatively 
dominating glutamate transporter in the mature forebrain, particularly in the  10
hippocampus, cerebral cortex, and striatum, whereas GLAST has the highest level of 
expression in the cerebellum, inner ear, and retina. GLT-1 has also been suggested to 
exist in certain neurons at the presynaptic terminals (Chen et al., 2004), but these 
immuno-electronmicroscopy (immuno-EM) results are not yet confirmed by 
functional studies. In contrast to GLAST and GLT-1, EAAC1 and EAAT4 are 
expressed by neurons. EAAT4 is highly expressed in cerebellar Purkinje cells, and is 
almost undetectable in other regions, where EAAC1 becomes the predominant 
neuronal glutamate transporter. EAAT5 expression is restricted to the retina. When 
considering neuronal and glial transporter function at excitatory synapses, there are 
advantages and disadvantages for both groups of transporters. The average density of 
astroglial transporters is greater than that of neuronal transporters (for review, see 
Danbolt, 2001). Inaddition, astrocytes possess many features that create an 
environment optimized for efficient uptake, including a high resting potential that 
facilitates voltage-dependent glutamate transport, a high resting conductance that 
prevents fluctuation of the membrane potential, and a low intracellular concentration 
of glutamate. By contrast, transporters operating in neuronal membranes must fight 
against a higher electrochemical gradient, and a more depolarized and constantly 
fluctuating membrane potential. Nonetheless, neuronal transporters may be positioned 
closer to the synaptic cleft than glial transporters; distribution of the latter is 
determined by the extent of ensheathment of synaptic structure by glial cell processes. 
 
Development of tools to investigate the differential function of glutamate  11
transporters 
Investigation of the individual contributions from different types of glutamate 
receptors has proven to be challenging, partly because pharmacology is lagging far 
behind the molecular identification of transporters and selective antagonists for each 
type of them have yet to be developed. Only one specific transporter antagonist, 
dihydrokainate (DHK), has been well characterized so far, which has a ~100x higher 
affinity for GLT-1 over other transporters. Several other selective transporter 
antagonists, WAY213613 and WAY-855 have recently been developed during the 
course of this study, and they exhibit > 40x higher affinity for GLT-1 over other 
transporters (personal communication; and Dunlop et al., 2003). 
Although selective transporter antagonists are largely unavailable, efforts have 
been made to take advantage of the fact that glutamate transporters are segregated into 
neuronal and glial cell compartments. To determine their specific functions, selective 
manipulation of single cells or single cell populations has been an alternative way to 
alter the operation or synaptic localizations of neuronal and glial transporters, and to 
study their differential impact on transmission. In two of the above-mentioned 
examples, when glial cell processes are dissociated from excitatory synapses either in 
the hypothalamus during lactation or in the cerebellum following viral infection of 
Bergmann glia with GluR2, there are changes in receptor activation during 
transmission. These observations point to the essential role of glial cell processes in 
delivering transporters to sites of release, and highlight the importance of glial 
transporters at excitatory synapses. To investigate the function of neuronal  12
transporters, several studies took advantage of the dependence of transport on voltage 
and intracellular K
+ to selectively inhibit uptake in the postsynaptic neurons. 
Complete replacement of K
+ with Tris
+, a cation that does not support glutamate 
transporter cycling, increases the parallel fiber-evoked mGluR EPSCs in Purkinje 
neurons (Brasnjo and Otis, 2001). In the hippocampus, activation of extrasynaptic 
NMDA receptors is potentiated when postsynaptic glutamate transporters are 
inhibited either by high positive membrane potential or by depletion of intracellular 
K
+. These studies suggest that postsynaptic transporters (e.g. EAAC1 and EAAT4) 
also may shield receptors during transmission. Furthermore, recent studies by 
Wadiche and Jahr (2005) also reveal an inverse correlation among different cerebellar 
lobules between the density of EAAT4 transporters and the size of mGluR-mediated 
synaptic currents in Purkinje neurons, although it is not yet conclusive if EAAT4 
expression alone is sufficient to explain the observed differences in synaptic mGluR 
activation, considering that the comparison is made between two cerebellar cortical 
lobules, and that the EAAT4 expression level is only one of many potential variables. 
Other than pharmacology and single cell manipulations there have been 
alternative approaches to address the individual contribution of glutamate transporters 
to the clearance of glutamate. These approaches include chronic administration of 
antisense oligonucleotide to inhibit the synthesis of the targeted glutamate transporter 
(Rothstein et al., 1996), and generation of selective transporter knockout animals. To 
further differentiate the contributions from different types of glutamate transporters, 
gene-specific knockout mice have been generated (Peghini et al., 1997; Tanaka et al.,  13
1997; Watase et al., 1998). EAAC1 knockout mice show no CNS phenotype (Peghini 
et al., 1997); GLT-1 knockout mice have increased susceptibility to acute forebrain 
injury, and they cannot survive till adulthood due to lethal spontaneous epileptic 
seizures (Tanaka et al., 1997); GLAST knockout mice are mildly discoordinated, 
more susceptible to cerebellar injury (Watase et al., 1998), and develop exacerbated 
noise-induced hearing loss (Hakuba et al., 2000). In addition, detailed examination of 
synaptic physiology in glial transporter knockout mice revealed that in GLT-1 
deficient mice, there is increased basal activity of NMDA receptors in the 
hippocampal CA1 region, which impairs NMDA receptor-dependent long-term 
potentiation at Schaffer collateral synapses (Katagiri et al., 2001); and in the 
cerebellum of GLAST deficient mice, Purkinje neurons remain to be innervated by 
multiple climbing fibers even in adulthood (Watase et al., 1998). These results 
indicate that glutamate transporters play distinct roles in clearing glutamate from the 
extracellular space, and that different phenotypes of glial transporter knockout mice 
may reflect the regional differences of GLT-1 and GLAST expression. Nonetheless, it 
remains to be determined the individual contribution of transporters to clearance at a 
given synapse. 
 
Methods to monitor glutamate transporter activity 
Glutamate transport is associated with movements of a variety of substances across 
the membrane, which provides the means to monitor transporter activity. Glutamate 
uptake leads to accumulation of substrates (e.g. glutamate and H
+) on one side of the  14
membrane, which can be monitored by measuring radiolabeled substrates 
accumulation or optical measurements of cytosolic pH changes. Glutamate uptake 
also leads to net charge movement because two positive charges are carried into the 
cell during each cycle of transport (Levy et al., 1998; Zerangue and Kavanaugh, 1996), 
and binding of glutamate to the transporter increases its conductance to certain anions 
(Wadiche et al., 1995). The resulting change in voltage across the plasma membrane 
can be monitored by voltage-sensitive dyes, or by electrical recordings of 
transporter-associated currents (for review, see Danbolt, 2001). Transporter-associated 
currents are proportional to the movement of glutamate (Otis and Jahr, 1998; 
Zerangue and Kavanaugh, 1996), providing a quantitative measure for glutamate 
transporter activity in individual cells that can be resolved with high temporal fidelity. 
 
Main objectives of this thesis 
As summarized above, glutamate transporters prevent the accumulation of 
extracellular glutamate that would otherwise lead to tonic activation of receptors, 
disrupted signaling, and excitotoxic damage. At excitatory synapses, glutamate 
transporters regulate the spatial and temporal concentration profile of glutamate 
transients and therefore can potentially impact transmission by regulating receptor 
occupancy. This work combines electrophysiological recordings with usage of 
genetically modified mice defective in selective glutamate transporters to address the 
following questions: (1) What are the relative contributions of neuronal and glial 
glutamate transporters to glutamate uptake at excitatory synapses and (2) how do  15
different types of glutamate transporters influence transmission at excitatory synapses? 
In  Chapter II, we investigated the relative contributions of neuronal transporters 
EAAC1 and EAAT4, as well as glial transporters (GLAST and GLT-1), to the 
clearance of synaptic glutamate at the cerebellar climbing fiber-Purkinje neuron 
synapse; this synapse is the only location in CNS where quantitative analysis for 
neuronal glutamate transporter activity during transmission is possible. We found that 
EAAT4 but not EAAC1 contributes to the synaptic uptake of glutamate by Purkinje 
neurons. Postsynaptic EAAT4 transporters remove ~10% of total released glutamate 
at this synapse, and the rest is presumably taken up by glial transporters. We also 
identified a novel conductance mediated by GluR5-containing kainate receptors at this 
synapse, whose presence led to an overestimation of the Purkinje neuron contribution 
to synaptic uptake in previous studies. For other CNS synapses where direct 
measurements of total neuronal or glial uptake are not possible, we used an 
extrasynaptically localized glutamate receptor to estimate the relative contributions of 
neuronal and glial transporters to clearance (Chapter III). We found that at an 
excitatory synapse in the hippocampus, the glial transporters GLT-1 and GLAST, but 
not the neuronal transporter EAAC1, have a significant impact on the occupancy of 
extrasynaptic mGluRs during transmission. Thus, at these two groups of excitatory 
synapses glial transporters dominate the clearance of glutamate following release, 
raising the question of whether transporters on neuronal membranes are important to 
regulate transmission. In Chapter IV, we describe the synthesis and characterization 
of a caged transporter substrate, 4-methoxy-7-nitroindolinyl-D-aspartate, for rapid and  16
selective activation of glutamate transporters in their native membranes. Using 
photolysis approach, we describe the observation (Chapter V) that GLT-1, the 
predominant astroglial glutamate transporter, is also expressed by a selective 
population of neurons, the hippocampal CA3 pyramidal neurons. The potential 
function of GLT-1 in these neurons is discussed. 
  17
Figure I-1. The location of glutamate transporters and receptors at a typical 
excitatory synapse. Unlike receptors, glutamate transporters are excluded from the 
synaptic cleft. EAAT1 (GLAST) and EAAT2 (GLT-1) are present at high densities in 
the membranes of astrocytes that often ensheath synapses. EAAT3 (EAAC1) is found 
in the soma and dendrites of neurons, but is also found in GABAergic terminals (not 
shown). Glutamate transporters shield extrasynaptic NMDA receptors and mGluRs 
from glutamate as it diffuses from the cleft, and prevent glutamate from reaching 
receptors at nearby synapses. Inhibition of these transporters potentiates excitatory 
responses mediated by these receptors, and allows glutamate spillover, which suggests 
that transporter regulation might be used to regulate synaptic efficacy. Note that 
presynaptic mGluRs have been omitted from this diagram. 
  18
Figure I- 1 
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Chapter II 
Climbing Fiber Activation of EAAT4 Transporters and Kainate 
Receptors in Cerebellar Purkinje Cells 
 
Introduction 
Our knowledge about neuronal glutamate uptake is based largely on studies of 
climbing fiber-Purkinje cell (CF-PC) synapses in the cerebellum, the only CNS 
synapses where both anion and stoichiometric (coupled) currents associated with 
glutamate transport have been resolved in the postsynaptic neuron. In addition to 
EAAC1, PCs express EAAT4, a transporter that exhibits a 10-fold higher affinity for 
glutamate than other glutamate transporters (Fairman et al., 1995). Measurements of 
the charge transferred during CF synaptic transporter currents have been used to 
estimate the amount of glutamate taken up by PCs (Auger and Attwell, 2000; Otis et 
al., 1997). An initial study concluded that at least 22% of the glutamate released at CF 
synapses was removed by PCs, more if EAAC1 also contributes to uptake currents 
(Otis et al., 1997). Although this estimate was based on measurements of 
transporter-associated anion currents, a recent study described a CF-induced synaptic 
current that was attributed to the movement of charge directly coupled to glutamate 
transport (Auger and Attwell, 2000); this study concluded that PCs remove the 
majority of glutamate (56 − 230 %) released at CF synapses. However, this putative 
transporter current was only partially inhibited by TBOA (Auger and Attwell, 2000), 
an antagonist that blocks all glutamate transporters (Shigeri et al., 2001; Shimamoto  20
et al., 1998), raising questions about the accuracy of these estimates.   
To determine both the contribution of EAAC1 and EAAT4 to uptake of 
synaptic glutamate, and the reason for the partial sensitivity of the putative synaptic 
transporter current to TBOA, we recorded CF responses in cerebellar slices prepared 
from mice deficient in neuronal transporters. We find that EAAT4 is responsible for 
the glutamate transporter currents recorded at CF-PC synapses. In addition, our results 
indicate that previous studies have overestimated the amount of glutamate captured by 
PCs, because non-AMPA glutamate receptors account for more than 40% of the 
putative coupled transporter current recorded from PCs. These non-AMPA receptors 
at CF synapses exhibited pharmacological and kinetic features characteristic of 
GluR5-containing kainate receptors and were responsible for about 5% of the CF 
EPSC.  
 
Materials and Methods 
Generation of mice deficient in neuronal transporters. EAAC1
-/- and GluR5
-/- mice 
were generated as described (Contractor et al., 2000; Peghini et al., 1997). For 
targeted disruption of the EAAT4 gene, the exon 7 including the sixth transmembrane 
segment was replaced by a neomycin-resistance gene. The linearized targeting vector 
was electroporated into E14 ES cells and one ES cell line with a single targeted allele 
was used for the generation of EAAT4
-/- mice (H. Maeno, K. Watase, K. Wada, and K. 
Tanaka, unpublished observations). To generate EAAC1
-/- x EAAT4
-/- mice as well as 
other genotypes with comparable backgrounds, hybrids of the two lines (genotype:  21
EAAC1
+/- x EAAT4
+/-) were used to generate two sets of mice. The first set had one 
mutant allele (EAAC1
-/- or EAAT4
-/-) and one heterozygous allele (EAAC1
+/- or 
EAAT4
+/-), which were then used to generate double mutants (EAAC1
-/- x EAAT4
-/-) or 
single mutants (EAAC1
-/- or EAAT 
-/-). The second set had one wild-type allele 
(EAAC1
+/+ or EAAT4
+/+) and one heterozygous allele (EAAC1
+/- or EAAT4
+/-), which 
were then used to generate wild-type mice (EAAC1
+/+ x EAAT4
+/+) as well as single 
mutant mice. All comparisons between different genotypes (Figures I-1, 2, & 3) were 
performed using mice generated in this manner. Additional double mutants were 
obtained from the subsequent mating of double mutants (Figures I-4 & 5). The 
genotype of all experimental animals was confirmed by PCR. 
Immunoblotting and immunostaining. Mice were euthanized using approved 
animal welfare protocols and perfused by cardiac puncture with 4% 
paraformaldehyde/Phosphate buffered saline (PBS). Brains were removed and tissue 
blocks were cryopreserved for sectioning. For immunoblotting, tissue was rapidly 
frozen on dry ice, and stored at −70° C until assayed. Samples from P18-21 
cerebellum were homogenized with a Brinkmann Polytron or by sonication in 20 mM 
Tris-HCl (pH 7.4) containing 10% sucrose, and protease inhibitor cocktail (Roche 
Diagnostics). These cerebellar extracts were subjected to 7.5% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose 
membrane (Hybond ECL) by electroblotting (30 V, 60 min). Western analysis was 
performed as described (Rothstein et al., 1994). Bots were probed with affinity 
purified polyclonal antibody specific for EAAC1 (carboxy terminus-directed antibody  22
at 0.6 µg/ml), EAAT4 (carboxyterminus-directed antibody at 0.4 µg/ml ) or actin 
(1:500; Sigma Chemical) using horseradish peroxidase-conjugated donkey anti-rabbit 
Ig (Amersham) (diluted 1:5000 in blocking solution) as secondary antibody. 
Immunoreactive proteins were visualized by enhanced chemilumine- scence (ECL). 
Immunoblots were run at least two times. 
For immunohistochemistry, sections (50 µm) of cryopreserved mouse brain 
(P19-20) were cut on a sliding microtome then transferred to cold TBS (0.05 M Tris, 
0.15M NaCl, pH 7.4). Sections were pre-treated with 3% hydrogen peroxide/ 0.1% 
Triton X-100 in TBS, rinsed and blocked (1 hour, 4° C) in TBS containing 5% normal 
goat serum, and 0.1% Triton X-100. Sections were incubated (48 − 72 hours, 4° C) in 
one of the affinity-purified anti-peptide antibodies (EAAC1 - 0.06, EAAT4 - 0.4 
ug/ml) or anti-calbindin (1:2000, Sigma) antibody in TBS containing 2% normal goat 
serum, 0.1% Triton X-100. The monospecificity of the affinity purified antibodies had 
been previously confirmed using pre-adsorption overnight with excess (5 µM) 
corresponding synthetic oligopeptide, or 2) primary antisera omitted. Following the 
primary antibody incubation, sections were incubated (1 hr, 4° C) with biotinylated 
secondary antibody (Vector Labs) to rabbit IgG diluted 1:400 (for all glutamate 
transporter antibodies) in TBS containing 2% normal goat serum, then rinsed and 
incubated (1 hour, 4° C) in ABC reagent 1:200 in TBS (Elite kit, Vector Labs), 
followed by 0.05% diaminobenzidine/0.01% hydrogen peroxide in TBS. Tissue 
staining was performed on 2 animals from each group (wild-type, EAAC1
-/-, EAAT4
-/-, 
and EAAC1
-/- x EAAT4
-/-).  23
Slice preparation. Parasagittal cerebellar slices were prepared from 15 to 19 day-old 
mice and 13 to 15 day-old rats @ 250 µm on a vibratome (Leica, VT1000S) in 
ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl (119), KCl 
(2.5), CaCl2 (2.5), MgCl2 (1.3), NaH2PO4 (1), NaHCO3 (26.2), and glucose (11) 
saturated with 95% O2/5% CO2. Slices were incubated in ACSF at 37° C for 30 min, 
and then allowed to recover for at least 30 min at room temperature before 
experimentation.  
Electrophysiological recordings. PCs were visualized through a 40x water 
immersion objective using infrared light, DIC optics, and a CCD camera (Sony 
XC-73). Whole-cell recordings were made under visual control with an internal 
solution consisting of (in mM): CsA (105), where A represents NO3
- or CH3O3S
- 
(MeS), TEA-Cl (20), EGTA (10), HEPES (20), Mg-ATP (2), Na-GTP (0.2), QX-314 
(1), pH 7.3. CFs were stimulated with a theta glass pipette filled with ACSF. A 
constant-current isolated stimulator (Digitimer DS3) was used to supply a 100 µs 
pulse of 2-30 µA. Pipette position was adjusted to minimize the stimulus intensity 
required to generate an all-or-none CF-evoked response. Subthreshold stimulation did 
not induce EPSCs, indicating that there was no contamination by parallel fiber 
synapses. Synaptic currents were recorded with a MultiClamp 700A amplifier (Axon 
instruments), filtered at 2 − 3 kHz, amplified 20x (Brownlee 440), and then digitized 
at 10 kHz with a Digidata 1322A analog-to-digital converter (Axon instruments). Data 
were analyzed off-line using pClamp (Axon Instruments) and Origin (Microcal) 
software. All recordings were made at room temperature.  24
Data analysis. By optimizing the position of the stimulation pipette, it was possible to 
obtain CF EPSCs and rEPSCs that were well separated from the stimulus artifact. 
Although subtraction of the artifact was not performed, in most traces the artifact has 
been blanked for clarity. The rise time of synaptic currents was measured from 10 – 
90% of peak amplitude. The decay kinetics of CF rEPSCs and EPSCs recorded in 
GYKI 53655 were calculated by fitting a single exponential (y = y0+A1e
-(x-x
0
)/t
1) to the 
decay from ~ 10% below the peak. The decay of CF EPSCs under control conditions 
could not be fitted with a single exponential, therefore the half-decay time was 
measured to provide an indication of the decay time course. Reversal potentials for 
CF EPSCs and rEPSCs were measured by performing a linear regression fit of the I-V 
data from each individual experiment. The estimated reversal potentials have not been 
corrected for the junction potential. All results are presented as mean ± S.E.M. 
 
Results  
CF synaptic transporter currents from wild-type mice 
To determine the relative contribution of EAAC1 and EAAT4 to the PC glutamate 
transporter current, we compared CF synaptic currents recorded from wild-type mice 
to those recorded from mice lacking EAAC1 (Peghini et al., 1997), EAAT4, or both 
EAAC1 and EAAT4 transporters. We confirmed that transporter expression was 
disrupted in EAAC1
-/-, EAAT4
-/-, and EAAC1
-/- x EAAT4
-/- mice by PCR (data not 
shown), western blot (Figure II-1A), and immunocytochemistry (Figure II-1B).  25
Despite the absence of neuronal glutamate transporters, these animals survived into 
adulthood (Peghini et al., 1997), did not exhibit obvious motor discoordination, and 
had grossly normal cerebellar architecture (Figure II-1B). In slices prepared from 
wild-type mice, CF stimulation elicited large amplitude all-or-none synaptic currents 
in PCs similar to those observed in rats (Perkel et al., 1990) (Figure II-2A). This CF 
EPSC was reduced to < 1% of its original amplitude upon application of antagonists 
of AMPA receptors (NBQX, 25 µM; GYKI 52466, 25 µM), NMDA receptors 
(RS-CPP, 10 µM) and GABAA receptors (SR-95531, 5 µM; bicuculline, 20 µM). The 
residual synaptic current (rEPSC) recorded in the presence of these antagonists was 
–23.0 ± 1.5 pA (n = 9) (Vm = –65 mV) when recordings were made with an internal 
solution that contained MeS as the primary internal anion, which does not permeate 
the glutamate transporter anion channel (Bergles et al., 2002), and exhibited the same 
threshold and all-or-none behavior as the CF EPSC (Figure II-2B). This current had 
rapid rise and decay kinetics (rise time: 2.3 ± 0.2 ms; decay tau: 9.1 ± 1.2 ms, n = 9) 
(Figure II-2B), similar to currents recorded from rat (Auger and Attwell, 2000), and 
was inhibited by 38.2 ± 2.9 % (n = 4) by DL-threo-β-benzyloxyaspartic acid (TBOA, 
200 µM), a non-selective antagonist of glutamate transporters (Shigeri et al., 2001; 
Shimamoto et al., 1998). These results indicate that a stoichiometric or coupled 
transport current, reflecting the movement of charge directly associated with 
glutamate uptake, mediates a portion of the CF rEPSC. When recordings were made 
with NO3
- as the primary internal anion, which is highly permeant through glutamate 
transporters (Wadiche et al., 1995), this residual current was larger (amplitude: –76.4  26
± 15.9 pA; p < 0.05) and decayed more slowly (rise time: 2.8 ± 0.4 ms, p = 0.27; 
decay tau: 37.2 ± 2.3 ms, n = 4; p < 0.001) (Figure II-2C), and was inhibited to a 
greater extent by TBOA (inhibition: 73.2 ± 2.8 %, n = 4; p < 0.001) (Figure II-2C), 
effects similar to that observed for transporter currents in outside-out patches (Auger 
and Attwell, 2000; Bergles et al., 2002). These data indicate that both stoichiometric 
(coupled) and anion (uncoupled) currents associated with glutamate transport can be 
recorded in PCs from wild-type mice in response to CF stimulation. We used these 
two features of glutamate transporters, the potentiation by permeant anions and the 
inhibition by TBOA, to address whether glutamate transporter currents were disrupted 
in mice lacking EAAC1 and/or EAAT4. 
 
EAAT4 is responsible for the CF glutamate transporter current. 
As shown in Figure II-3A, both the amplitude and decay time of CF rEPSCs from 
EAAC1
-/- mice were increased when NO3
- rather than MeS was used as the primary 
internal anion, similar to responses from wild-type mice (see Figure II-2). In contrast, 
there was no significant difference in the amplitude or decay time of CF rEPSCs from 
EAAT4
-/- or EAAC1
-/- x EAAT4
-/- mice when NO3
- rather than MeS was used as the 
primary internal anion (Figure II-3A, B). Furthermore, the amount of inhibition of CF 
rEPSCs by TBOA was reduced in EAAT4
-/- mice, and there was no significant 
difference in TBOA inhibition between EAAT4
-/- and EAAC1
-/- x EAAT4
-/- mice 
(Figure II-3A,C). These data indicate that EAAT4 is responsible for the 
anion-potentiated CF glutamate transporter current. However, because EAAT4  27
exhibits a much higher anion permeability than EAAC1 (Fairman et al., 1995; 
Wadiche et al., 1995), it is possible that EAAT4 could be the predominant transporter 
when NO3
- is the main internal anion, but a minor component when permeant anions 
are not present. If EAAC1 contributes to the coupled transporter current (recorded 
with MeS), there should be a difference in the amount of inhibition by TBOA between 
EAAT4
-/- and EAAC1
-/- x EAAT4
-/- mice. However, there was no significant difference 
in TBOA inhibition of CF rEPSCs between these animals (Figure II-3C). Furthermore, 
under these conditions, CF rEPSCs from EAAT4
-/- mice were inhibited significantly 
less than CF rEPSCs from wild-type mice (P < 0.05). These data indicate that both 
stoichiometric and anion transporter currents recorded at CF synapses are mediated by 
EAAT4, rather than EAAC1. 
The presence of a small TBOA-sensitive current in mice lacking both EAAC1 
and EAAT4 suggested that TBOA may have secondary effects, or that PCs may 
express an additional glutamate transporter. Previous studies have shown that 
blocking glutamate transporters with TBOA causes glutamate to accumulate in the 
extracellular space (Arnth-Jensen et al., 2002; Jabaudon et al., 1999), which could 
inhibit release by activating presynaptic metabotropic glutamate receptors on CF 
terminals (Harrison and Jahr, 2003; Tamaru et al., 2001). Consistent with this 
possibility, TBOA increased the paired-pulse ratio (PPR) of CF rEPSCs by 37.9 ± 8.3 
% (n = 5, p < 0.01) in EAAC1
-/- x EAAT4
-/- mice (Figure II-4A), suggesting that TBOA 
decreased the release probability of CF terminals. Furthermore, both the decrease in 
amplitude and the increase in PPR ratio were blocked when TBOA was applied in the  28
presence of the group I/II metabotropic glutamate receptor antagonist 
(RS)-a-methyl-4-carboxyphenylglycine (MCPG, 1 mM) (amplitude decreased by 0.6 
± 4.0 %, n = 7, p = 0.62; PPR increased by 1.5 ± 3.7 %, n = 5, p = 0.44) (Figure II-4B). 
These results indicate that the TBOA-induced decrease in amplitude of the CF 
response in EAAC1
-/- x EAAT4
-/- mice was due to a reduction in glutamate release 
from CF terminals, rather than an inhibition of latent glutamate transporters in PCs; in 
the absence of neuronal transporters, TBOA application presumably increases 
extracellular glutamate by inhibiting glutamate uptake into surrounding Bergmann 
glial cells (Bergles et al., 1997; Rothstein et al., 1994). We estimated the proportion of 
the CF rEPSC mediated by glutamate transporters by measuring the amplitude of the 
TBOA-sensitive current in the presence of MCPG. In recordings with MeS as the 
primary internal anion, EAAT4 transporters were responsible for 57.2 ± 3.9 % (n = 4) 
of the CF rEPSC in rats, and 36.4 ± 5.5 % (n = 4) of the CF rEPSC in wild-type mice 
(Figure II-4C). 
 
Non-AMPA glutamate receptors at CF synapses 
As shown above (see Figure II-2), and previously (Auger and Attwell, 2000), the CF 
rEPSC recorded from wild-type animals in the presence of 25 µM NBQX was only 
partially inhibited by TBOA (200 µM). Because TBOA blocks all high affinity, Na
+ 
dependent glutamate transporters with a Km of 3 – 50 µM (Ki at EAAT4 = 4.4 µM) 
(Shigeri et al., 2001; Shimamoto et al., 2000), these data suggest that a significant 
portion of the CF rEPSC is not mediated by glutamate transporters. Consistent with  29
this hypothesis, a CF synaptic current remained in EAAC1
-/- x EAAT4
-/- mice in the 
presence of 25 µM NBQX and 25 µM GYKI 52466 (see Figure II-3A). To determine 
the properties of the receptors responsible for this current, we examined CF rEPSCs in 
EAAC1
-/- x EAAT4
-/- mice, avoiding contamination of this current by glutamate 
transporters. The reversal potential of the rEPSC was 8.6 ± 2.4 mV (n = 6) (Figure 
II-5A, B), similar to that of the CF EPSC (reversal potential = 8.2 ± 1.0 mV, n = 5; p = 
0.46), suggesting that this current also is mediated by a non-selective cation channel. 
Although it is unlikely that the CF rEPSC is mediated by unblocked AMPA receptors 
given the slow dissociation rate of NBQX (Diamond and Jahr, 1997), and the 
non-competitive nature of antagonism by GYKI 52466, we tested this possibility by 
examining whether the rEPSC was sensitive to cyclothiazide, a compound that blocks 
AMPA receptor desensitization. As shown in Figure II-5C, cyclothiazide (CTZ, 200 
µM) had no effect on the amplitude or decay time of the CF rEPSC, although it 
caused a dramatic slowing of the CF EPSC (Figure II-5D). The CF rEPSC was 
insensitive to NMDA receptor antagonists (RS-CPP, 10 µM; MK-801, 50 µM; and 
7-Cl-kynurenate, 20 µM; recordings made in 0 Mg
2+ ACSF) (5.9 ± 1.1 % inhibition, n 
= 3), consistent with the conclusion that PCs do not express functional NMDA 
receptors at this age (Hausser and Roth, 1997). The insensitivity to NMDA receptor 
antagonists also indicates that the CF rEPSC is not mediated by an aspartate receptor 
(Yuzaki et al., 1996). However, the CF rEPSC was largely blocked by 100 µM NBQX 
(83.0 ± 2.7 % inhibition, n = 4) (Figure II-5E, F), suggesting that this current is 
mediated by a glutamate receptor, rather than a receptor for another neurotransmitter.  30
This conclusion is supported by the observation that TBOA slowed the decay of the 
CF rEPSCs in EAAC1
-/- x EAAT4
-/- mice (decay tau: control, 8.1 ± 0.8 ms; TBOA, 
11.1 ± 1.6 ms, n = 7, p < 0.05) (see Figure II-4B), which suggests that the ligand for 
these receptors is a substrate for glutamate transporters. 
The sensitivity of the CF rEPSC to a higher concentration of NBQX suggested 
that the receptors underlying this current might have been partially blocked in 25 µM 
NBQX. To determine the actual size of this glutamate receptor current we measured 
the amplitude of the CF EPSC in GYKI 53655 (100 µM), a selective, non-competitive 
AMPA receptor antagonist (Paternain et al., 1995). As shown in Figure II-6A, GYKI 
53655 inhibited the CF EPSC by 94.5 ± 0.1 % (n = 2) in cerebellar slices from 
wild-type mice, and by 94.8 ± 0.8 % (n = 4) in cerebellar slices from rats. The CF 
EPSC recorded in the presence of 100 µM GYKI was not contaminated by unblocked 
AMPA receptors, as CTZ did not affect the amplitude or time course of these residual 
responses (Figure II-6B). Although this non-AMPA EPSC was only a small fraction of 
the total CF EPSC, at –65 mV this current was –281.2 ± 18.5 pA (n = 3) in wild-type 
mice and  –409.4 ± 63.6 pA (n = 7) in rats.   
 
Low occupancy of non-AMPA receptors at CF synapses 
CF EPSCs exhibit paired-pulse depression when two stimuli are applied at short 
intervals, due to the high release probability of CF terminals (Silver et al., 1998; 
Wadiche and Jahr, 2001). A striking difference in PPR was observed between CF 
EPSCs recorded under control conditions, and responses recorded in 25 µM NBQX or  31
100 µM GYKI 53655. As shown in Figure II-7A, the PPR of the CF EPSC was 0.73 ± 
0.01 (n = 6), while it was 0.33 ± 0.03 (n = 6, p < 0.001) for the non-AMPA CF EPSC 
recorded in 100 µM GYKI 53655. As expected, the PPR of the non-AMPA EPSC was 
not significantly different from the PPR of the CF rEPSC recorded from EAAC1
-/- x 
EAAT4
-/- mice (0.34 ± 0.02, n = 6, p = 0.325) (Figure II-7A). These differences in PPR 
cannot be explained by voltage clamp errors arising from the differences in the size of 
the AMPA and non-AMPA currents, because the PPR of the CF EPSC was unchanged 
when the amplitude of the CF EPSC was reduced by 48.1 ± 1.0 % by holding cells 
slightly more positive (PPR @ –10 mV = 0.77 ± 0.01; PPR @ –2 mV = 0.77 ± 0.01, n 
= 3, p = 0.777). Recent results indicate that individual CF synapses may release 
multiple vesicles in response to a single stimulus, causing saturation of AMPA 
receptors (Wadiche and Jahr, 2001). This saturation of PC AMPA receptors leads to an 
underestimate of CF depression in paired-pulse protocols, because AMPA receptors 
are not able to provide an accurate measure of the first glutamate transient (Harrison 
and Jahr, 2003). Therefore, the greater depression of the non-AMPA EPSC suggested 
that these receptors might have a lower occupancy than AMPA receptors following 
release at CF synapses. To test this possibility, we examined the sensitivity of CF 
AMPA and CF non-AMPA responses (recorded in 100 µM GYKI 53655) to a 
reduction in release probability. As shown in Figure II-7B, partial block of presynaptic 
voltage-dependent Ca
2+ channels with 5 µM Cd
2+ (CdCl2), caused a 28.3 ± 2.7 % (n = 
5) reduction in peak amplitude of the non-AMPA EPSC, but only a 3.5 ± 0.9 % (n = 4, 
p < 0.001) decrease in the CF EPSC. This differential effect of Cd
2+ on the two  32
components of the CF EPSC is not likely to have resulted from a preferential 
inhibition of the non-AMPA receptors themselves, because the non-AMPA current 
exhibited a linear I-V (see Figure II-5A) characteristic of receptors that are Ca
2+ 
impermeable. These results indicate that the non-AMPA receptors experience lower 
occupancy following release at CF synapses. 
 
Slow time course of non-AMPA EPSCs at CF synapses 
The rise time of the non-AMPA response (recorded in 100 µM GYKI 53655) was 
significantly slower than the CF EPSC (rise time: AMPA, 0.8 ± 0.04 ms; non-AMPA, 
1.7 ± 0.1, n = 8, p < 0.001); however, the non-AMPA response decayed more rapidly 
than the AMPA current (half decay time: AMPA, 8.7 ± 0.6 ms; non-AMPA, 5.9 ± 0.3, 
n = 8, p < 0.001) (Figure II-8A). The decay of the CF AMPA current may be 
prolonged due to saturation of AMPA receptors and slow clearance of glutamate 
(Barbour et al., 1994), which allows repeated binding to receptors and perhaps 
spillover onto nearby receptor clusters (Wadiche and Jahr, 2001). To address whether 
the slower decay of the CF AMPA response is a consequence of AMPA receptor 
saturation, we examined the decay of these two components when release probability 
at CF terminals is closer to that exhibited by most CNS glutamatergic terminals. 
Because the AMPA response in 5 µM Cd
2+ was still close to saturation (see Figure 
II-7B), we raised the Cd
2+ concentration to 12 µM. This reduced the peak amplitude 
of the AMPA response by 20.4 ± 1.8 % (n = 3) and the decay time to 4.7 ± 0.4 ms 
(half decay) (decay tau: 5.4 ± 0.4 ms, n = 3, p < 0.01) (Figure II-8B), similar to results  33
shown by Wadiche and Jahr (2001). In contrast, application of 5 µM Cd
2+ did not alter 
the decay of the non-AMPA response (decay tau: control, 10.1 ± 0.4 ms; + Cd
2+, 9.6 ± 
0.5 ms, n = 8, p = 0.101) (Figure II-8C). In Figure II-8D, the non-AMPA recorded in 
100 µM GYKI 53655 is scaled to the peak amplitude of the AMPA response recorded 
under lowered release conditions (12µM Cd
2+), illustrating the significantly slower 
rise and decay of the non-AMPA response (p < 0.001). 
 
Kainate receptors are responsible for the non-AMPA EPSC 
Fast excitatory transmission is mediated by three classes of ionotropic glutamate 
receptors, AMPA, NMDA and kainate receptors. At synapses where both AMPA and 
kainate receptors are expressed, kainate receptor-mediated currents exhibit a smaller 
amplitude and slower kinetics (Lerma, 2003), similar to the non-AMPA receptor 
currents recorded at CF synapses. To determine whether kainate receptors are 
responsible for the non-AMPA CF EPSC, we measured the inhibition of this response 
by LY 382884, an antagonist that exhibits a ~ 100-fold greater selectivity for kainate 
receptors over AMPA receptors (Bortolotto et al., 1999; Lerma et al., 2001). As shown 
in Figure II-9A, CF non-AMPA responses (recorded in 100 µM GYKI 53655) were 
inhibited by 78.0 ± 0.2 % (n = 4) by 10 µM LY 382884, a concentration that does not 
inhibit AMPA receptors (Bortolotto et al., 1999), and by 88.5 ± 1.4 % (n = 4) by 50 
µM LY 382884. The PPR was unchanged in the presence of LY 382884 (PPRcontrol: 
0.31 ± 0.01; PPRLY: 0.32 ± 0.01, n = 5, p = 0.150), indicating that this inhibition did 
not result from presynaptic actions of this compound. These results suggest that the  34
non-AMPA CF response is mediated by kainate receptors. 
PCs express both GluR5 and KA1 kainate receptors (Wisden and Seeburg, 
1993), and LY 382884 has a higher affinity for GluR5-containing receptors 
(Bortolotto et al., 1999). To address the possible contribution of GluR5 to the CF 
EPSC, we recorded CF responses from PCs in slices prepared from GluR5
-/- mice 
(Contractor et al., 2000). If GluR5-containing kainate receptors contribute to the 
non-AMPA response, GYKI 53655 should inhibit a greater fraction of the CF EPSC 
in animals lacking this subunit. As shown in Figure II-9B, application of 100 µM 
GYKI 53655 inhibited CF EPSCs by 98.3 ± 0.3 % (n = 4) in GluR5
-/- mice compared 
to 96.1 ± 0.5 % (n = 4, p < 0.01) in wild-type littermates, and the amplitude of the 
residual current was dramatically reduced in GluR5
-/- mice (peak current in GYKI @ 
−65 mV: GluR5
-/-, −74.8 ± 15.6 pA, n = 4; wild-type, −263.0 ± 68.7 pA, n = 4, p < 
0.05). These data indicate that the CF EPSC is generated by two distinct glutamate 
receptors, AMPA receptors and kainate receptors, and that GluR5 containing kainate 
receptors are responsible for the majority of the non-AMPA EPSC at CF synapses.   
 
Discussion 
In this study we analyzed CF synaptic currents from mice deficient in EAAC1 and/or 
EAAT4 and found that both stoichiometric and anion transporter currents were absent 
in mice lacking EAAT4, but not EAAC1, suggesting that EAAT4 has a specialized 
role in clearing glutamate released at CF synapses. The inability to detect synaptic 
currents mediated by EAAC1 suggests that this transporter is present at a much lower  35
density than EAAT4 near CF synapses. These data are in accordance with the 
hypothesis that EAAC1 is primarily a metabolic transporter (Rothstein et al., 1996; 
Sepkuty et al., 2002), rather than one involved in clearing synaptic glutamate. 
However, because EAAT4 is largely restricted to PCs in the mature brain, EAAC1 
may perform a similar role at some excitatory synapses (Diamond, 2001; He et al., 
2000), perhaps at synapses that are partially ensheathed by glia (Ventura and Harris, 
1999).  
CF synaptic currents recorded in the presence of 25 µM NBQX were believed 
to reflect the activity of glutamate transporters exclusively, with the amount of charge 
transferred during these responses proportional to the amount of glutamate taken up 
into PCs. Estimates based on transporter-associated anion currents suggested that at 
least 22% of the glutamate released at CF synapses is taken up by PCs (Otis et al., 
1997), while measurements based on stoichiometric transporter currents suggested 
that the majority of this glutamate (56 – 230 %) is removed by PCs (Auger and 
Attwell, 2000). The latter estimate is surprising given the tight ensheathment of PC 
synapses by Bergmann glial cells (Spacek, 1985), and the higher density of 
transporters in these membranes (Lehre et al., 1995). However, the putative 
transporter current recorded in 25 µM NBQX was only partially inhibited by a 
saturating dose of TBOA, and a residual synaptic current (rEPSC) was observed in 
EAAC1
-/- x EAAT4
-/- mice in the presence of 25 µM NBQX, indicating that the 
currents recorded previously were not mediated entirely by transporters. These results 
indicate that the amount of glutamate removed by PCs has been overestimated.  36
Unfortunately, merely subtracting the rEPSC in TBOA from control will not provide 
an accurate measure of the charge transferred by glutamate transporters, because 
TBOA altered the activation of the receptors underlying the rEPSC (see Figure II-4). 
If the transporter kinetics are similar to the rEPSC, our results indicate that glutamate 
transporters transfer 43% less charge than previously estimated (Auger and Attwell, 
2000). Because transporters contribute proportionally more to the rEPSC when 
permeant anions are present in the internal solution (see Figure II-2), the error is less 
(25%) for estimates based on rEPSCs recorded with NO3
- as the primary internal 
anion (Otis et al., 1997). However, both estimates are based on the assumption that 
each CF synapse releases only a single vesicle upon stimulation, while recent results 
indicate that multivesicular release predominates at CF synapses (Wadiche and Jahr, 
2001). Assuming that CFs release on average three vesicles per site, then less than 
10% of the glutamate released by the CF is removed by EAAT4; the majority is 
presumably cleared by diffusion and uptake into Bergmann glial cells (Bergles et al., 
1997). Although glutamate transporters are generally more abundant in glial 
membranes (total transporter density: 5,400 µm
2) (Lehre et al., 1995), EAAT4 is 
enriched in the region of the spine membrane just outside the synapse (estimated 
density: 3,600 µm
2)
 (Dehnes et al., 1998) and has a 10-fold higher affinity than glial 
transporters (Fairman et al., 1995), suggesting that it should out compete other 
transporters. These data raise the possibility that this peridendritic region is exposed 
to a smaller fraction of the glutamate released, perhaps due to a preferential diffusion 
of glutamate towards the presynaptic side (Lehre and Rusakov, 2002; Spacek, 1980).  37
Kainate receptors contribute to the excitation of PCs 
A CF synaptic current remained in EAAC1
-/- x EAAT4
-/- mice in the presence of 25 
µM NBQX, that reversed at the same potential as the CF EPSC and was not blocked 
by TBOA, indicating that it was not mediated by glutamate transporters. Given the 
large amount of glutamate released at CF synapses (Wadiche and Jahr, 2001) and the 
slow clearance of this glutamate away from PC AMPA receptors (Barbour et al., 
1994), there is concern that a competitive antagonist such as NBQX could be 
displaced. However, neither the amplitude nor the decay time of rEPSCs were 
affected by CTZ (200 µM), as would be expected if this current was mediated by 
unblocked AMPA receptors (Rammes et al., 1998). This residual current was, however, 
largely blocked by a higher dose of NBQX (100 µM), suggesting that it is mediated 
by non-NMDA glutamate receptors. By measuring the size of the CF EPSC remaining 
in the non-competitive AMPA receptor antagonist GYKI 53655 (100 µM) we 
determined that these receptors mediate ~ 5% of the CF EPSC; although a minor 
component, this current was ~ –250 pA (mice) to –400 pA (rats) at the resting 
potential (– 65 mV). 
Glutamate receptor currents that are insensitive to GYKI 53655 and blocked 
by NBQX are thought to be mediated by kainate receptors (Lerma, 2003). Both 
GluR5 and KA1 kainate receptor subunits are expressed by PCs (Wisden and Seeburg, 
1993), and the selective kainate receptor agonist domoate elicits currents in PCs (in 
GYKI 53655) (Brickley et al., 1999), indicating that functional kainate receptors are 
formed. A previous study (Brickley et al., 1999) reported that CF EPSCs in PCs from  38
wild-type mice were completely blocked by 100 µM GYKI 53655, concluding that 
kainate receptors were restricted to extrasynaptic sites. However, we show here that 
the portion of the CF EPSC that was insensitive to GYKI 53655 was inhibited by the 
kainate receptor antagonist LY 382884, at a concentration that does not affect AMPA 
receptors (Bortolotto et al., 1999), and the size of the current remaining in GYKI 
53655 was dramatically reduced in GluR5
-/- mice. These data suggest that 
GluR5-containing kainate receptors are responsible for the majority of the 
GYKI-insensitive CF response. The cause of the discrepancy between our data and 
that of Brickey et al. (1999) are not known, but small currents at the CF-PC synapses 
can be obscured by stimulation artifacts (Auger and Attwell, 2000).   
At synapses that express both AMPA and kainate receptors, kainate receptor 
synaptic currents are typically about 10% as large as those mediated by AMPA 
receptors and exhibit slower rise and decay kinetics (Lerma, 2003). Consistent with 
these observations, the CF kainate receptor EPSC was much smaller than the AMPA 
receptor current and had a much slower rise and decay time (under reduced release 
conditions) (see Figure II-8). The decay time of these currents was ~ 10 ms (decay 
tau), remarkably similar to the decay of kainate receptor synaptic currents recorded 
from hippocampal interneurons (Cossart et al., 2002) and for heterologously 
expressed kainate receptors (Swanson and Heinemann, 1998). Perhaps related to their 
slower kinetics, kainate receptors appear to be further from saturation than AMPA 
receptors (Bureau et al., 2000; Kidd and Isaac, 2001). CF EPSCs recorded in GYKI 
53655 (or NBQX) exhibited a much smaller PPR than CF EPSCs recorded under  39
control conditions, and were more sensitive to a reduction in release probability (see 
Figure II-7B). These results suggest that despite the large amount of glutamate 
released from CFs, PC kainate receptors experience a lower occupancy than AMPA 
receptors. The small effect of transporter inhibition on CF rEPSCs suggests that this 
may result from their lower affinity rather than a location remote from release sites 
(Bureau et al., 2000; Kidd and Isaac, 2001).   
Although much smaller in amplitude than AMPA receptor currents, the slower 
time course of kainate receptor responses allows greater temporal summation of 
synaptic inputs at some synapses (Frerking and Ohliger-Frerking, 2002). It is unlikely 
that kainate receptors perform a similar function at CF synapses, because under 
physiological release conditions the decay of the kainate receptor current was faster 
than the AMPA receptor current. The small amplitude of the kainate response 
suggests that these receptors also are not essential for complex spike generation. 
While the functional significance of these PC kainate receptors remains to be 
determined, recent results suggest that kainate receptors also may function as 
metabotropic receptors (Rozas et al., 2003), raising the possibility that these receptors 
may regulate the efficacy of other inputs onto PCs. 
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Figure II-1. Generation of mice deficient in neuronal glutamate transporters. A, 
Western blot of cerebellar tissue from wild-type and transporter knockout mice, using 
anti-EAAC1 and anti-EAAT4 antibodies. EAAC1 protein was not detected in tissue 
from EAAC1
-/- and EAAC1
-/- x EAAT4
-/- mice, and EAAT4 protein was not detected in 
EAAT4
-/- and EAAC1
-/- x EAAT4
-/- mice. Immunoblotting with anti-actin antibodies 
demonstrate that a comparable amount of protein was loaded into each lane. B, 
Immunostaining of cerebellar slices from wild-type and transporter knockout mice. 
EAAT4 and EAAC1 immunoreactivity was absent in EAAC1
-/- x EAAT4
-/- mice. 
Immunostaining with anti-calbindin antibodies shows that the morphology of Purkinje 
cells was normal in EAAC1
-/- x EAAT4
-/- mice. Scale bar = 50 µm.  41
Figure II- 1 
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Figure II-2. Glutamate transporter activation at CF-PC synapses. A, A CF EPSC 
recorded in a PC from a wild-type mouse (P16). The CF response exhibited a sharp 
stimulation threshold of 10 µA and all-or-none behavior. The holding potential was 
–10 mV and the internal solution was CsMeS. B, The CF EPSC recorded from the cell 
in A after application of 25 µM NBQX, 25 µM GYKI 52466, 10 µM RS-CPP, 5 µM 
SR-95531, and 20 µM bicuculline to block AMPA, NMDA and GABAA receptors. 
This residual current was clearly separated from the stimulus artifact and exhibited the 
same threshold as the CF EPSC. This response was inhibited by TBOA (200 µM) 
(dark trace). The holding potential was –65 mV. C, A CF EPSC recorded with a 
CsNO3 internal solution in the same antagonists as B. This CF response was larger, 
had slower kinetics, and was inhibited to a greater extent by TBOA (dark trace). The 
holding potential was –65 mV. 
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Figure II-3. Glutamate transporter currents are absent in mice lacking EAAT4. 
A, CF synaptic currents recorded from mice lacking EAAC1, EAAT4 or both EAAC1 
and EAAT4 glutamate transporters. Recordings were made with either MeS (left 
traces) or NO3
- (right traces) as the primary internal anion. The dark traces show the 
response after application of 200 µM TBOA. B, Summary of the decay tau of CF 
synaptic currents from wild-type and transporter knockout mice recorded with either 
MeS (open bars) or NO3
- (closed bars) as the primary internal anion. CF synaptic 
currents from mice lacking EAAT4 did not exhibit anion-induced slowing, while CF 
synaptic currents from mice lacking EAAC1 were indistinguishable from wild-type. 
The numbers in parentheses indicate the number of experiments performed. 
Comparisons refer to recordings made with NO3
-. C, Summary of the % inhibition of 
CF synaptic currents by 200 µM TBOA. TBOA inhibition was reduced in mice 
lacking EAAT4, but unaffected in mice lacking EAAC1. * refers to MeS groups, and 
*** refers to NO3
- groups. All currents were recorded in the presence of 25 µM 
NBQX, 20 µM GYKI 52466, 10 µM RS-CPP, 5 µM SR-95531, and 20 µM 
bicuculline at a holding potential of –65 mV. (* = p < 0.05, *** = p < 0.001; NS = not 
significant)  
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Figure II- 3 
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Figure II-4.  Measurement of the glutamate transporter component of CF 
rEPSCs. A, CF rEPSCs recorded from an EAAC1
-/- x EAAT4
-/- mouse under control 
conditions (light traces) and in TBOA (200 µM) (dark traces). Below is the summary 
data showing that TBOA increased the PPR of these responses. (** = p < 0.01). 
Interstimulus interval = 50 ms. ▲= average. B, CF rEPSCs recorded from an 
EAAC1
-/- x EAAT4
-/- mouse under control conditions (light traces) and in the presence 
of TBOA (200 µM) and MCPG (1 mM). Below is the summary data showing that 
MCPG prevented the change in PPR produced by TBOA (NS = not significant). ▲= 
average. C, CF rEPSCs recorded from a wild-type mouse (left traces) or a rat (right 
traces) under control conditions and in the presence of TBOA (200 µM) and MCPG 
(1 mM). Below is the summary data showing the fractional contribution of 
transporters to the peak amplitude of the CF rEPSC. All currents were recorded in the 
presence of 25 µM NBQX, 25 µM GYKI 52466, 10 µM RS-CPP, 5 µM SR-95531, 
and 20 µM bicuculline at a holding potential of –65 mV. The primary internal anion 
was MeS for all recordings. 
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Figure II- 4 
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Figure II-5.  The CF rEPSC is mediated by non-AMPA ionotropic glutamate 
receptors.  A, CF rEPSCs (left traces) and CF EPSCs (right traces) recorded at 
potentials from –65 to 40 mV. B, Comparison of the current-to-voltage relationship of 
CF rEPSCs (○) and CF EPSCs (●). CF rEPSCs were recorded in 25 µM NBQX, and 
CF EPSCs were recorded in 1 µM NBQX to decrease the size of the responses in 
order to prevent voltage escape at negative potentials. C, CF rEPSCs and CF EPSCs 
D recorded under control conditions (light traces) and in the presence of 200 µM 
cyclothiazide (CTZ) (dark traces). The holding potential in C was –65 mV and –10 
mV in D. E, CF rEPSCs recorded under control conditions (light trace) and in the 
presence of 100 µM NBQX (dark trace). The holding potential was –65 mV. F, 
Summary graph showing the sensitivity of CF rEPSCs to different concentrations of 
NBQX. All synaptic responses were recorded from PCs in cerebellar slices from 
EAAC1
-/- x EAAT4
-/- mice. The primary anion in the internal solution was MeS for all 
recordings. 
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Figure II- 5 
 
 
        50
Figure II-6.  Size of the non-AMPA EPSC at CF-PC synapses.  A, CF EPSCs 
recorded from a wild-type mouse (left traces) or a rat (right traces) under control 
conditions and in the presence of 100 µM GYKI 53655. Below is the summary data 
showing the % contribution of the non-AMPA current to the CF EPSC and the 
absolute size of the non-AMPA CF synaptic current in mouse and rat. Percent 
inhibition was recorded at –10 mV and peak current was measured at –65 mV. B, CF 
EPSCs recorded in 100 µM GYKI 53655 with and without 200 µM CTZ. Below is 
the summary data showing the effect of CTZ on the decay tau of CF EPSCs recorded 
in 100 µM GYKI 53655. All recordings were made from PCs in cerebellar slices from 
rat. NS = not significant. 
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Figure II- 6 
 
 
 
 
     52
Figure II-7. Non-AMPA receptors have lower occupancy than AMPA receptors at 
CF-PC synapses. A, Paired-pulse responses of CF EPSCs recorded under control 
conditions (left traces), in the presence of 100 µM GYKI 53655 (middle traces), or 25 
µM NBQX (right traces). Interstimulus interval = 50 ms. Below is the summary data 
showing that the non-AMPA CF EPSC exhibited a smaller PPR. CF EPSCs in control 
were recorded at –10 mV, while CF EPSCs in antagonists were recorded at –65 mV. B, 
CF EPSCs (left traces) and CF EPSCs in 100 µM GYKI 53655 (right traces), 
recorded in the presence or absence of 5 µM Cd
2+. Below is the summary data 
showing that the non-AMPA CF EPSC was more sensitive to extracellular Cd
2+. (*** 
= p < 0.001; NS = not significant). 
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Figure II- 7 
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Figure II-8.  The non-AMPA CF synaptic current has a slow time course.  A, 
Overlay of a CF EPSC recorded in 100 µM GYKI 53655 (dark trace) scaled to the 
peak of the CF ESPC recorded under control conditions (light trace), illustrating the 
slower rise time of the non-AMPA current. Inset shows the two responses at a faster 
time scale. Holding potential = –10 mV. B, CF EPSCs recorded under control 
conditions and in the presence of 12 µM Cd
2+. Red trace is the response in Cd
2+ 
scaled to the control response, showing the faster decay of the CF EPSC when release 
probability is reduced. C, CF EPSCs recorded in the presence of 100 µM GYKI 
53655 ± 5 µM Cd
2. Red trace is the response in Cd
2+ scaled to the control response, 
showing that the reduction in release probability did not alter the decay of the 
non-AMPA EPSC. D, Overlay of a CF EPSC recorded in 12 µM Cd
2+ (light trace) 
and in 100 µM GYKI 53655 (dark trace). The response in GYKI has been scaled to 
the peak of the CF response in 12 µM Cd
2+. Holding potential = –10 mV for the CF 
EPSC, and –65 mV for the response in GYKI. 
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Figure II- 8 
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Figure II-9. Kainate receptors are responsible for the non-AMPA CF EPSC. A, 
CF EPSCs recorded in the presence of 100 µM GYKI 53655 were inhibited by the 
kainate receptor antagonist LY 382884. Holding potential = −65 mV. Graph below 
plots the sensitivity of this non-AMPA EPSC to LY 382884. B, CF EPSCs recorded 
from wild-type littermates (left traces) and GluR5
-/- mice (right traces), under control 
conditions and in the presence of 100 µM GYKI 53655. Holding potential = −10 mV. 
The graph below shows the percent contribution of teh non-AMPA current to the CF 
EPSC and the peak amplitude of the current remaining in GYKI 53655 in these two 
groups of animals (recorded at –65 mV).   
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Figure II- 9 
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Chapter III 
Astrocyte glutamate transporters regulate metabotropic glutamate 
receptor-mediated excitation of hippocampal interneurons 
 
Introduction 
The studies described in Chapter II indicate that astroglial transporters are 
responsible for removing the majority of glutamate at cerebellar climbing fiber- 
Purkinje cell (CF-PC) synapses; the neuronal transporter EAAT4 contributes to ~10% 
of total clearance; and EAAC1 contributes a negligible amount. This devision of labor 
between different transporters presumably reflects a collection of features at CF-PC 
synapses including the structure of the synapses, the amount of glutamate released, 
and the types and distribution of glutamate transporters. The CF-PC synapse is unique 
in that (1) EAAT4 transporters are abundant in PCs at the perisynaptic regions 
(Dehnes et al., 1998; Tanaka et al., 1997), but they are not expressed by other cell 
types of the CNS; (2) CF-PC synapses also exhibit a high release probability (~ 2−3 
vesicles per synapse, see Wadiche and Jahr, 2001), which is unusually high compared 
to most other excitatory synapses in the CNS (for review, see Thomson, 2000); and 
(3), CF-PC synapses are among the most tightly ensheathed synapses in the CNS 
(Palay and Chan-Palay, 1974; Spacek, 1985). Recent studies indicate that 94% of 
CF-PC synapses are ensheathed by glial cell membranes (Xu-Friedman et al., 2001), 
whereas only 58% of spine synapses are associated with astroglial membranes in the 
hippocampus (Ventura and Harris, 1999); this percentile is comparable to that of  59
cortical spine synapses as well (Spacek, 1985). The close association of glial cell 
membranes with CF-PC synapses also brings high concentrations of glial glutamate 
transporters close to release sites. In summary, although CF-PC synapses provide an 
unparalleled opportunity to quantitatively measure proportional uptake by neuronal 
and glial glutamate transporters, the unique properties of these synapses raise the 
concern that mechanisms of glutamate clearance found here may not be applicable to 
other more conventional CNS synapses. 
Compared to CF-PC synapses, excitatory synapses in the hippocampal are a 
better representative for studying glutamate clearance at typical CNS synapses. The 
reasons are the following: (1) hippocampal neurons express EAAC1 but not EAAT4 
transporters, a character shared by most CNS synapses; (2) hippocampal synapses 
exhibit average probability of release; and (3) synapses in the hippocampus are 
partially ensheathed by astroglial processes, which is another feature shared by most 
CNS synapses. Therefore, excitatory synapses in the hippocampus are distintly 
different from CF-PC synapses, raising the question whether neuronal transporters   
contribute more to synaptic clearance of glutamate when glial transporters are 
positioned further away from release sites. To study these synapses, however, we and 
others have not been able to directly measure uptake by neuronal transporters during 
transmission through isolating synaptic transporter currents from postsynaptic neurons. 
This is presumably because the amount of synaptically released glutamate is much 
less than that following a single CF activation, and there are presumably fewer 
neuronal transporters on the postsynaptic membrane to be activated.  60
To study glutamate clearance at hippocampal synapses an alternative approach 
is to examine clearance indirectly by monitoring the occupancy of glutamate receptors 
during transmission. One potential candidate receptors are the metabotropic glutamate 
receptors (mGluRs), because they are typically located at perisynaptic regions where 
glutamate transporters are enriched (Baude et al., 1993; Lujan et al., 1996; Tamaru et 
al., 2001), and the affinity of mGluRs for glutamate binding is comparable to that of 
glutamate transporters (see Introduction), making them sufficiently sensitive to the 
ambient glutamate level controlled by transporters. A subtype of mGluRs, mGluR1α, 
has been shown in cerebellar Purkinje neurons to be located perisynaptically (Baude 
et al., 1993); and its activation is regulated by postsynaptic transporter activity during 
parallel fiber-Purkinje neuron transmission (Brasnjo and Otis, 2001; Wadiche and Jahr, 
2005). 
Hippocampal oriens-lacunosum moleculare (O-LM) interneurons (or oriens 
alveus, OA-interneurons) in the CA1 region selectively express high levels of 
mGluR1α (Baude et al., 1993), the same mGluR1 splice variant that is expressed by 
cerebellar Purkinje neurons. Activation of mGluR1α in Purkinje neurons leads to 
opening of a non-selective cation channel and the associated current can be used to 
monitor the extent of mGluR1α activation (Batchelor et al., 1994; Kim et al., 2003). 
Electronmicroscopy studies have further revealed that in O-LM interneurons, synaptic 
mGluR1α receptors are predominantly located at perisynaptic regions (Baude et al., 
1993; Lujan et al., 1996). In addition, activation of mGluRs by an exogenous agonist 
elicits an inward current in these neurons (McBain et al., 1994), suggesting that  61
mGluR1α is similarly coupled to activation of a non-selective cation channel in 
O-LM interneurons. Nonetheless, unlike in Purkinje neurons, synaptically evoked 
mGluR currents have not been observed in O-LM interneurons (Gee et al., 2001). 
Therefore, we aimed to isolate synaptic mGluR currents in O-LM interneurons to 
examine the differential contributions of transporters to the clearance of glutamate at 
hippocampal synapses, and the potential impact of glutamate transporters on 
mGluR-mediated synaptic transmission.   
Here we show that mGluR1α-mediated synaptic currents could be evoked in 
O-LM interneurons if intracellular Ca
2+ was elevated in these cells prior to stimulation. 
These synaptic mGluR currents were greatly potentiated by pharmacological 
inhibition of glutamate transporters, and recordings from mice deficient in glutamate 
transporters revealed that GLAST and GLT-1, but not EAAC1, were primarily 
responsible for shielding these perisynaptic receptors. Furthermore, inhibition of these 
transporters potentiated di-synaptic inhibition of CA1 pyramidal cells, indicating that 
astroglial glutamate transporters may regulate hippocampal network excitability by 
regulating mGluR occupancy at interneuron synapses. 
 
Materials and Methods 
Glutamate transporter deficient mice. The generation of EAAC1
-/- mice and 
GLAST
-/- mice have been described previously (Peghini et al., 1997; Watase et al., 
1998). All comparisons between specific transporter knockout mice and wild-type 
mice were performed between littermates obtained from heterozygous matings. The  62
genotype of all experimental animals was determined by PCR.   
Slice preparation. Postnatal day 18 to 20 (P18-20) rats and P15-20 mice were deeply 
anesthetized by halothane and killed by decapitation, in accordance with protocols 
approved by the Johns Hopkins University Animal Care and Use Committee. 
Hippocampi were removed and cut into 400 µm slices using a vibratome (Leica, 
VT1000S) in ice-cold saline solution containing (in mM): 110 choline chloride, 2.5 
KCl, 7 MgSO4, 0.5 CaCl2, 1.25 NaH2PO4, 25 NaHCO3, 25 glucose, 11.6 Na-ascorbate, 
and 3.1 Na-pyruvate, saturated with 95% O2, 5% CO2. Slices were then incubated at 
37° C for 30 minutes in artificial cerebrospinal fluid (ACSF) composed of (in mM): 
119 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 1 NaH2PO4, 26.2 NaHCO3, and 11 glucose, 
saturated with 95% O2, 5% CO2, and then allowed to recover for at least 30 minutes at 
room temperature before experimentation.   
Electrophysiological recordings. During experimentation, slices were superfused 
with ACSF that was heated to 33-35° C by passing the solution through a feedback 
controlled in-line heater (Warner Instruments, Hamden, CT) prior to entering the 
chamber. O-LM interneurons were visualized in stratum oriens using infrared-DIC 
imaging with a 40x water immersion objective on an upright microscope (Axioskop 
FS2, Zeiss) equipped with a CCD camera (Sony XC-73). Whole-cell recordings were 
made under visual control with an internal solution consisting of (in mM): 105 
CsCH3O3S, 20 TEA-Cl, 20 HEPES, 10 EGTA (or 10 BAPTA), 2 Mg-ATP, 0.2 
Na-GTP, 1 QX-314, pH 7.3. Excitatory afferents were stimulated using a glass pipette 
filled with ACSF. Stimuli (20−35 µA) were generated using a constant current  63
isolated stimulator (Digitimer DS3), and a programmable pulse generator (Master-8, 
A.M.P. Instruments) was used to trigger a train of pulses (10 pulses @ 100 Hz; 200 µs 
duration for each pulse). Synaptic currents were recorded with a MultiClamp 700A 
amplifier (Axon instruments), filtered at 3 kHz, amplified 5x or 10x (Brownlee 440; 
Brownlee Precision), and then digitized at 10 kHz (Digidata 1322A, Axon 
instruments). Data were analyzed off-line using pClamp 9 (Axon Instruments) and 
Origin (OriginLab) software. The action potentials for waveform analysis were 
elicited by injecting just enough current to induce spontaneous firing. Action potential 
properties were determined as previously described (Zhang and McBain, 1995). The 
charge transfer associated with IPSCs recorded from CA1 pyramidal neurons was 
determined by integrating the charge over a window of 4000 ms, starting 220 ms after 
the last stimulus artifact. Statistical significance was determined using the student’s 
t-test (paired or unpaired, depending on the experiment), and mean values are 
expressed ± standard error of the mean (S.E.M.).   
Photolysis experiments were performed on an upright microscope (Axioskop 
FS2) to which the output of an Argon ion laser (Stabilite 2017S, Spectra-Physics) was 
coupled using a multi-mode quartz fiber optic cable (Oz Optics Ltd.) and a high-speed 
shutter (NM Laser) using the fluorescence light path. The laser output was tuned to 
333.6 – 363.8 nm and had an average output of ~230 mW before entering the fiber. 
The UV beam was focused to a ~50 µm spot on the preparation using a 40x water 
immersion objective (Olympus). This spot was centered on the soma of the recorded 
cell using a second targeting laser (632 nm) and photolysis was induced by opening  64
the shutter for 1 ms. The caged compound, 4-methoxy-7-nitroindolinyl-L-glutamate 
(MNI-L-glutamate, 125 µM; Tocris) was dissolved in a HEPES-buffered solution 
composed of (in mM): 137 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 20 HEPES, pH 7.3. 
Any antagonists included in the bath solution were also included in solutions 
containing caged compound. Solutions containing MNI-L-glutamate were superfused 
locally onto the slice through a wide-bore pipette placed near the recording area. 
Whole cell currents were recorded with an Axopatch 200B amplifier (Axon 
Instruments), filtered at 2 kHz and digitized at 20 kHz. 
Morphological reconstruction and immunocytochemistry. O-LM interneurons 
were filled with neurobiotin (0.2% weight/volume in intracellular solution; Vector 
Laboratories, Burlingame, CA) for 30 minutes during recordings and then incubated 
in oxygenated ACSF for 5-9 hours in ACSF after removal of the recording electrode. 
Slices were then fixed over night in 4% formaldehyde, 0.2% picric acid in phosphate 
buffered saline at 4° C, and resectioned @ 80 µm on a vibratome (Leica VT1000S). 
These sections were processed using avidin-HRP reaction (Elite ABC, Vector 
Laboratories, Burlingame, CA), developed using 3-3’-diaminobenzidine (DAB, 
Peroxidase Substrate Kit, Vector Laboratories), and intensified using DAB enhancing 
solution (Vector Laboratories). Morphological reconstruction was made with the aid 
of an upright Zeiss microscope and drawing tube. 
  65
Results 
Isolation of an mGluR1α-mediated synaptic current in O-LM interneurons 
To determine if glutamate transporters are essential for clearing glutamate away from 
mGluRs at excitatory synapses on hippocampal interneurons, we recorded from 
O-LM interneurons (sometimes referred to as O-A interneurons) in the oriens/alveus 
region of area CA1. mGluR1α is highly expressed by O-LM interneurons (Baude et 
al., 1993), and application of RS-1-aminocyclopentane-trans-1,3-dicarboxylic acid 
(trans-ACPD), a Group I/II mGluR agonist, elicits an inward current in these cells 
(McBain et al., 1994). 
The ability of mGluRs to induce opening of cation channels in these neurons 
provides a means to monitor mGluR activity using electrophysiological techniques. 
Putative O-LM interneurons had large, oval-shaped cell bodies with two prominent 
dendrites extending parallel to the pyramidal cell layer. Injection of depolarizing 
current induced a train of action potentials in these neurons that did not exhibit spike 
frequency adaptation, and each action potential during the train was followed by a 
large spike after-hyperpolarization (Figure III-1A,  inset). Spontaneous action 
potentials recorded from these interneurons were 73.5 ± 3.2 mV in amplitude and 1.3 
± 0.1 ms in duration (n = 6). These electrophysiological properties are in accordance 
with those reported for O-LM interneurons (Zhang and McBain, 1995). 
Reconstruction of neurobiotin-filled interneurons revealed that they had dendrites that 
extended parallel to the pyramidal cell layer and axons that projected through the 
pyramidal cell layer and ramified extensively in stratum lacunosum-moleculare (n =  66
9/9 cells), morphological features unique to O-LM interneurons (Freund and Buzsáki, 
1996).  
Although application of trans-ACPD elicits an inward current in O-LM 
interneurons (Gee et al., 2001; McBain et al., 1994), activation of an mGluR current 
in these cells following synaptic stimulation has not been previously reported. We 
found that brief, high frequency stimulation in stratum oriens (100 Hz, 10 pulses, 200 
µs, 20-35 µA per pulse) elicited a slowly developing inward current in some O-LM 
interneurons (n = 7/20 cells) (Figure III-1B), which persisted when AMPA (15 µM 
NBQX, 25 µM GYKI 52466), NMDA (10 µM RS-CPP, 50 µM MK-801, 20 µM 
7-chlorokynurenate) and GABAA receptors (5 µM SR 95531, 20 µM bicuculline) 
were blocked (n = 7/7 cells); evoked responses also were not affected by the GABAB 
antagonist CGP 55845A (data not shown). However, the low probability of observing 
this current limited our ability to examine transporter-receptor interactions. In 
cerebellar Purkinje neurons, mGluR1α–mediated currents are potentiated when the 
cytosolic concentration of Ca
2+ is increased (Batchelor and Garthwaite, 1997), 
suggesting that this manipulation might similarly increase mGluR-mediated currents 
in O-LM interneurons. As shown in Figure III-1B, when O-LM interneurons were 
briefly depolarized to 0 mV (from –65 mV) just prior to stimulation to allow Ca
2+ 
influx through voltage-gated Ca
2+ channels, the amplitude of the evoked response was 
larger (– step = –29.8 ± 6.2 pA; + step = –112.2 ± 27.7 pA, n = 11, p < 0.01), and the 
rise time was faster (20–80% rise time: – step = 957 ± 282 ms; + step = 94 ± 9 ms, n = 
3, p < 0.05), although it was only possible to measure the latter feature accurately  67
when the stimulus artifact did not obscure the onset of the response (3/11 cells). Using 
this protocol, slow synaptic currents were observed in 27/28 O-LM interneurons in 
AMPA, NMDA, and GABAA receptor antagonists (see above). This synaptic current 
was inhibited by 92.8 ± 1.1 % (n = 9) by the selective mGluR1α antagonist LY 
367385 (50 µM) (Figure III-1C), indicating that the response was dependent on 
activation of mGluR1α. This response was also blocked by SKF 96365 (50 µM) (n = 
4/4 cells), an antagonist of receptor-gated cation channels that also inhibits 
mGluR1α-mediated inward currents in Purkinje neurons (Kim et al., 2003), 
suggesting that the synaptic currents recorded from O-LM interneurons resulted from 
activation of non-selective cation channels. 
To confirm that the step depolarization facilitated the mGluR1α response by 
increasing [Ca
2+]i we examined the size of these EPSCs when a high concentration of 
BAPTA (40 mM) was included in the pipette solution to rapidly chelate free Ca
2+. As 
shown in Figure III-2A, responses recorded with this solution were significantly 
smaller than those recorded with the control solution (peak amplitude: 10 mM 
BAPTA = –121.2 ± 36.2 pA, n = 8; 40 mM BAPTA = –5.3 ± 4.5 pA, n = 5, p < 0.01), 
suggesting that elevation of [Ca
2+]i was responsible for step-induced potentiation of 
the mGluR1α EPSC. To examine the dependence of this response on the step 
parameters and to maximize the amplitude of the mGluR EPSC, we varied both the 
step duration and the delay between the end of the step and the beginning of the 
stimulus (Figure III-2B, C). The slow EPSC was close to its maximal amplitude when 
a 500 ms depolarization (from –65 to 0 mV) was applied 1 s prior to stimulation; thus,  68
this protocol was used for eliciting mGluR1 EPSCs in subsequent experiments.   
 
Inhibition of glutamate transporters enhances activation of mGluR1α 
Ultrastructural studies indicate that mGluR1α receptors in O-LM interneurons are 
predominantly localized at the periphery of the postsynaptic density of type 1 
excitatory synapses (Baude et al., 1993), in close proximity to ensheathing glial 
membranes (Spacek, 1985; Ventura and Harris, 1999). Despite the high affinity of 
mGluR1α (EC50  ≅ 10 µM) (Conn and Pin, 1997) and the amplification of 
mGluR-mediated currents by second messengers, the amplitude of mGluR1 EPSCs 
were small compared to responses evoked by exogenous mGluR1 agonists (McBain 
et al., 1994), suggesting that these receptors may be exposed to only a fraction of the 
glutamate that is released. To determine if glutamate transporters restrict activation of 
mGluRs on O-LM interneurons we examined whether glutamate transporter 
antagonists potentiated these synaptic currents. Application of 300 µM dihydrokainate 
(DHK), a concentration that results in selective antagonism of GLT-1 (Arriza et al., 
1994), caused a ~ 3-fold increase in the amplitude of mGluR1 EPSCs (control: –97.5 
± 31.8 pA; + DHK: –365.0 ± 100.7 pA, n = 8, p < 0.01) (Figure III-3A,B); a similar 
effect was seen on the amount of charge transferred during mGluR1 EPSCs (control: 
–7.0 ± 4.0 x 10
-11 C; + DHK: 20.7 ± 6.5 x 10
-11 C, n = 8, p < 0.001) (Figure III-3A,B). 
These results indicate that GLT-1, a transporter that is present at a high density in 
astrocyte membranes (Lehre and Danbolt, 1998), restricts activation of these 
interneuron receptors. Subsequent application of a saturating dose of  69
DL-threo-b-benzyloxyaspartic acid (TBOA, 100 µM), an antagonist that blocks all 
glutamate transporters, caused a further, more dramatic enhancement of these slow 
EPSCs (Figure III-3A,B). The current enhanced by transporter antagonists was 
mGluR1-dependent, as the peak amplitudes of the synaptic responses in TBOA were 
inhibited 94.0 ± 2.2 % (n = 7) by LY 367385 (50 µM) (charge transfer was inhibited 
by 94.0 ± 2.1 %). As shown in Figure III-3C, TBOA dramatically increased the size of 
mGluR1-mediated EPSCs elicited in response to a given stimulation intensity. Neither 
DHK nor TBOA induced an increase in holding current in the absence of stimulation 
(data not shown) (Arnth-Jensen et al., 2002), presumably because NMDA receptors 
were blocked in these experiments and the mGluR1-associated conductance depends 
on elevation of [Ca
2+]i.  
To determine the effect of transporter inhibition on interneuron excitation as a 
consequence of increased mGluR activation, we made current-clamp recordings from 
O-LM interneurons and measured their response to a similar stimulus. As shown in 
Figure III-4, stimulation in the presence of TBOA led to a dramatic depolarization and 
sustained firing of action potentials that was not visible under control conditions (n = 
5/5 cells). This effect was blocked by LY 367385 (50 µM) (n = 2/2 cells), indicating 
that this powerful excitatory response was dependent on mGluR1.   
 
Astrocyte glutamate transporters shield interneuron mGluRs. 
mGluR1 EPSCs were potentiated more by TBOA than by DHK, suggesting that 
glutamate transporters other than GLT-1 also may be involved in clearing glutamate  70
away from these receptors. Immunocytochemical localization studies indicate that 
three distinct transporters could participate in glutamate clearance at these synapses: 
GLT-1, GLAST, and EAAC1 (Lehre et al., 1995; Rothstein et al., 1994); a splice 
variant of GLT-1 (termed GLT-1b) also may be expressed, but has pharmacological 
properties similar to full-length GLT-1 (Utsunomiya-Tate et al., 1997). To determine 
the relative contribution of GLAST and EAAC1 to clearance at these synapses, we 
carried out a similar set of experiments in mice deficient in EAAC1 or GLAST, as 
selective antagonists for these transporters have not yet been developed. If a particular 
transporter is involved in clearing glutamate away from mGluRs, then the potentiation 
of mGluR1 EPSCs by DHK should be greater in mice lacking this transporter, 
because in the absence of this transporter GLT-1 would be expected to contribute 
proportionally more to uptake. As shown in Figure III-5A & C, application of DHK 
(300  µM) caused a ~ 1-2 fold potentiation of mGluR1 EPSCs in EAAC1
-/- mice, 
similar to that observed in wild-type littermates (fold increase, amplitude/charge 
transfer: EAAC1
+/+: 1.34 ± 0.47/1.78 ± 0.68, n = 5; EAAC1
-/-: 1.60 ± 0.21/0.96 ± 0.31, 
n = 6, p = 0.32/0.16). In contrast, DHK (300 µM) produced a much greater 
enhancement of mGluR1 EPSCs in GLAST
-/- mice than in wild-type littermates 
(Figure III-5B,  C) (fold increase, amplitude/charge transfer: GLAST
+/+: 1.57 ± 
0.28/1.74 ± 0.58, n = 6; GLAST
-/-: 7.25 ± 1.47/6.90 ± 1.07, n = 11, p < 0.01/0.001). 
The size of mGluR1 EPSCs were not significantly different between transporter 
knockout and wild-type littermates for EAAC1 (peak amplitude/charge transfer: 
EAAC1
+/+, –113.9 ± 18.2 pA/8.5 ± 1.8 x 10
-11 C, n = 5; EAAC1
-/-, –77.1 ± 25.9 pA/6.8  71
± 1.5 x 10
-11 C, n = 6, p = 0.28/0.48) and GLAST (peak amplitude/charge transfer: 
GLAST
+/+, –149.7 ± 44.6 pA/11.0 ± 3.3 x 10
-11 C, n = 6; GLAST
-/-, –111.9 ± 15.4 
pA/6.4 ± 0.6 x 10
-11 C, n = 8, p = 0.45/0.23). These results suggest that GLT-1 and 
GLAST, but not EAAC1, determine how much glutamate is available to activate 
mGluR1 receptors in O-LM interneurons. 
The effect of DHK was not equivalent to TBOA in GLAST
-/- mice, raising 
concerns that in the absence of GLAST another transporter (i.e. EAAC1, or another 
unidentified transporter) might also be involved in clearance. Alternatively, the 
discrepancy in potentiation by these two antagonists could be explained by 
differences in the ability of DHK and TBOA to inhibit GLT-1 (Bergles et al., 2002). 
To examine the efficacy of GLT-1 antagonism by DHK, we recorded glutamate 
transporter currents from stratum oriens astrocytes elicited through photolysis of 
caged L-glutamate (MNI-L-glutamate, 125 µM). As shown in Figure III-6, a brief (1 
ms) flash of UV light elicited an inward current in astrocytes that were exposed to 
MNI-L-glutamate. This current was not observed when MNI-L-glutamate was absent 
from the superfusing solution or when the UV beam was shuttered, and the response 
was blocked by TBOA (200 µM), indicating that this current was produced by the 
electrogenic cycling of glutamate transporters. DHK (300 µM) inhibited the peak 
amplitude of these responses by 54.3 ± 1.3 % and slowed their decay (tau decay, 
single exponential fit: control = 14.7 ± 0.8 ms; DHK = 40.9 ± 3.0 ms, n = 10, p < 
0.001), similar to effects seen on transporter currents evoked in astrocytes through 
synaptic release (Bergles and Jahr, 1997). The effects of 300 µM DHK in EAAC1
-/-  72
mice were similar to those seen in wild-type mice (% inhibition by DHK, 56.8 ± 1.8 
%, n = 4, p = 0.295) (tau decay in DHK, 53.8 ± 2.6 ms, n = 3, p < 0.05) (Figure III-6A, 
B). In contrast, DHK produced a greater inhibition of the peak amplitude (82.6 ± 0.7 
%, n = 8, p < 0.001) and a greater slowing of the decay of transporter currents in 
GLAST
-/- mice (tau decay in DHK, 125.3 ± 8.9 ms, n = 8, p <0.001) (Figure III-6A, B). 
However, this concentration of DHK (300 µM) did not completely block astrocyte 
transporter currents. Because only GLT-1 and GLAST are expressed by astrocytes, 
these results suggest that 300 µM DHK was not sufficient to block all GLT-1 activity, 
providing an explanation for the differential potentiation of mGluR EPSCs by TBOA 
and DHK in GLAST
-/- mice. Increasing the concentration of DHK to 1 mM increased 
the inhibition of the transporter current to 91.6 ± 0.5 % (n = 4, p <0.001) (Figure 
III-6A, B), and increased the potentiation of mGluR EPSCs in GLAST
-/- mice to the 
level of that observed with TBOA (Figure III-5C), although 1 mM DHK had no 
greater effect than 300 µM DHK on the amplitude or charge transfer of mGluR 
EPSCs in wild-type mice (Figure III-5C). 
 
Inhibition of glutamate transporters enhances inhibition of CA1 pyramidal 
neurons 
The axons of O-LM interneurons ramify extensively in stratum LM where the distal 
dendrites of CA1 pyramidal cells are located, and results obtained from paired 
recordings indicate that GABA released from O-LM interneurons elicits GABAA 
receptor-mediated currents in pyramidal neurons (Maccaferri et al., 2000). The ability  73
of astrocyte glutamate transporters to regulate mGluR-dependent excitation of O-LM 
interneurons (see Figure III-4) suggested that transporter inhibition might facilitate the 
release of GABA from these cells. To investigate this possibility, we recorded the 
response of CA1 pyramidal neurons to the same stratum oriens stimulation used to 
elicit mGluR responses in interneurons. These experiments were done in the presence 
of AMPA (15 µM NBQX; 25 µM GYKI 52466), NMDA (10 µM RS-CPP, 50 µM MK 
801, 20 µM 7-Chlorokynurenate) and GABAB receptor (1 µM CGP 55845) 
antagonists to isolate GABAA receptor currents, and an internal solution containing a 
high [Cl
–] to enlarge these responses. As shown in Figure III-7A, stimulation in 
stratum oriens elicited rapid inward currents in pyramidal neurons, the onset of which 
was partially obscured by the train of stimuli. In the presence of TBOA (100 µM) a 
burst of IPSCs became visible following stimulation (Figure III-7B), which reached 
its peak amplitude several hundred milliseconds after the end of the stimulus, in 
accordance with the delayed onset and slow rise of mGluR-mediated currents in 
O-LM interneurons (see Figure III-1B). Note that a depolarizing step was not applied 
to O-LM interneurons during this experiment. This burst of IPSCs increased the 
charge transfer in response to stimulation 3.69 ± 0.84-fold (n = 12, p < 0.001) (Figure 
III-7E). This increase in IPSC frequency was blocked by LY 367385 (50–100 µM) 
(0.38 ± 0.24-fold increase, n = 8, p = 0.602), indicating that it required activation of 
mGluR1. In the presence of TBOA, all evoked responses were blocked by SR 95531 
(5 µM) (n = 4/4 cells) (Figure III-7D, E), ruling out the possibility that the slow 
component was mediated by mGluRs on pyramidal cells themselves. These results  74
indicate that inhibition of astrocyte glutamate transporters facilitates the inhibition of 
CA1 pyramidal neurons by potentiating mGluR1-mediated excitation of O-LM 
interneurons. 
 
Discussion 
In this study we show that an mGluR1-dependent slow inward current can be elicited 
in hippocampal O-LM interneurons following stimulation of excitatory afferents in 
stratum oriens. This response was often revealed only when [Ca
2+]i was elevated in 
interneurons at the time of stimulation, providing an explanation for why this current 
has not been observed previously (Gee et al., 2001). A similar Ca
2+ dependence has 
been reported for postsynaptic mGluR1 activity at parallel fiber-Purkinje neuron 
synapses in the cerebellum (Batchelor and Garthwaite, 1997), suggesting that 
mGluR1 could serve as a coincidence detector to monitor presynaptic glutamate 
release and postsynaptic Ca
2+ transients in both types of GABAergic neurons.   
 
Regulation of perisynaptic mGluR1 activation by glial glutamate transporters 
Inhibition of GLT-1 transporters caused a ~ 2-fold increase in the size of mGluR1 
EPSCs in O-LM interneurons, while inhibition of all glutamate transporters caused a 
much larger potentiation, indicating that binding and/or uptake of glutamate by 
transporters restricts activation of mGluRs at these synapses. The relatively small 
enhancement of mGluR1 EPSCs by DHK suggests that GLT-1 is only a minor 
contributor to this regulation, particularly when considering that the potentiation by  75
TBOA, and to a lesser extent by DHK, may have been underestimated, as transporter 
inhibition in TBOA may have decreased glutamate release by simultaneously 
enhancing activation of presynaptic mGluRs (Scanziani et al., 1998). These results 
seem at odds with the density of GLT-1 in the hippocampus, which is almost four 
times more abundant than GLAST (Lehre and Danbolt, 1998). This discrepancy could 
be explained if the relative densities of GLAST and GLT-1 are different at these 
particular synapses. It is also possible that the coupling between mGluR1 and cation 
channels is non-linear, enabling the synaptic current to become disproportionately 
larger as more mGluRs are activated in TBOA. Nevertheless, the modest effect of 
DHK suggests that there are sufficient remaining transporters to compensate for the 
loss of GLT-1. This hypothesis is consistent with the observation that astrocyte 
transporter currents were inhibited only ~ 50% by 300 µM DHK (see Figure III-6), 
and that 1 mM DHK did not potentiate mGluR1 EPSCs more than 300 µM DHK in 
wild-type mice, even though this higher concentration of DHK inhibited astrocyte 
transporter currents and potentiated mGluR1 EPSCs to a greater extent in GLAST
-/- 
mice. Indeed, previous studies have shown that the pool of astrocyte transporters in 
stratum radiatum is not saturated following high frequency stimulation, even when 
GLT-1 transporters are blocked with DHK (Diamond and Jahr, 2000). The decrease in 
expression of GLAST during development (Furuta et al., 1997) suggests that a 
proportionally larger role will be played by GLT-1 as the animal matures. Together, 
these results indicate that two astrocyte transporters, GLT-1 and GLAST, restrict 
activation of mGluR1s at excitatory synapses on O-LM interneurons.    76
Although immunolocalization studies indicate that GLT-1 is highly expressed 
by astrocytes (Lehre et al., 1995; Rothstein et al., 1994), in situ hybridization (Berger 
and Hediger, 1998; Schmitt et al., 1996) and immunolocalization studies (Chen et al., 
2004) suggest that GLT-1 is also expressed by some CA3 pyramidal neurons. It is 
unlikely that the GLT-1 transporters contributing to uptake near interneuron mGluR1s 
reside in neuronal membranes, as O-LM interneurons in area CA1 receive primarily 
feedback excitation from CA1 pyramidal neurons rather than feed-forward excitation 
from CA3 pyramidal neurons (Freund and Buzsáki, 1996), immuno-EM studies 
indicate that GLT-1 is largely located intracellularly in neurons rather than at the 
plasma membrane (Chen et al., 2004), and glutamate transporter currents have not 
been observed in hippocampal neurons (Bergles and Jahr, 1998).   
 
Contribution of neuronal transporters to uptake at excitatory synapses 
Recent studies suggest that neuronal glutamate transporters shield postsynaptic 
receptors at cerebellar (Brasnjo and Otis, 2001) and hippocampal (Diamond, 2001) 
synapses. EAAC1 is expressed by most neurons in the hippocampus (Rothstein et al., 
1994), where it is found primarily in the somo-dendritic compartment (He et al., 
2000). Although a detailed analysis of EAAC1 expression by interneurons has not 
been performed, EAAC1 mRNA is observed in stratum oriens interneurons (Berger 
and Hediger, 1998). Nevertheless, the similar potentiation of mGluR1 responses by 
DHK in wild-type and EAAC1
-/- mice suggests that EAAC1 contributes little to 
clearance near these receptors. Although the amplitude of mGluR1 EPSCs in GLAST
-/-  77
mice were increased to a similar extent by 300 µM DHK and 100 µM TBOA, these 
responses were more prolonged in TBOA, as shown by the enhanced charge transfer 
(see Figure III-5). The Ki of TBOA is ~ 10-fold lower than DHK at EAAT2 (Ki TBOA 
= 5.7 µM; Ki DHK = 79 µM) (Shimamoto et al., 1998), and unbinds from GLT-1 
about 10x more slowly (Bergles et al., 2002). The persistent rise in extracellular 
glutamate resulting from high frequency stimulation may force displacement of DHK, 
allowing GLT-1 to participate in clearance. Consistent with this possibility, 1 mM 
DHK increased the inhibition of astrocyte transporter currents and potentiated 
mGluR1-mediated EPSCs to a similar extent as TBOA, suggesting that the 
discrepancy between the potentiation seen by DHK and TBOA in GLAST
-/- mice is 
due, in part, to poorer antagonism of GLT-1 by DHK. However, it has been reported 
that DHK inhibits EAAC1 with a Ki of 1.12 mM (Dowd et al., 1996) (but see Arriza 
et al., 1994), raising the possibility that inhibition of EAAC1 also may have 
contributed to the increased potentiation seen in GLAST
-/- mice in response to 1 mM 
DHK. Because 1 mM DHK did not produce greater potentiation than 300 µM DHK in 
wild-type animals, EAAC1, if involved, is likely to be redundant with GLAST. 
However, when analyzing complex phenomena in knockout animals there is the 
concern of compensation. Although a global upregulation of GLT-1 or GLAST is not 
observed in EAAC1
-/- mice (Peghini et al., 1997), there could be local changes in the 
distribution or expression of these transporters at a subset of synapses. Notably, there 
was no significant change in inhibition of astrocyte transporter currents by DHK in 
EAAC1
-/- mice (see Figure III-6), suggesting that relative abundance of GLAST and  78
GLT-1 is unaltered in astrocytes in these mice. 
The prominent role for astrocyte transporters in lowering mGluR1 occupancy 
at these synapses contrasts with parallel fiber-Purkinje neuron synapses in the 
cerebellum, where postsynaptic transporters appear to contribute significantly to 
clearance (Brasnjo and Otis, 2001). Purkinje neurons, unlike O-LM interneurons, 
express high levels of EAAT4, and recent studies indicate that EAAT4 is responsible 
for the postsynaptic transporter currents recorded from Purkinje neurons (Huang et al., 
2004). These studies, and the present results, suggest that EAAC1 contributes little to 
perisynaptic clearance at these two excitatory synapses. Notably, EAAC1 is expressed 
by GABAergic interneurons, and glutamate accumulated by these transporters is used 
for GABA synthesis (Mathews and Diamond, 2003; Rothstein et al., 1996; Sepkuty et 
al., 2002), suggesting that it may serve as a metabolic transporter, rather than one 
specialized for removing synaptic glutamate. However, inhibition of postsynaptic 
transporters (presumably EAAC1) has been shown to slow the decay of evoked 
NMDA synaptic currents in CA1 pyramidal neurons (Diamond, 2001). Although the 
association of astroglia with synapses is essential for placing transporters near release 
sites (Iino et al., 2001; Oliet et al., 2001), the extent of this ensheathment varies 
dramatically among hippocampal synapses (Ventura and Harris, 1999), raising the 
possibility that EAAC1 may prevent spillover of transmitter at synapses that are 
devoid of astroglia. 
 
Implications for neuronal excitability  79
Glutamate transporter inhibition potentiated mGluR1 activity in interneurons, 
increased their firing rate, and greatly enhanced the inhibition of CA1 pyramidal 
neurons. In cultured hippocampal slices, stimulation of mGluR1 and mGluR5 also 
have been shown to potentiate inhibition of CA3 pyramidal neurons by increasing 
interneuron excitability (Maccaferri and Dingledine, 2002; Mori and Gerber, 2002), 
and in acute slices from guinea-pig tetanic stimulation in the presence of AMPA and 
NMDA receptor antagonists induces a transient increase in IPSPs in CA3 pyramidal 
neurons (Miles and Poncer, 1993), indicating a prominent role for mGluRs in 
regulating interneuron activity. Under physiological conditions, even small shifts in 
the membrane potential of interneurons caused by moderate mGluR1 activity could 
serve as a mechanism for short-term regulation of local circuit inhibition, because the 
timing of action potential firing in these cells is highly sensitive to the resting 
potential (Freund and Buzsáki, 1996). This modulation of O-LM interneuron mGluR1 
activity by glutamate transporters may fine tune the inhibition of perforant path inputs 
to CA1 pyramidal neurons (Kang et al., 1998), providing insight into the potential 
consequences of transporter dysregulation. 
There is accumulating evidence that the activity of GLT-1 and GLAST are 
tightly regulated through changes in expression, trafficking, phosphorylation, and 
interactions with accessory proteins (Gegelashvili et al., 1997; Levy et al., 1995). 
Furthermore, their expression is closely correlated with neuronal activity (Rao et al., 
1998), and is disrupted after trauma (Wong et al., 2003), in epilepsy (Danbolt, 2001), 
and in many neurological diseases. The results presented here suggest that alterations  80
in transporter activity could profoundly impact the behavior of neuronal networks by 
regulating the excitability of interneurons, thereby contributing to the abnormal 
neuronal activity observed in disease states.  81
Figure III-1. Isolation of slow EPSCs mediated by mGluR1 in O-LM 
interneurons.  A, Morphology of an O-LM interneuron that was filled with 
neurobiotin through the recording electrode. a, alveus; so, stratum oriens; sp, stratum 
pyramidale; sr, stratum radiatum; lm, lacunosum-moleculare. Bottom inset shows a 
picture of this interneuron (scale bar = 200 µm), and the upper inset shows the 
response of this neuron to injection of depolarizing current (300 pA). B, Left, response 
of an O-LM interneuron to field stimulation in stratum oriens (black trace). The red 
trace shows the response of this interneuron to the same stimulus when the cell was 
depolarized (from –65 mV to 0 mV for 500 ms) 1 second prior to stimulation. Right, 
same traces displayed on a faster time scale. C, Inhibition of the slow EPSC recorded 
from an O-LM interneuron by the specific mGluR1 antagonist LY 367385 (50 µM). 
Responses in B & C were recorded in AMPA (15 µM NBQX, 25 µM GYKI 52466), 
NMDA (10 µM RS-CPP, 50 µM MK-801, 20 µM 7-chlorokynurenate) and GABAA 
receptor (5 µM SR 95531, 20 µM bicuculline) antagonists at a holding potential of 
–65 mV. 
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Figure III- 1 
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Figure III-2. Ca
2+ dependence of the mGluR synaptic current. A, mGluR1 EPSCs 
recorded from O-LM interneurons with an internal solution containing 10 mM or 40 
mM BAPTA. The grouped data below shows the average size of the mGluR1 EPSC 
recorded under these two conditions. The numbers in parenthesis indicate the number 
of experiments (** = p < 0.01). B, mGluR1 EPSCs elicited following depolarizing 
steps (from –65 mV to 0 mV) of different durations, as indicated. C, mGluR1 EPSCs 
evoked with varying delay (as indicated) after the end of a 500 ms step depolarization 
to 0 mV. 
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Figure III- 2 
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Figure III-3. Inhibition of glutamate transporters potentiates mGluR1 EPSCs. A, 
Evoked mGluR1 EPSCs recorded from O-LM interneurons with (traces labeled #2) or 
without (traces labeled #1) the step depolarization, under control conditions, in the 
presence of DHK (300 µM), TBOA (100 µM), or in LY 367385 (50 µM) and TBOA. 
B, Grouped data showing the peak amplitude (open bars) and charge transfer (closed 
bars) of the mGluR EPSC recorded under these different conditions. Numbers in 
parenthesis indicate the number of experiments. (** = p < 0.01, *** = p < 0.001). C, 
Plot of the peak amplitude of evoked AMPA EPSCs (single stimulus, ■) (n = 5−12), 
mGluR1 EPSCs under control conditions (10 stimuli @ 100 Hz, ○) (n = 5−13), and 
mGluR EPSCs in the presence of TBOA (10 stimuli @ 100 Hz, ●) (n = 8−13) in 
response to stimuli of different intensity. When absent, error bars were shorter than 
the points. 
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Figure III-4. Inhibition of glutamate transporters potentiates mGluR1-mediated 
depolarization of O-LM interneurons. Response of an O-LM interneuron to a train 
of stimuli (arrow) following a depolarizing current injection (200 pA) recorded under 
control conditions (left trace), in the presence of TBOA (100 µM, center trace), and 
in the presence of TBOA and LY 367385 (50 µM, right trace). Transporter inhibition 
revealed an mGluR1-mediated response in this O-LM interneuron. 
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Figure III- 4 
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Figure III-5. GLT-1 and GLAST, but not EAAC1 restrict the activation of 
mGluR1 receptors.  A, Evoked mGluR1-mediated EPSCs recorded in O-LM 
interneurons from an EAAC1
-/- mouse and a wild-type littermate under control 
conditions and in the presence of DHK (300 µM) or TBOA (100 µM). B, The same 
set of experiments as in A, performed on slices from a GLAST
-/- mouse and a 
wild-type littermate. The arrow highlights the larger effect of DHK (300 µM) 
observed in the GLAST
-/- mouse. C, Grouped data showing the effects of DHK and 
TBOA on the peak amplitude (left) and charge transfer (right) of mGluR1-mediated 
EPSCs in mice with different genotypes (as indicated). The effect of 1 mM DHK on 
mGluR1-mediated EPSCs was studied in GLAST
-/- mice and wild-type littermates. (** 
= p < 0.01, *** = p < 0.001). Numbers in parenthesis indicate the number of 
experiments. 
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Figure III- 5 
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Figure III-6. Differential effects of transporter antagonists on astrocyte 
transporter currents recorded from transporter deficient mice.  A, Astrocyte 
transporter currents elicited by UV photolysis of MNI-L-glutamate (125 µM) 
recorded under control conditions (black traces), in the presence of DHK (300 µM, 
red traces; 1 mM, blue traces) or TBOA (200 µM) (green traces) from mice with 
different genotypes (as indicated). B, Grouped data showing % inhibition of the peak 
amplitude of these transporter currents by DHK and TBOA in wild-type, EAAC1
-/-, 
and GLAST
-/- mice (*** = p < 0.001; compared to wild-type). Numbers in parenthesis 
indicate the number of experiments (ND = not done). 
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Figure III- 6 
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Figure III-7. Inhibition of glutamate transporters induces an mGluR1-dependent 
delayed burst of IPSCs in CA1 pyramidal cells. A, Whole-cell recording from a 
CA1 pyramidal neuron showing the response to stimulation (10 stimuli @ 100 Hz) in 
stratum oriens under control conditions. B, Response of this cell to the same stimulus 
in the presence of TBOA (100 µM). C, Response of this cell to the same stimulus in 
the presence of TBOA (100 µM) and the mGluR1 antagonist LY 367385 (100 µM). D, 
Response of this cell to the same stimulus in the presence of TBOA (100 µM) and the 
GABAA receptor antagonist SR 95531 (5 µM). E, Grouped data showing the charge 
transfer conveyed by IPSCs recorded from CA1 pyramidal neurons under different 
conditions, as indicated. The effect of SR 95531 on the burst of IPSCs was analyzed 
by performing a separate set of experiments (n = 4), in which SR 95531 was applied 
in the presence of TBOA, but in the absence of LY 367385. (*** = p < 0.001; NS = 
not significant.). Numbers in parenthesis indicate the number of experiments. 
Recordings were performed using a high Cl
– -based internal solution (Vm = –65 mV) 
and the ACSF contained 15 µM NBQX, 25 µM GYKI 52466, 10 µM RS-CPP, 50 µM 
MK-801, 20 µM 7-Chlorokynurenate, and 1 µM CGP 55845.  94
Figure III- 7 
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Chapter IV 
Synthesis and characterization of 4-methoxy-7-nitroindolinyl-D- 
aspartate, a caged compound for selective activation of glutamate 
transporters and N-methyl-D-aspartate (NMDA) receptors in brain 
tissue 
 
Introduction 
Glutamate transporter activity can be monitored with high temporal fidelity by 
recording transport-associated charge movements in individual cells. Transporter 
currents can be elicited from astrocytes in brain slices following stimulation of 
excitatory afferents (Bergles and Jahr, 1997), by bath application of substrate, by focal 
application of substrate using pressure, or by photolysis of caged substrates (Huang et 
al., 2004). The analysis of synaptic transporter currents is complicated by the 
dependence on nerve terminals for glutamate, while bath application is very slow and 
lacks spatial precision. Pressure application improves temporal and spatial resolution, 
but requires positioning of the application pipette within tissue, and responses elicited 
using this approach exhibit poor stability due to repeated mechanical disruption of 
surrounding tissue. In contrast, photolysis of caged substrates allows rapid and focal 
activation of transporters, in a manner free from mechanical artifact. 
The D-isomer of aspartate is efficiently transported by high affinity Na
+/K
+ 
dependent glutamate transporters and is an effective ligand of N-methyl-D-aspartate 
(NMDA) receptors. To facilitate analysis of the regulation of glutamate transporters in  96
their native membranes we synthesized a photolabile analogue of D-aspartate, 
4-methoxy-7-nitroindolinyl -D-aspartate (MNI-D-aspartate) to allow rapid and focal 
activation of transporters by brief exposure to near UV light. 
An ideal caged compound should have the following properties: (1) it must be 
biologically inert (neither an agonist or antagonist); (2) the compound should be 
rapidly released upon photolysis (release half-time < 20 microseconds); (3) uncaging 
should make efficient use of the incident light (exhibit a large extinction coefficient 
and quantum yield); (4) the caging group by-product should not exhibit activity nor be 
harmful to cells; and (5) the caged compound must not undergo spontaneous 
hydrolysis during storage or in physiological buffer. For studies of high affinity 
receptors such as transporters (Km range: 4−97 µM) (Arriza et al., 1994) and NMDA 
receptors (Km ~ 5 µM) (Olverman et al., 1988), this latter property is particularly 
important, as this free substrate will alter baseline conditions by causing transporter 
activation in the absence of light. Our previous studies indicate that MNI-caged 
L-glutamate (MNI-L-glutamate) is very stable (Matsuzaki et al., 2001), and this 
knowledge was a prime driving force for the synthesis of MNI-D-aspartate. Although 
L-glutamate is the primary physiological substrate of glutamate transporters, caged 
versions of L-glutamate are of limited use for studying the interaction of glutamate 
receptors and glutamate transporters in situ, as the liberated L-glutamate will act on 
receptors and transporters simultaneously (Canepari et al., 2001). In contrast, 
D-aspartate offers significant advantages, as it is efficiently transported (Arriza et al., 
1994) but it is unlikely to have appreciable activity at AMPA receptors, kainate  97
receptors, or mGluRs. A previous report described the synthesis of an CNB-caged 
D-aspartate, and showed that this compound could be used to study the activation 
kinetics of EAAC1, the primary neuronal glutamate transporter, when heterologously 
expressed in HEK293 cells (Grewer et al., 2001). However, this caged compound has 
been reported to be somewhat unstable, a common problem of excitatory amino acids 
caged with CNB (Pettit et al., 1997), and its activity at glutamate transporters in situ 
has not been examined. 
Here we describe the synthesis of a novel caged form of D-aspartate 
(MNI-D-aspartate), in which the β-carboxylate of D-aspartate is coupled to 
4-methoxy-7-nitroindolinyl (MNI) through a photolabile amidic bond (Amit et al., 
1976), and examine the responses triggered in neurons and glial cells in acute brain 
slices upon photolysis. MNI-D-aspartate is stable in solution, can be photolyzed 
rapidly, and is biologically inert. Upon brief exposure to near-UV light, this 
compound reliably evoked glutamate transporter currents in astrocytes, Bergmann 
glial cells, and Purkinje cells, as well as NMDA receptor currents in pyramidal 
neurons; however, it did not evoke AMPA/kainate or metabotropic glutamate receptor 
currents. Thus, MNI-D-aspartate can be used to activate glutamate transporters and 
NMDA receptors in native membranes, and reveal the interactions between receptors 
and transporters at excitatory synapses in acute brain slices.   
 
Materials and Methods 
Synthesis of MNI-D-aspartate:  98
General Remarks. Silica gel 60 (mesh 63-200 micron) was used for flash 
chromatography. A Beckman System Gold fitted with Hamilton PRP-1 columns (4.1 x 
250 mm, or 20.1 x 250 mm) was used for HPLC. 
1H and 
13C NMR were measured on 
a Varian Mercury 300.   
Synthesis. N-(tert-Butoxycarbonyl)-D-aspartic acid  α-tert-butyl ester (2) was 
prepared according to a published procedure (Li et al., 2001). 
4-Methoxyindolinyl N-(tert-butoxycarbonyl)-D-aspartic acid α-tert-butyl ester (3). 
N-(tert-Butoxycarbonyl)-D-aspartic acid α-tert-butyl ester (356 mg, 1.23 mmol), 
1,3-dicyclohexylcarbodiimide (254 mg, 1.23 mmol), and 4-dimethylaminopyridine 
(150 mg, 1.23 mmol) were added to a solution of 4-methoxyindoline (142 mg, 0.95 
mmol), synthesized as described previously (Matsuzaki et al., 2001), in 
dichloromethane (7 ml). The reaction mixture was stirred at room temperature for 20 
hours, then it was filtered, diluted with CH2Cl2, washed with saturated NaHCO3 
solution, 0.5N HCl and brine. The organic layer was dried (MgSO4) and evaporated to 
dryness. The crude product was purified by flash column chromatography (ethyl 
acetate/hexane 1:3) to yield product 3 as white solid (357 mg, 0.85 mmol, 89%). 
1H 
NMR (CDCl3) δ 7.8 (1H, d, J=8.1 Hz), 7.15 (1H, t, J=8.1 Hz), 6.58 (1H, d, J=8.1 Hz), 
5.82 (1H, d, J=8.9 Hz), 4.48 (1H, m), 4.04 (2H, t, J=8.2 Hz), 3.83 (3H, s), 3.1 (3H, m), 
2.83 (1H, dd, J = 4.0, 16.8 Hz), 1.45 (9H, s), 1.44 (9H, s); 
13C NMR (CDCl3) δ 170.6, 
168.6, 156.0, 155.9, 144.1, 129.1, 118.5, 110.2, 106.4, 82.1, 79.8, 55.6, 50.9, 48.7, 
38.7, 28.7, 28.3, 25.5; IR (neat) 3440, 3040, 2980, 2938, 1740, 1710, 1660, 1610, 
1490, 1465, 1415, 1365, 1340, 1150, 1060, 840 cm
-1; MS (ESI) m/z 421.2 (M+H
+).  99
 
4-Methoxy-7-nitroindolinyl N-(tert-butoxycarbonyl)-D-tert-butyl-aspartic acid (4). 
To a solution of 3 (357 mg, 0.85 mmol) and silver nitrate (0.287 g, 1.7 mmol) in 
acetonitrile (10 ml) was added a solution of acetyl chloride (0.133 g , 1.7 mmol) in 
acetonitrile (5 ml). The reaction mixture was filtered; the filtrate was diluted with 
ethyl acetate and washed with saturated solution of sodium bicarbonate. The solvent 
was removed by rotary evaporation, leaving a dark orange oil, which was purified 
over silica gel using ethyl acetate/hexane (1:2) to yield 251 mg (0.54 mmol, 64%) of 
product 5. 
1H NMR (CDCl3) δ 7.74 (1H, d, J=9.0 Hz), 6.63 (1H, d, J=9.0 Hz), 5.67 
(1H, broad d, J=8.1 Hz), 4.44 (1H, m), 4.22 (2H, t, J=8.1 Hz), 3.90 (3H, s), 3.16 (1H, 
dd, J = 4.1, 16.5 Hz), 3.07 (2H, t, J=8.1 Hz), 2.97 (1H, dd, J = 4.1, 16.5 Hz), 1.47 (9H, 
s), 1.42 (9H, s); 
13C NMR (CDCl3) δ 170.0, 169.1, 158.8, 155.8, 136.4, 135.4, 125.5, 
122.8, 106.5, 82.4, 79.8, 56.1, 51.1, 49.0, 37.7, 28.6, 28.1, 26.5; IR (neat) 3420, 3050, 
2980, 2930, 1740, 1710, 1680, 1610, 1590, 1530, 1490, 1450, 1390, 1365, 1340, 1270, 
1250, 1230, 1150, 1080, 1050, 890, 750, 700 cm
-1; MS (ESI) m/z 488.2 (M+Na
+). 
4-Methoxy-7-nitroindolinyl-D-aspartic acid (1). TFA (0.7 ml) was slowly added to a 
solution of compound 4 (113 mg, 0.24 mmol) in dichloromethane (3 ml). The reaction 
mixture was stirred at room temperature for 20 hours, then the solvent was removed 
and the crude material was purified by preparative HPLC (isocratic elution with 20% 
CH3CN in H2O) to yield 37 mg (0.12 mmol, 50%) of product 1. 
1H NMR (D2O) δ 
7.78 (1H, d, J=9.3 Hz), 6.88 (1H, d, J=9.3 Hz), 4.43 (1H, t, J=5.0 Hz), 4.29 (2H, t, 
J=8.0 Hz), 3.94 (3H, s), 3.39 (2H, m), 3.08 (2H, t, J=8.0 Hz); 
13C NMR (D2O) δ  100
171.0, 169.2, 159.5, 135.0, 134.3, 125.7, 123.9, 108.3, 56.3, 50.5, 49.7, 34.9, 26.1; 
MS m/z 307.8 (M-H
+). 
Quantum Yield. The quantum yield for uncaging MNI-D-aspartate was measured by 
comparing the time of photolysis with the filtered (280-400 nm) output of a 500 W 
medium pressure Hg lamp of an equimolar solution (250 µM) of MNI-L-glutamate 
and MNI-D-aspartate in HEPES ACSF. Inosine was used as an inert internal standard 
(Ellis-Davies and Kaplan, 1994). The path-length of the cuvette was 0.1 mm. 
Slice preparation and Electrophysiology: 
Slice Preparation. Hippocampal slices were prepared from 12-17 day-old 
Sprague-Dawley rats in accordance with a protocol approved by the Animal Care and 
Use Committee at Johns Hopkins University. Rats were deeply anesthetized with 
halothane and decapitated, the hippocampi were dissected free, mounted in agar 
blocks, cut in 400 µm thick transverse sections using a vibratome (VT1000S, Leica), 
in oxygenated ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM): 
NaCl 119, KCl 2.5, CaCl2 2.5, MgCl2 1.3, NaH2PO4 1, NaHCO3 26.2 and D-Glucose 
11. Slices were allowed to recover on a gauze net submerged in ACSF at 37
o C for 30 
minutes and kept at room temperature thereafter. For cerebellar slices, 250 µm thick 
parasagittal sections were prepared. Brain slices were used within 7 hours of 
preparation. 
Whole Cell Recording. Brain slices that had recovered for at least one hour were 
transferred to a Lucite chamber with a coverslip bottom and continuously superfused 
with oxygenated ACSF. Individual cells (astrocytes, CA1 pyramidal neurons,  101
Bergmann glial cells, or Purkinje neurons) were visualized through a 40x water 
immersion objective (Olympus LUMPlanFl, NA = 0.8) using an upright microscope 
(Axioskop FS2, Zeiss) equipped with infrared-Nomarski optics and a CCD camera 
(Sony XC-73). Recording electrodes were pulled from glass capillary tubing and had 
a combined resistance of 1.5-3.0  MΩ when filled with the internal solution. For 
astrocytes and Bergmann glial cells, the internal solution contained (in mM): 
KCH3O3S (KMeS) 120, EGTA 10, HEPES 20, MgCl2 1, Na2ATP 2, NaGTP 0.2; the 
pH was 7.3. For neuronal recordings the internal solution contained (in mM): 
CsCH3O3S (CsMeS) 105, TEA-Cl 20, EGTA 10, HEPES 20, MgCl2 1, QX-314 1, 
Na2ATP 2, NaGTP 0.2; the pH was 7.3. To record transporter associated anion 
currents from Purkinje neurons, the internal solution contained (in mM): CsNO3 100, 
TEA-Cl 20, EGTA 10, HEPES 20, MgCl2 1, QX-314 1, Na2ATP 2, NaGTP 0.2; the 
pH was 7.3. With these solutions the series resistance during recordings was <10 MΩ, 
and was left uncompensated. Unless stated otherwise, holding potentials have not 
been corrected for the junction potential. Whole-cell currents were amplified using an 
Axopatch 200B (Axon Instruments), filtered at 2-5 kHz and sampled at 10-20 kHz. A 
0.5-5  mV step was applied at the beginning of each trace to measure both the 
membrane and access resistances. Perforated patch recordings were performed in the 
cell attached patch mode by including Amphotericin-B (120 µg/ml) in the KMeS 
internal solution. 
Solution Application. Caged compounds were dissolved in HEPES buffered saline 
(HEPES ACSF) containing (in mM): NaCl 137, KCl 2.5, CaCl2 2.5, MgCl2 1.3,  102
HEPES 20; the pH was 7.3. Solutions containing caged compounds were applied to 
the slice using a wide bore (tip diameter 50-100 µm) pipette connected to a manifold 
fed by four 10 ml reservoirs. Solutions were switched by alternately opening and 
closing valves attached to each reservoir. Antagonists were used to block 
voltage-gated Na
+ channels (tetrodotoxin; TTX, 1  µM), AMPA/kainate receptors 
(2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt; 
NBQX, 10  µM), NMDA receptors ((RS)-3-(2-carboxypiperazin-4-yl)-propyl-1- 
phosphonic acid; R,S-CPP, 10  µM; and (5R,10S)-(+)-5-methyl-10,11-dihydro-5H- 
dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate; MK-801, 50  µM), and 
GABAA receptors (6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid 
dihydrobromide; SR-95531, 5  µM). In some experiments, group I mGluRs were 
blocked with LY367385 (100  µM). Glutamate transporters were inhibited using 
DL-threo-β-benzyloxyaspartic acid (TBOA, 100-200 µM). The specific blockers used 
in each experiment are indicated in the figure legends. For each experiment, the caged 
compound solution contained the same concentration of antagonists present in the 
bath solution. In some experiments, D-aspartate (500 µM dissolved in HEPES ACSF) 
was applied locally through a small tip pipette (~1 µm diameter) using a picospritzer 
(Pressure System IIe, Toohey Company); a 5-10 ms pulse of 15-20 psi was used to 
eject the solution. All appropriate blockers were included in the puffer pipette 
solution. 
Photolysis of Caged Compounds:  For photolysis, an argon ion laser (Stabilite 
2017-AR, Spectra-Physics) providing ~ 230 mW or 380 mW of multi-line UV light  103
(333.6-363.8 nm) was coupled to the microscope through a multi-mode quartz fiber 
optic cable (Oz Optics Ltd.). The output of the fiber optic was collimated using a 
quartz lens, projected through the fluorescence port of a Zeiss Axioskop FS2 
microscope, and focused to a ~50 µm spot using a 40x water immersion objective 
(Olympus LUMPlanFl) , or to a ~100 µm spot using a 20x water immersion objective 
(Olympus UMPlanFl). The UV spot was centered on the soma of astrocytes or 
pyramidal cells or on the dendritic arbor of the Purkinje cells, using a targeting laser 
(633 nm HeNe). To control the length of exposure, a computer controlled 
programmable pulse generator (Master 8, AMP Instruments) was used to trigger a 
high-speed laser shutter (NM laser) placed between the laser head and the fiber launch. 
Photolysis was achieved by opening the shutter for 1 ms. In some experiments, the 
intensity of the laser was varied using the aperture on the laser head. The output 
intensity for each aperture was measured using a power meter. A laser intensity (at the 
output) of 230 mW was used for recordings from astrocytes, Bergmann glial cells and 
pyramidal neurons (40x objective), corresponding to a total light energy of 29 mJ/cm
2. 
An intensity of 380 mW was used for recordings from Purkinje neurons (20x 
objective), corresponding to a total light energy of 48 mJ/cm
2. These values reflect the 
laser power prior to entering the fiber optic; the energy reaching the cell is likely to be 
considerably less due to loss at the fiber launch, the microscope lenses, and the 
intervening tissue.   
Chemicals Used for Photolysis Experiments:  MNI-L-glutamate, NBQX, R,S-CPP, 
MK-801, LY367385, SR-95531, and TBOA were purchased from Tocris. D-aspartate  104
was purchased from Sigma. TTX and QX-314 (N-(2,6-dimethylphenyl 
carbamoylmethyl) triethylammonium chloride) were purchased from Alomone Labs. 
Data Analysis and Statistics:  Data were analyzed off-line using Clampfit (Axon 
Instruments) and Origin (Microcal) software. For experiments on astrocytes, only 
cells in which the amplitude of the response to a –5 mV step changed by less than 
25% during the course of an experiment were analyzed. All values are represented as 
mean ± standard error of the mean. The Student’s t-test (paired or unpaired, as 
appropriate) was used for statistical comparison; p < 0.05 was considered significant. 
The rise time of responses were calculated from 10−90% of the peak the response, 
and the tau decay was measured using a single exponential least squares fit. Half 
decay refers to the time required for the response to decay to 50% of the peak 
amplitude.  
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Results 
Synthesis and quantum yield of MNI-D-aspartate.  
The steps involved in the synthesis of MNI-D-aspartate are outlined in Figure IV-1. 
The requisitely protected D-aspartate was synthesized in the same manner as reported 
previously for L-aspartate (Li et al., 2001) in a yield of 73%. The beta carboxylate 
was coupled to 4-methoxyindoline (Matsuzaki et al., 2001) using standard 
DCCD/DMAP conditions to give 3 in a yield of 89%. The essential nitro functionality 
was introduced into intermediate 3 using silver nitrate and acetyl chloride (Norman 
and Radda, 1961) to give 7-nitro indoline 4, along with the undesired 5-nitro isomer. 
The yield of 4 after flash chromatography was 64% (the 7 and 5 nitro isomers could 
easily be separated at this stage, unlike MNI-L-glutamate). The BOC and tert-butyl 
protecting groups were removed by treatment of 4 with TFA to give the target caged 
D-aspartate,  1, in a yield of 50% after HPLC purification. HPLC purification of 
MNI-D-aspartate was essential to remove free D-aspartate. 
 
Quantum yield of photolysis.  
The quantum yield of uncaging of MNI-D-aspartate was determined by direct 
comparison with MNI-L-glutamate. Both caged compounds have the same extinction 
coefficient, so analysis of the irradiation of an equimolar solution of both compounds, 
to test the relative extent of photolysis, yields the quantum of MNI-D-aspartate 
uncaging. We found that when a solution containing 0.25 mM of each compound was 
irradiated (total OD = 0.215, to ensure uniform photolysis), the quantum yield was  106
0.09 ± 0.01 (n = 3), slightly faster than MNI-L-glutamate (Matsuzaki et al., 2001). 
 
Photolysis of MNI-D-aspartate triggers glutamate transporter currents in 
astrocytes.  
Glutamate transporters are present at a high density in the membranes of astrocytes in 
the hippocampus (Lehre and Danbolt, 1998), and application of L-glutamate through 
pressure or photolysis in brain slices induces an inward current in astrocytes that is 
blocked by glutamate transporter antagonists (Bergles and Jahr, 1997; Huang et al., 
2004). To determine whether photolysis of MNI-D-aspartate is also capable of 
eliciting glutamate transporter currents in situ, we made whole-cell voltage-clamp 
recordings from astrocytes in the CA1 region of hippocampus and measured their 
response to UV light in the presence of MNI-D-aspartate. When the ACSF contained 
antagonists of AMPA, NMDA, and GABAA receptors, as well as TTX (see Methods) 
to block possible indirect effects resulting from excitation of surrounding neurons, 
brief (1 ms) exposure to laser UV light produced a rapidly activating, transient inward 
current in astrocytes (Figure IV-2A), that was only observed when the superfusing 
solution contained MNI-D-aspartate (125 µM). These currents had a slightly faster 
rise time than responses elicited by photolysis of 125 µM MNI-L-glutamate (rise time: 
MNI-D-aspartate, 3.1 ± 0.2 ms; MNI-L-glutamate, 3.5 ± 0.2 ms, p < 0.001) but 
slightly slower decay kinetics (decay tau: MNI-D-aspartate, 16.9 ± 0.9 ms, n = 11; 
MNI-L-glutamate, 15.4 ± 0.6 ms, p < 0.05, n = 11) (Figure IV-2B) (Huang et al., 
2004). The peak amplitude of these responses was reduced by 94.5 ± 0.6 % (n = 4) by  107
TBOA (200 µM), a selective antagonist of glutamate transporters (Shigeri et al., 2001; 
Shimamoto et al., 1998) (Figure IV-2C). These currents reflect the movement of 
charges that are directly coupled to the flux of glutamate, as they were recorded with 
an internal solution (KMeS) which does not reveal the glutamate 
transporter-associated anion conductance (Bergles et al., 2002). Increasing the 
temperature from room temperature (22−24° C) to near physiological temperature 
(34−36° C) increased the amplitude of these responses by 34.1 ± 6.2 % (P < 0.01) and 
decreased the rise time by 10.0 ± 3.5 % (P < 0.05) and the decay time by 29.9 ± 2.6 % 
(n = 5, p < 0.001) (Figure IV-2D), in accordance with the high temperature 
dependence exhibited by glutamate transporters (Bergles and Jahr, 1998; Wadiche et 
al., 1995). However, the charge transfer induced by these currents was similar at 
higher temperature (5.0 ± 3.2 % increase, p = 0.099, n = 5), suggesting that a 
comparable amount of D-aspartate was transported at both temperatures. These results 
indicate that laser induced photolysis of MNI-D-aspartate releases the free amino acid, 
which is then removed by glutamate transporters in astrocyte membranes.   
By varying the intensity of UV light it was possible to control the amount of 
D-aspartate liberated. As shown in Figure IV-3A, the peak amplitude of astrocyte 
transporter currents increased monotonically with increasing laser power, suggesting 
that glutamate transporters were operating in a linear range of their dose-response 
curve under these conditions. As expected from the concentration dependence of 
binding, the rise times of glutamate transporter currents became faster as the laser 
intensity was increased, from 2.1 ± 0.1 ms at 50% laser power to 1.7 ± 0.1 ms (n = 3,  108
p < 0.01) at 100% (relative) power (230 mW at laser output; 50 µm spot illumination), 
similar to concentration-dependent effects on transporter currents observed in 
outside-out patches removed from astrocytes (Bergles and Jahr, 1997). However, 
unlike responses recorded from patches, photolysis-induced glutamate transporter 
currents recorded in situ became more prolonged as more D-aspartate was released 
(half decay time: 50% relative intensity, 22.8 ± 4.1 ms; 100% relative intensity, 27.2 ± 
4.5 ms, n = 3, p < 0.01), suggesting that clearance from within the tissue is delayed as 
more D-aspartate is liberated, or that additional GLAST transporters, which exhibit a 
lower affinity and slower transport rate for D-aspartate (17), are recruited at higher 
laser intensities. 
In addition to the transient response, glutamate transporter currents recorded 
from astrocytes exhibited a slowly decaying “tail current” that required several 
seconds to return to baseline (Figure IV-3B), similar to transporter currents evoked in 
astrocytes through synaptic release (Bergles and Jahr, 1997). The amplitude of this 
prolonged inward current was ~ 2% of the peak, and this proportion remained fixed at 
all laser intensities (Figure IV-3B). This tail current is unlikely to have resulted from 
activation of voltage-gated channels in surrounding neurons, as UV illumination 
under these conditions did not elicit a response from surrounding neurons (see Figure 
IV-7). These results suggest that the photolysis induced tail current occurs as a direct 
result of glutamate transporter activation. 
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Physiological properties and aqueous stability of MNI-D-aspartate.   
An ideal caged substrate of glutamate transporters should not act as a substrate or an 
antagonist, and should be stable in aqueous solution. To determine whether our new 
caged compound is a substrate for glutamate transporters we measured the response of 
astrocytes to a high concentration of MNI-D-aspartate. Although perfusion of free 
D-aspartate (500  µM) induced an inward current of –134.7 ± 41.0  pA (n = 4), 
application of 500 µM MNI-D-aspartate did not elicit a consistent response (–15.2 ± 
11.3 pA, n = 6, p > 0.05), indicating that the caged compound is not a substrate for 
glutamate transporters. Although MNI-D-aspartate did not activate glutamate 
transporters, it could act as an antagonist, similar to the aspartate analogues TBOA 
and THA (Shimamoto et al., 1998). This is a significant concern because other caged 
neurotransmitters (e.g., 4-methoxycarbonyl-7-nitroindolinyl-caged-GABA and 
-glycine) have been demonstrated to have antagonistic properties at their respective 
receptors (Canepari et al., 2001). To determine whether MNI-D-aspartate is an 
antagonist of glutamate transporters, we examined the effect of the caged compound 
on responses evoked through local pressure application of D-aspartate (500 µM). As 
shown in Figure IV-4A, application of MNI-D-aspartate (500  µM) did not 
significantly change the amplitude, charge transfer, or time course of transporter 
currents induced by D-aspartate, indicating that the caged compound is not a 
glutamate transporter antagonist. To assess the stability of the caged compound, a 500 
µM solution of MNI-D-aspartate was prepared in HEPES-ACSF (pH 7.3), stored at 
4
o C in the dark, and applied to astrocytes 2 and 4 days later. This solution produced a  110
change in holding current of 10.0 ± 18.8 pA (n = 6) at 2 days and –8.7 ± 3.3 pA (n = 3) 
at 4 days, indicating that this compound is highly stable in aqueous solution. The 
amplitude of glutamate transporter currents induced by photolysis of MNI-D-aspartate 
was dependent on the concentration of MNI-D-aspartate, the relative locations of the 
superfusion pipette, the cell, and the illumination area, as well as the depth of the cell 
within the slice. For a given configuration, the peak amplitude of the transporter 
current was stable for ~30 minutes with repeated uncaging (Figure IV-4B), but 
became more prolonged over time (half decay time was increased by 26.5 ± 5.9 % 
after 30 min, n = 4, p < 0.001). 
 
Glutamate transporter currents evoked in Bergmann glial cells through 
photolysis of MNI-D-aspartate.   
Astroglial cells throughout the CNS express glutamate transporters (Danbolt, 2001), 
but the types of transporters expressed and their density vary among cells in different 
brain regions. Bergmann glial cells contribute to the clearance of glutamate released 
at climbing fiber and parallel fiber terminals in the molecular layer of the cerebellum 
(Bergles et al., 1997; Clark and Barbour, 1997; Lehre et al., 1995; Rothstein et al., 
1994). To determine if MNI-D-aspartate can also be used to activate glutamate 
transporters in Bergmann glial cells, we made whole cell recordings from these cells 
in acute cerebellar slices and measured their response to uncaging of MNI-D-aspartate. 
As shown in Figure IV-5A, an inward current was triggered in Bergmann glial cells by 
the same uncaging conditions that were used to elicit glutamate transporter currents in  111
astrocytes (125 µM MNI-D-aspartate, 1 ms UV exposure), and this current was 
similarly inhibited by TBOA (200 µM) . Responses elicited from Bergmann glial cells 
were smaller on average than responses recorded from astrocytes (Bergmann glia: 
63.2 ± 7.3 pA, n = 7; Astrocytes: 454.5 ± 84.9 pA, n = 4, p < 0.01) and were inhibited 
less by TBOA (% inhibition: Bergmann glia, 81.5 ± 1.1 %, n = 7, p < 0.01) (Figure 
IV-5B). These data are consistent with the lower affinity of TBOA for GLAST 
(Shimamoto et al., 1998), the primary glutamate transporter expressed by Bergmann 
glia (Lehre et al., 1995; Rothstein et al., 1994), than GLT-1, the primary glutamate 
transporter expressed by astrocytes (Lehre and Danbolt, 1998). Bergmann glial 
responses also exhibited slower rise and decay kinetics than transporter currents 
recorded from astrocytes, perhaps reflecting both the lower affinity of GLAST for 
D-aspartate (Arriza et al., 1994) and the lower density of transporters expressed by 
Bergmann glial cells (Lehre and Danbolt, 1998). 
 
Glutamate transporter currents evoked in Purkinje cells through photolysis of 
MNI-D-aspartate.  
The previous results indicate that MNI-D-aspartate can be used to probe transporter 
activity in astroglial cells. To determine whether this compound is also suitable for 
monitoring glutamate transporter activity in neurons, we examined photolysis-induced 
responses in cerebellar Purkinje neurons. Purkinje neurons express EAAT4, a 
glutamate transporter that exhibits a 10-fold higher affinity for glutamate, cycles 5-10 
times more slowly than other glutamate transporters, and exhibits a high permeability  112
to anions (Fairman et al., 1995). This transporter contributes to uptake at parallel fiber 
and climbing fiber synapses, and currents produced by EAAT4 cycling have been 
recorded in response to synaptic (Auger and Attwell, 2000; Huang et al., 2004; Otis et 
al., 1997) and photorelease of L-glutamate (Brasnjo and Otis, 2004; Canepari et al., 
2001), and have been used to estimate the amount of glutamate released at climbing 
fiber synapses (Auger and Attwell, 2000; Huang et al., 2004; Otis et al., 1997). To 
determine if photolysis of MNI-D-aspartate is able to elicit detectible glutamate 
transporter currents in Purkinje neurons, we measured the response of these neurons 
to photolysis of 500 µM MNI-D-aspartate in the presence of ionotropic glutamate and 
GABAA receptor antagonists, and TTX (see Methods). When the UV illumination (~ 
100  µm diameter spot) was centered in the molecular layer over Purkinje cell 
dendrites, an inward current of –89.6 ± 25.9 pA (range: –41.1 to –172.6 pA, n = 6) 
was elicited following a 1 ms exposure to UV light (Figure IV-6A). These currents 
exhibited a rise time of 4.0 ± 0.6 ms and a half decay time of 54.8 ± 3.8 ms (n = 6; 
CsMeS-based internal solution), and were inhibited by 86.3 ± 0.13 % (n = 3) by 200 
µM TBOA. These transporter currents were much smaller than the currents recorded 
from astrocytes or Bergmann glia under comparable conditions (see Figures 2 & 5), 
consistent with the lower density of transporters in Purkinje neurons (Dehnes et al., 
1998). Charge movements associated with glutamate transport are enhanced in the 
presence of anions such as nitrate (NO3
-) and thiocyanate (SCN
-), which permeate 
these transporters in a manner uncoupled from the flux of glutamate (Wadiche et al., 
1995). Photolysis-induced transporter currents recorded from Purkinje neurons  113
recorded with a CsNO3-based internal solution were larger (CsNO3
-: –634.4 ± 62.5 
pA, p < 0.001) and exhibited slower rise times (CsNO3
–: 13.1 ± 0.8 ms, n = 8, p < 
0.001) than responses recorded with a CsMeS-based internal solution (Figure IV-6B, 
C), consistent with previous observations (Auger and Attwell, 2000; Huang et al., 
2004). 
Purkinje neurons also express mGluR1, a metabotropic glutamate receptor that 
triggers release of calcium from internal stores and opens non-selective cation 
channels in the plasma membrane (Canepari et al., 2001; Kim et al., 2003). 
Photorelease of L-glutamate has been shown to elicit inward currents mediated by 
mGluRs in these neurons (Canepari et al., 2001). To determine whether the 
D-aspartate liberated by photolysis activates mGluRs we compared the response of 
Purkinje neurons to photolysis of MNI-D-aspartate (500 µM) and MNI-L-glutamate 
(500 µM). In the presence of TBOA (and antagonists of AMPA, NMDA, and GABAA 
receptors, and TTX), photolysis of MNI-L-glutamate produced a large (–500 to 
–1600 pA), slowly activating inward current in Purkinje neurons (Figure IV-6D) that 
was inhibited by 93.5 ± 2.4 % (n = 3) by the mGluR1 antagonist LY 367385 (100 µM) 
(Figure IV-6E). This slow inward current was not observed in response to photolysis 
of MNI-D-aspartate (n = 7/7 cells) (Figure IV-6D, F), even when uptake was blocked 
with TBOA, indicating that the released D-aspartate does not activate mGluR1. 
Notably, a small (~10 pA) rapidly activating inward current was observed in response 
to photolysis of MNI-L-glutamate (in the presence of 25 µM NBQX and TBOA), but 
not MNI-D-aspartate (see Figure IV-6D,E), presumably due to the activation of  114
kainate receptors (Huang et al., 2004).   
 
NMDA receptor activation following photolysis of MNI-D-aspartate.  
Ionotropic glutamate receptors exhibit striking differences in affinity and 
stereoselectivity for aspartate; NMDA receptors have a similar affinity for D- and 
L-aspartate (D-aspartate, 10 µM; L-aspartate, 11 µM) (Olverman et al., 1988), while 
AMPA receptors have an extremely low affinity for both L- and D-aspartate (Patneau 
and Mayer, 1990). To determine if MNI-D-aspartate can also be used to selectively 
activate NMDA receptors in neurons, we measured the response of CA1 pyramidal 
neurons to photolysis of MNI-D-aspartate. In the absence of antagonists of glutamate 
receptors or transporters, photolysis of MNI-D-aspartate produced an inward current 
when pyramidal neurons were held at –30 mV (Figure IV-7A). The current-to-voltage 
relationship of this response reversed at 0 mV and contained an area of negative slope 
conductance, characteristic of responses mediated by NMDA receptors (Figure IV-7B). 
These currents were blocked by R,S-CPP (10 µM) and MK-801 (50 µM), indicating 
that the D-aspartate released by photolysis of MNI-D-aspartate results in selective 
activation of NMDA receptors in CA1 pyramidal neurons (Figure IV-7B). Transporter 
currents were not observed in these neurons, presumably due to the low level of 
expression of EAAC1 (Bergles and Jahr, 1998; Danbolt, 2001). MNI-D-aspartate (500 
µM) did not induce an outward current in neurons held at 25 mV (n = 6), indicating 
that there was little free D-aspartate in the solution and that MNI-caged D-aspartate 
does not activate NMDA receptors. To address whether MNI-D-aspartate acts as an  115
inhibitor, we measured D-aspartate evoked NMDA receptor currents in the presence 
or absence of MNI-D-aspartate. As shown in Figures 7C and 7D, MNI-D-aspartate 
(500 µM) did not alter the amplitude or kinetics of NMDA receptor currents evoked 
through focal application of D-aspartate (500 µM) (n = 6). These data indicate that 
MNI-D-aspartate is neither an agonist nor antagonist of NMDA receptors, yet can be 
rapidly photolyzed by UV light to release free D-aspartate that can activate NMDA 
receptors in neuronal membranes.    116
Discussion 
Glutamate transporters expressed in neuronal and glial membranes set the level of 
ambient glutamate, shape the activation of receptors at synapses, and help maintain 
synapse specificity (Danbolt, 2001; Huang and Bergles, 2004). Despite the 
importance of these transporters in regulating glutamate dynamics under 
physiological and pathological conditions, we know little about how their activity is 
regulated  in vivo. Studies of glutamate transporters in heterologous systems have 
yielded conflicting results (Dowd and Robinson, 1996; Gonzalez and Robinson, 2004; 
Trotti et al., 2001), highlighting the importance of studying these processes in their 
native membranes. Yet, few studies have examined the regulation of transporters in 
brain tissue, due to the challenges inherent in working with intact preparations. To 
enable such analysis, we have developed a novel caged analogue of D-aspartate 
(MNI-D-aspartate), because D-aspartate is efficiently transported by glutamate 
transporters (Arriza et al., 1994) but has a low affinity for many glutamate receptors. 
We found that MNI-D-aspartate is neither an agonist nor an antagonist of glutamate 
transporters, and is stable in aqueous solution for a period of days (in the dark at 4° C), 
yet can be photolyzed to release D-aspartate upon exposure to near-UV light. 
Photolysis of this compound elicited transient glutamate transporter currents in 
astrocytes, Bergmann glia, and Purkinje neurons in acute brain slices, but did not 
activate AMPA/kainate receptors or mGluRs. Thus, the combination of 
MNI-D-aspartate photolysis and electrophysiological monitoring of glutamate 
transporter currents represents a promising approach for examining the interaction  117
between receptors and transporters at synapses in semi-intact tissue. 
 
Photorelease of D-aspartate reveals a high density of transporters in astrocyte 
membranes 
Laser induced photolysis of MNI-D-aspartate in hippocampal slices triggered an 
inward current in astrocytes. Because these currents were recorded in the absence of 
anions that exhibit a high permeability through glutamate transporters (Wadiche et al., 
1995), they reflect the net influx of two positive charges that accompany each 
molecule of glutamate (Levy et al., 1998; Zerangue and Kavanaugh, 1996). Thus, a 
movement of 33.6 pC of charge (see Figure IV-2) corresponds to the transport of 10.5 
x 10
7 molecules of D-aspartate, and activation of an equal number of transporters, if it 
is assumed that the transporters complete a single cycle following brief photolysis 
(Bergles and Jahr, 1997); this assumption is based on the slow cycling time of 
astrocyte glutamate transporters (time constant: 35 ms) (Bergles and Jahr, 1998) and 
EAAT2 (time constant: 137 ms) (Wadiche and Kavanaugh, 1998) when transporting 
D-aspartate, as compared to the decay of the photolysis-induced transporter current 
(time constant: 17 ms). It is likely that this measurement underestimates the total 
number of transporters activated in a single cell, as some of the charge associated with 
transport is lost through the low resistance astrocyte membrane (Bergles and Jahr, 
1997; Dzubay and Jahr, 1999). It is possible that activation of glutamate transporters 
on a neighboring astrocyte could have contributed to the currents recorded from single 
astrocytes; however, previous studies suggest that the high resting conductance of the  118
astrocyte membrane limits current spread through the astrocyte syncytium (Bergles 
and Jahr, 1997). The slow time course of these transporter currents suggests that the 
peak concentration of D-aspartate achieved during the 1 ms pulse was sub-saturating 
(Bergles et al., 2002). Together, these data indicate that a high density of functional 
glutamate transporters are expressed by astrocytes in this region, consistent with 
previous immunogold density measurements (Lehre and Danbolt, 1998), and 
functional assays (Bergles and Jahr, 1997; Diamond and Jahr, 2000). By comparison, 
glutamate transporter currents recorded from Purkinje neurons under similar 
conditions (50 µm spot, 125 µM MNI-D-aspartate) were more than 100-fold smaller. 
In order to maximize the transporter current from Purkinje neurons, we increased the 
area of illumination and the concentration of MNI-D-aspartate. Photolyic release of 
D-aspartate under these conditions resulted in the movement of ~ 8.4 pC of charge 
(see Figure IV-6), reflecting the activation of 2.6 x 10
7 transporters in these neurons, if 
it is assumed that the only one cycle of transport is completed due to slow transport of 
D-aspartate by EAAT4 (Fairman et al., 1995). Although these results indicate that 
there are fewer EAAT4 transporters in the membranes of Purkinje neurons (Dehnes et 
al., 1998; Lehre and Danbolt, 1998), these transporters may reach a high density near 
synapses, particularly in parasagittal zones that are enriched in EAAT4 (Dehnes et al., 
1998). Somewhat surprisingly, glutamate transporter currents recorded from 
Bergmann glial cells were ~10 fold smaller than those recorded from astrocytes. This 
may reflect the ~2-fold lower density of glutamate transporters in Bergmann glial cell 
membranes (Lehre and Danbolt, 1998), and the smaller membrane area of individual  119
Bergmann glial cells.   
 
Glutamate transport raises extracellular K
+ 
In astrocyte recordings, photolysis of either MNI-D-aspartate or MNI-L-glutamate 
(Huang et al., 2004) produced a fast transient current that decayed in ~ 30 ms, and a 
small tail current that decayed over several seconds. This biphasic waveform is 
similar to glutamate transporter currents recorded from astrocytes (Bergles and Jahr, 
1997) and Bergmann glial cells (Clark and Barbour, 1997) following electrically 
evoked release of glutamate from nerve terminals. It was initially proposed that the 
slowly decaying component of the synaptic transporter current resulted from the 
release of K
+ from axons following stimulation (Bergles and Jahr, 1997); because 
astrocytes exhibit a very high resting conductance to K
+, release of K
+ during axonal 
repolarization may shift the K
+ equilibrium potential and depolarize the astrocyte 
membrane. Indeed, the slow decay of the tail current is consistent with the slow 
clearance of K
+ from the extracellular space (Aitken and Somjen, 1986). Glutamate 
transporters counter transport one K
+ ion to complete the transport cycle (Kanner and 
Bendahan, 1982), suggesting that transporter activity alone may contribute to the 
accumulation of K
+. In support of this conclusion, the tail current was observed 
following photolysis of MNI-D-aspartate when all neuronal activity was blocked. 
Furthermore, the amplitude of this current was the same proportion (~ 2%) of the 
peak amplitude over a wide range of light intensities, as expected if the tail current 
occurs as a consequence of transporter activity. The tail current depolarized astrocytes  120
by ~1 mV in response to intense UV illumination (500 µM MNI-D-aspartate; data not 
shown), suggesting that glutamate transporter activity increased the extracellular 
concentration of K
+ by about 100 µM, assuming that the astrocyte membrane behaves 
like a perfect K
+ electrode. These results suggest that glutamate transporters may 
contribute to the rise in extracellular K
+ during periods of intense coordinated activity. 
By comparison, the tail current observed in astrocytes following electrical stimulation 
of axons was ~10% of the peak amplitude of the transporter current (Bergles and Jahr, 
1997), indicating that the majority of the tail current recorded under these conditions 
results from the release of K
+ from axons rather than by transporters.   
 
Comparison of CNB-D-aspartate and MNI-D-aspartate 
A prior study examined the kinetics of transporter-associated anion currents in 
EAAC1-expressing HEK293 cells following photolysis of CNB-D-aspartate (Grewer 
et al., 2001), a compound that has an approximately two-fold higher quantum yield 
than that of MNI-D-aspartate (MNI-D-aspartate: 0.09; α-CNB-D-aspartate: 0.19). In 
these cells, D-aspartate-induced transporter currents exhibited a slower rise time than 
currents evoked by photolysis of CNB-L-glutamate, and lacked discrete peak and 
steady-state components (Grewer et al., 2001). In contrast, astrocyte transporter 
currents induced by photolysis of MNI-D-aspartate exhibited rise and decay kinetics 
that were comparable to responses evoked by MNI-L-glutamate (see Figure IV-2B). 
These results are consistent with the similar kinetics of GLT-1 transporter currents 
induced by L-glutamate and D-aspartate (Bergles et al., 2002). Notably, EAAT2  121
(GLT-1) exhibits a higher affinity for D-aspartate than for L-glutamate (Km: 
D-aspartate, 13 µM; L-glutamate, 18 µM), while EAAT3 (EAAC1) exhibits a lower 
affinity for D-aspartate (Km: D-aspartate, 47 µM; L-glutamate, 28 µM)(Arriza et al., 
1994). As suggested by Grewer et al. (Grewer et al., 2001), the slower kinetics of 
EAAC1 currents in response to D-aspartate may indicate that binding of D-aspartate 
was rate limiting in their experiments. However, their study examined transporter 
associated anion currents, which do not always mimic the movement of coupled 
charges (Bergles et al., 2002). In addition, the duration of the responses triggered by 
CNB-D-aspartate (> 120 ms), and the distinct steady-state component of the EAAC1 
transporter current, indicate that transporters were exposed to D-aspartate for a longer 
time in their experiments, which may accentuate kinetic differences among substrates. 
Carboxylic acids caged by esterification with the CNB chromophore have been shown 
to undergo (spontaneous) hydrolysis in physiological buffers (Grewer et al., 2001; 
Pettit et al., 1997). In contrast, we were unable to detect free D-aspartate in solutions 
of MNI-D-aspartate, indicating that this compound may be more suitable for analysis 
of high affinity receptors and transporters in situ. 
 
D-aspartate accumulation and operation of transporters in exchange mode   
Although the rise times of astrocyte transporter currents to photorelease of 
D-aspartate and L-glutamate were similar, the decay of responses to D-aspartate was 
slightly slower (see Figure IV-2B). Furthermore, the decay time of D-aspartate 
induced transporter currents became longer over time with repeated stimulation, an  122
effect that was less apparent when L-glutamate was photoreleased. Transporters can, 
under certain conditions, operate in an exchange mode during which the movement of 
substrate into the cell is followed by the movement of this or another substrate back 
out (Dunlop, 2001; Kanner and Bendahan, 1982). Such activity can prolong 
transporter currents and slow the clearance of substrate (Isaacson and Nicoll, 1993), 
and may contribute to the relatively low efficiency of glutamate transporters (Bergles 
et al., 2002; Otis and Jahr, 1998; Wadiche and Kavanaugh, 1998). Because 
D-aspartate is not metabolized, it is possible that the prolongation of the transporter 
currents results from accumulation and subsequent release of D-aspartate by 
homoexchange.  
Cerebellar Purkinje neurons are the only neurons in the brain where glutamate 
transporter currents have been resolved. These neurons express EAAT4, a glutamate 
transporter that exhibits a high conductance to anions (Fairman et al., 1995). 
Transporter currents mediated by EAAT4 have been recorded from Purkinje neurons 
in response to synaptic stimulation (Auger and Attwell, 2000; Huang et al., 2004; Otis 
et al., 1997) and photorelease of glutamate (Brasnjo and Otis, 2004; Canepari et al., 
2001). Photorelease of L-glutamate elicits a complex response resulting from the 
activation of AMPA, kainate, and mGluRs, in addition to glutamate transporters 
(Canepari et al., 2001); in contrast, we found that photolysis of MNI-D-aspartate 
reliably evoked a small inward current in these neurons that was selectively mediated 
by glutamate transporters, as this D-aspartate induced current was larger when 
recorded with a NO3
––based internal solution and was blocked by TBOA. Purkinje  123
cell transporter currents decayed in two phases, an initial rapid decay (to 27.2 ± 1.2 % 
of peak in 16.8 ± 1.6 ms, n = 6), and a slower phase that became prominent at higher 
laser intensities, similar to responses observed in Purkinje neurons with 
7-nitroindolinyl (NI)-caged L-glutamate when glutamate receptors were blocked 
(Canepari et al., 2001). The slower phase of decay was also enhanced when Cs
+ rather 
than K
+ was used as the primary internal cation (data not shown). Because internal 
Cs
+ does not support transporter cycling as well as K
+ (Barbour et al., 1991; Bergles 
et al., 2002), internal solutions with this cation may allow a greater fraction of the 
transporters to operate in exchange mode (Kanner and Bendahan, 1982). Thus, 
although internal Cs
+ and TEA will increase membrane resistance and improve 
voltage-clamp in whole-cell recordings, they may significantly disrupt transporter 
cycling and alter baseline synaptic currents. 
 
MNI-D-aspartate as a tool for activating NMDA receptors in brain slices 
Unlike AMPA receptors, NMDA receptors exhibit little stereoselectivity for aspartate 
isomers, and exhibit an affinity for aspartate that is comparable to L-glutamate 
(Olverman et al., 1988). We found that photolysis of MNI-D-aspartate triggered 
NMDA receptor-mediated currents, but not AMPA-, kainate- or mGluR-mediated 
currents, in hippocampal CA1 pyramidal neurons. These currents were comparable in 
both kinetics and amplitude to NMDA receptor mediated currents evoked through 
release of glutamate at Schaffer collateral-commissural synapses (Arnth-Jensen et al., 
2002; Diamond, 2001). MNI-D-aspartate did not act as an antagonist of NMDA  124
receptors, and was stable in physiological saline. A photolabile analogue of NMDA 
(β-DNB NMDA) has been developed as a tool for investigating the kinetics of 
NMDA receptors (Gee et al., 1999). However, because NMDA is not a substrate for 
glutamate transporters, clearance of NMDA within the slice is dependent on diffusion 
alone. As a result, photorelease of NMDA is likely to produce long-duration NMDA 
receptor-mediated currents, limiting temporal resolution and causing substantial 
receptor desensitization. The properties of MNI-D-aspartate described here suggest 
that it may be more suitable than caged analogues of NMDA for examining NMDA 
receptor function in brain slices.  125
Figure IV-1. Synthesis and structure of MNI-D-aspartate.  126
Figure IV- 1 
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Figure IV-2.  Photolysis of MNI-D-aspartate activates glutamate transporter 
currents in hippocampal astrocytes. A, A transient inward current was elicited in an 
astrocyte by a 1 ms flash of UV laser light in the presence but not in the absence of 
MNI-D-aspartate (MNI-D-Asp, 125 µM). The trace above shows the duration of UV 
exposure. B, The response elicited by photolysis of MNI-D-aspartate (MNI-D-Asp, 
125 µM, red trace) exhibited similar kinetics to the response elicited by photolysis of 
MNI-L-glutamate (MNI-L-Glu, 125 µM). C, The current evoked by photolysis of 
MNI-D-aspartate was reversibly inhibited by TBOA (200  µM). D, The glutamate 
transporter current evoked in astrocytes by photolysis of MNI-D-aspartate exhibited a 
larger peak amplitude and faster decay at near physiological temperature. (R.T., room 
temperature). All recordings were made from astrocytes located in stratum radiatum 
of area CA1, in the presence of TTX (1 µM), R,S-CPP (10 µM), MK-801 (50 µM) 
and NBQX (10 µM). Astrocytes were voltage-clamped at –80 mV with a 
KMeS-based internal solution.   
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Figure IV- 2 
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Figure IV-3. Photolysis evoked glutamate transporter currents recorded at 
different UV light intensities. A, Left, Glutamate transporter currents induced in a 
hippocampal astrocyte by uncaging MNI-D-aspartate (125 µM) with a range of UV 
light intensities. Right, Grouped data showing the relationship between light intensity 
and the normalized peak amplitude of the evoked transporter current (n = 3). B, Left, 
A single response recorded from an astrocyte in response to MNI-D-aspartate 
photolysis illustrating the discrete peak and tail currents. Right, Grouped data showing 
the relative amplitude of the tail current (% of peak) at different UV light intensities. 
The tail current was measured by averaging the current 500-600 ms after the flash (n 
= 3). All recordings were made from astrocytes located in stratum radiatum of area 
CA1, in the presence of TTX (1 µM), R,S-CPP (10 µM), MK-801 (50 µM) and 
NBQX (10 µM). Astrocytes were voltage-clamped at –80 mV with a KMeS-based 
internal solution. 
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Figure IV- 3 
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Figure IV-4. MNI-D-aspartate does not antagonize glutamate transporters. A, 
Left, Glutamate transporter currents evoked in a hippocampal astrocyte by local 
pressure application of D-aspartate (500 µM; pressure pulse: 5-10 ms at 15-20 psi), in 
the absence and presence of MNI-D-aspartate (MNI-D-Asp, 500 µM). A 1 ms UV 
flash was applied at the end of the recording to demonstrate the presence of the caged 
compound.  Right, Grouped data showing the change in peak amplitude, charge 
transfer, 10−90% rise time and half decay time of transporter currents elicited through 
pressure application of D-aspartate recorded in the absence and presence of 
MNI-D-aspartate (n = 4). B, Left, Peak amplitude of glutamate transporter currents 
recorded from an astrocyte over a period of 25 minutes in a perforated-patch 
recording configuration ([MNI-D-aspartate] = 125 µM). Three representative traces 
are shown in the inset to illustrate the time course of the transporter currents over the 
duration of the recording. Right, Grouped data showing normalized peak amplitudes 
over the 25 minute recording period for four experiments. All recordings were made 
from astrocytes located in stratum radiatum of area CA1, in the presence of TTX (1 
µM), R,S-CPP (10 µM), MK-801 (50 µM) and NBQX (10 µM). Astrocytes were 
voltage-clamped at –80 mV with a KMeS-based internal solution. 
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Figure IV- 4 
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Figure IV-5. Photolysis of MNI-D-aspartate elicits glutamate transporter 
currents in Bergmann glia of the cerebellum. A, Inward currents recorded from a 
Bergmann glial cell in response to photolysis of MNI-D-aspartate (125 µM), were 
inhibited by the glutamate transporter antagonist TBOA (200 µM). SR 95531 (5 µM), 
R,S-CPP (10 µM) and NBQX (10 µM) were present throughout the experiment. B, 
Grouped data comparing the peak amplitudes and % inhibition by TBOA of responses 
recorded in Bergmann glia and hippocampal astrocytes in response to photolysis of 
MNI-D-aspartate. Numbers in parenthesis indicate the number of experiments. 
Transporter currents in each case were recorded with a 40x objective using 125 µM 
MNI-D-aspartate. Astrocytes and Bergmann glia were voltage-clamped at –80 mV 
with a KMeS-based internal solution. ** p < 0.01; *** p < 0.001. 
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Figure IV- 5 
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Figure IV-6.  Glutamate transporter currents evoked in Purkinje neurons 
through photolysis of MNI-D-aspartate.  A, Inward currents recorded from a 
Purkinje neuron to photolysis of MNI-D-aspartate (500 µM), in the absence and 
presence of TBOA (200 µM). CsMeS-based internal solution. B, Same experiment as 
in A except that the recording was made with a CsNO3-based internal solution. C, 
Grouped data showing the peak amplitude and 10−90% rise time of glutamate 
transporter currents recorded in Purkinje neurons using two different internal 
solutions. Numbers in parenthesis indicate the number of experiments. *** p < 0.001. 
D, Comparison of the response of a Purkinje neuron to photolysis of 
MNI-L-glutamate (500 µM) and MNI-D-aspartate (MNI-D-Asp, 500 µM) in the 
presence of TBOA (100 µM). E, Response of a Purkinje neuron to photolysis of 
MNI-L-glutamate (MNI-L-Glu, 500 µM) recorded in the absence or presence of the 
mGluR1 selective antagonist LY 367385 (100 µM). F, A glutamate transporter current 
recorded from the cell shown in D in response to photolysis of MNI-D-aspartate. All 
currents were recorded at –65 mV in the presence of SR 95531 (5 µM), picrotoxin 
(100 µM), R,S-CPP (10 µM) and NBQX (15 µM).   
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Figure IV- 6 
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Figure IV-7.  Photolysis of MNI-D-aspartate elicits NMDA receptor-mediated 
currents in hippocampal CA1 pyramidal neurons. A, Response of a pyramidal 
neuron to photolytic release of D-aspartate recorded at different holding potentials (as 
indicated). The ACSF contained 1 µM TTX, and responses were recorded with a 
CsMeS-based internal solution. B, Plot of the current-voltage relationship of currents 
recorded from CA1 pyramidal neurons in response to photolysis of MNI-D-aspartate 
under control conditions (closed circles) or in the presence of R,S-CPP (10 µM) and 
MK-801 (50 µM) (open squares). Peak amplitudes were normalized to the value 
recorded at Vm = –30 mV (n = 3). C, NMDA receptor currents recorded at Vm = 
25  mV in response to local pressure application of 500 µM D-aspartate in the 
presence or absence of MNI-D-aspartate (500 µM). A 1 ms UV flash was applied at 
the end of the recording to demonstrate the presence of the caged compound. D, 
Grouped data showing the change in peak amplitude, charge transfer, 10−90% rise 
time and half decay time of transporter currents elicited through pressure application 
of D-aspartate, recorded in the absence and presence of 500 µM MNI-D-aspartate (n 
= 6).  138
Figure IV- 7 
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Chapter V 
GLT-1 function in hippocampal CA3 pyramidal neurons 
 
Introduction 
The studies described in Chapters II and III suggest that glutamate transporters 
GLT-1 and GLAST are responsible for removing the majority of glutamate at 
excitatory synapses, whereas neuronal transporters EAAC1 and EAAT4 contribute 
minimally. GLT-1 and GLAST are the quantitatively dominant transporters in the 
brain, and they are almost exclusively expressed by glial cells. However, there has 
been a long-standing debate on the putative expression of GLT-1 protein in a 
subpopulation of neurons in the normal adult brain. GLT-1 mRNA has been detected 
in a selective population of neurons in multiple regions of the normal adult brain 
(Berger and Hediger, 1998; Schmitt et al., 1996; Torp et al., 1994; Torp et al., 1997), 
and GLT-1 protein has been found in neurons in the retina (Euler and Wassle, 1995; 
Rauen and Kanner, 1994; Rauen et al., 1996), transiently during development 
(Northington et al., 1998), in cell cultures (Chen et al., 2002) and in pathological brain 
tissue (Martin et al., 1997). Based on these observations, it was speculated that GLT-1 
protein may also exist in certain neurons, perhaps at nerve terminals for synaptic 
recycling of glutamate. However, immunohistological studies using a variety of 
GLT-1 antibodies initially failed to reveal neuronal GLT-1 expression in vivo in the 
normal adult brain (for review, see Danbolt, 2001). It was concluded that either GLT-1 
is expressed in much lower levels in neurons than in astroglial cells, or that the GLT-1  140
protein present in neurons is a novel isoform not recognized by currently available 
antibodies. Two recent studies have re-evaluated the expression of GLT-1 by neurons 
in the hippocampus. Initial results suggested that GLT-1b, a carboxy-terminal splice 
variant (Utsunomiya-Tate et al., 1997), was found in nerve terminals (Chen et al., 
2002). However, this labeling was subsequently shown to be artifactual, as a similar 
pattern of labeling was observed in tissue taken from GLT-1 knockout mice (Chen et 
al., 2004). Nonetheless, further examination using peroxidase-enhanced immuno-EM 
suggests that full-length GLT-1 is present in a subset of nerve terminals in area CA1  
that presumably arise from CA3 Schaffer collateral-commissural fibers (Chen et al., 
2004). Further analysis is required to obtain information about the precise localization 
and quantification, as well as functional demonstration of this GLT-1 expression.   
To facilitate the study of regional distribution of GLT-1 in vivo, we developed 
GLT-1-BAC-eGFP reporter mouse in collaboration with the laboratory of Dr. Jeffrey 
Rothstein. This transgenic mouse has the eGFP gene downstream of GLT-1 promoter 
and therefore is expressed whenever and wherever the GLT-1 promoter is activated. 
Because the BAC DNA used for this expression construct includes the complete 
sequence of GLT-1 promoter, it is thought to contain all regulatory cis elements 
required for faithful control by endogenous transcriptional regulation machinery. As 
shown in Figure V-1A, eGFP signal was present throughout the brain, as expected for 
GLT-1 promoter activity. In the hippocampus, eGFP signal level was high in stratum 
radiatum and low in pyramidal cell layers, consistent with the predominant glial 
expression of GLT-1. In addition, eGFP signal was also detected in CA3 pyramidal  141
cell layer (Figure V-1A, arrows), reminiscent of previous observations of GLT-1 
mRNA expression in CA3 pyramidal neurons (Berger and Hediger, 1998; Schmitt et 
al., 1996; Torp et al., 1997). Measurements of eGFP intensity by confocal microscopy 
in the adult hippocampus revealed high GLT-1 promoter activity in astroglial cells, 
low but significant promoter activity in CA3 pyramidal neurons, and undetectable 
promoter activity in CA1 pyramidal neurons (Figure V-1B). These results suggest that 
GLT-1 promoter activity is strictly regulated in different populations of cells, and that 
GLT-1 protein may be expressed by CA3 pyramidal neurons. 
To examine whether there is functional GLT-1 expressed on the plasma 
membrane of CA3 pyramidal neurons, we aimed to isolate and characterize glutamate 
transporter currents in these neurons. We used MNI-D-aspartate, a caged form of 
transporter substrate (for synthesis and characterization see Chapter IV), to allow 
rapid and focal activation of transporters by brief exposure to near UV light. 
Photolysis of MNI-D-aspartate by 1 ms flash of near UV light reliably elicited an 
inward current in CA3, but not CA1, pyramidal neurons. The current was inhibited by 
selective glutamate transporter antagonists and exhibited a current-to-voltage (I-V) 
relationship characteristic of glutamate transporter currents. The current was also 
inhibited by a GLT-1-selective antagonist and was absent in GLT-1 knockout mouse 
selectively, suggesting that the photolysis-evoked current was solely mediated by 
GLT-1. Functional mapping of the subcellular distribution of the transporter current 
suggests that GLT-1 is present on both apical and basal dendrites of CA3 pyramidal 
neurons.  142
Materials and Methods 
Glutamate transporter deficient mice. The generation of GLT-1
-/- mice, EAAC1
-/- 
mice and GLAST
-/- mice have been described previously (Peghini et al., 1997; Tanaka 
et al., 1997; Watase et al., 1998). All comparisons between specific transporter 
knockout mice and wild-type mice were performed between littermates obtained from 
heterozygous matings. The genotype of all experimental animals was determined by 
PCR.  
Slice Preparation. Hippocampal slices were prepared in similar ways as described in 
Chapter III. Slices were prepared from postnatal day 18 to 20 (P18-20) rats in 
ice-cold saline solution containing (in mM): choline chloride 110, KCl 2.5, MgSO4 7, 
CaCl2 0.5, NaH2PO4 1.25, choline bicarbonate 25, D-glucose 25, kynurenic acid 1, 
saturated with 95% O2, 5% CO2. Slices were incubated in ACSF for 30 min at 37°C, 
and then allowed to recover for at least 30 min at room temperature before 
experimentation. Brain slices were used within 7 hours of preparation. 
Whole Cell Recording. Brain slices that had recovered for at least one hour were 
transferred to a Lucite chamber with a coverslip bottom and continuously superfused 
with oxygenated ACSF. Individual cells (CA1 and CA3 pyramidal neurons) were 
visualized through a 40x water immersion objective (Olympus LUMPlanFl, NA = 0.8) 
using an upright microscope (Axioskop FS2, Zeiss) equipped with infrared-Nomarski 
optics and a CCD camera (Sony XC-73). Recording electrodes were pulled from glass 
capillary tubing and had a combined resistance of 1.5-3.0 MΩ when filled with the 
internal solution. To record the coupled transporter current in CA3 pyramidal neurons,  143
the internal solution contained (in mM): KCH3O3S (KMeS) 120, EGTA 10, HEPES 
20, MgCl2 1, Na2ATP 2, NaGTP 0.2; the pH was 7.3. To record transporter associated 
anion currents from pyramidal neurons, the internal solution contained (in mM): 
KSCN 130, EGTA 10, HEPES 20, MgCl2 1, Na2ATP 2, NaGTP 0.2; the pH was 7.3; 
to record the current-voltage relationship of the transporter anion current, KSCN was 
substituted with CsNO3 103, and TEA-Cl 20 was included. With these solutions the 
series resistance during recordings was <10 MΩ, and was left uncompensated. Unless 
stated otherwise, holding potentials have not been corrected for the junction potential. 
Whole-cell currents were amplified using an Axopatch 200B (Axon Instruments), 
filtered at 2-5 kHz and sampled at 10-20 kHz. A 0.5-5 mV step was applied at the 
beginning of each trace to measure both the membrane and access resistances.   
Solution Application. Caged compounds were dissolved in HEPES buffered saline 
(HEPES ACSF) containing (in mM): NaCl 137, KCl 2.5, CaCl2 2.5, MgCl2 1.3, 
HEPES 20; the pH was 7.3. Solutions containing caged compounds were applied to 
the slice using a wide bore (tip diameter 50-100 µm) pipette connected to a manifold 
fed by four 10 ml reservoirs. Solutions were switched by alternately opening and 
closing valves attached to each reservoir. Antagonists were used to block 
voltage-gated Na
+ channels (tetrodotoxin; TTX, 1  µM), AMPA/kainate receptors 
(2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f] quinoxaline-7-sulfonamide disodium 
salt; NBQX, 10  µM), NMDA receptors ((RS)-3-(2-carboxypiperazin-4-yl)-propyl-1 
-phosphonic acid; R,S-CPP, 10  µM; (5R,10S)-(+)-5-methyl-10,11-dihydro-5H- 
dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate; MK-801, 50  µM; and  144
5,7-dichlorokynurenic acid, 50 µM), and GABAA receptors (6-imino-3-(4- 
methoxyphenyl)-1(6H)- pyridazinebutanoic acid dihydrobromide; SR-95531, 5 µM). 
All appropriate blockers were included in the puffer pipette solution. Glutamate 
transporters were inhibited using DL-threo-β-benzyloxyaspartic acid (TBOA, 
100-200 µM). GLT-1 was selectively inhibited by WAY 213613 (10 µM). The specific 
blockers used in each experiment are indicated in the figure legends. For experiments 
mapping the subcellular distribution of transporters in CA3 pyramidal neurons, the 
Alexa dye 647 (100 µM) was included in the recording pipette; the CMNB-caged 
fluorescein (500-1000 µM) was dissolved in dH2O and locally perfused following 
MNI-D-aspartate application. 
Photolysis of Caged Compounds. For photolysis, an argon ion laser (Stabilite 
2017-AR, Spectra-Physics) providing ~ 380 mW of multi-line UV light 
(333.6-363.8 nm) was coupled to the microscope through a multi-mode quartz fiber 
optic cable (Oz Optics Ltd.). The output of the fiber optic was collimated using a 
quartz lens, projected through the fluorescence port of a Zeiss Axioskop FS2 
microscope, and focused to a ~100 µm spot using a 20x water immersion objective 
(Olympus UMPlanFl) to cover the soma and proximal dendrites of pyramidal neurons, 
or to a ~33 µm spot using a 60x water immersion objective (Olympus LUMPlanFl) to 
cover a restricted region on the soma or dendritic arbor. The UV spot was centered on 
the soma or dendritic arbor of pyramidal neurons, using a targeting laser (633 nm 
HeNe). To control the length of exposure, a computer controlled programmable pulse 
generator (Master 8, AMP Instruments) was used to trigger a high-speed laser shutter  145
(NM laser) placed between the laser head and the fiber launch. Photolysis was 
achieved by opening the shutter for 1 ms. In some experiments, the intensity of the 
laser was varied using the aperture on the laser head. The output intensity for each 
aperture was measured using a power meter. A laser intensity (at the output) of 380 
mW was used for recordings from hippocampal CA3 pyramidal neurons (20x 
objective), corresponding to a total light energy of 48 mJ/cm
2. These values reflect the 
laser power prior to entering the fiber optic; the energy reaching the cell is likely to be 
considerably less due to loss at the fiber launch, the microscope lenses, and the 
intervening tissue.   
Chemicals Used for Photolysis Experiments. NBQX, R,S-CPP, MK-801, 
5,7-dichlorokynurenic acid, SR-95531, and TBOA were purchased from Tocris. 
D-aspartate was purchased from Sigma. TTX was purchased from Alomone Labs. 
Alexa dye 647 and the CMNB-caged fluorescein were purchased from Molecular 
Probes (Invitrogen). 
Data Analysis and Statistics. Data were analyzed off-line using Clampfit (Axon 
Instruments) and Origin (Microcal) software. All values are represented as mean ± 
standard error of the mean. The Student’s t-test (paired or unpaired, as appropriate) 
was used for statistical comparison; p < 0.05 was considered significant.   
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Results 
Photolysis of MNI-D-aspartate elicits glutamate transporter currents in CA3 but 
not CA1 pyramidal neurons. 
To maximize the probability of detecting glutamate transporter currents in CA3 
neurons, we used a 20x objective to create a wide UV spot of ~ 100 µm to cover the 
soma and proximal dendrites of CA3 neurons; and used a SCN
--based internal 
solution (see Methods) to amplify the anion conductance associated with glutamate 
transport. Whole-cell voltage-clamp recordings were made from hippocampal CA3 
pyramidal neurons, and their response to photolysis of MNI-D-aspartate (500 µM) 
was measured in the presence of AMPA, NMDA, and GABAA receptor antagonists, 
as well as TTX (see Methods). Brief (1 ms) exposure to UV light produced a rapidly 
activating, transient inward current in these neurons, which was only observed when 
the superfusing solution contained MNI-D-aspartate (Figure V-2A). The peak 
amplitude of these responses was −7.7 ± 0.9 pA (n = 6) when a MeS-based internal 
solution was used to reveal the coupled charge movement; when MeS was replaced 
with SCN
- (see Methods), the photolysis-evoked response was much larger (−44.8 ± 
9.5 pA, n = 8, p < 0.01), suggesting that transporter associated anion conductance was 
activated by uncaging of MNI-D-aspartate. The peak amplitude of the photolysis- 
evoked anion current was reduced by 81 ± 2 % (n = 7) by TBOA (200 µM) (Figure 
V-2A), confirming that the anion conductance resulted from the activation of 
glutamate transporters. Using responses recorded by MeS-based internal solution, the 
charge transfer induced by photolysis was calculated to be ~ 0.9 pC, which  147
corresponds to the transport of 2.8 x 10
6 molecules of D-aspartate based on the 
stoichiometry of glutamate transporters (net influx of two positive charges per 
glutamate molecule), and activation of an equal number of transporters, if it is 
assumed that the transporters complete a single cycle following brief photolysis 
(Bergles and Jahr, 1997). Measurement of the current-voltage (I-V) relationship of 
these responses using a CsNO3-based internal solution revealed that the photolysis- 
evoked current continuously decreased as the membrane potential was depolarized, 
but the current was not reversed even at +40 mV (Figure V-2B). This is consistent 
with the behavior of Na
+-dependent glutamate transport; as the membrane potential 
approaches the equilibrium potential for Na
+, Na
+-dependent glutamate binding is 
reduced, but glutamate transport is not reversed (Levy et al., 1998). These results 
indicate that functional glutamate transporters are present on the membrane of 
hippocampal CA3 pyramidal neurons. 
In contrast, photolysis of MNI-D-aspartate under similar conditions revealed 
no such current in CA1 pyramidal neurons (SCN
--based internal solution; peak 
amplitude at −65 mV: −8.8 ± 1.9 pA, n = 7, p < 0.01 compared to CA3 pyramidal 
neurons) (Figure V-3A). There was a small and sustained current evoked in the 
presence but not absence of MNI-D-aspartate, but it was not likely to be mediated by 
glutamate transporters, as it persisted in the presence of TBOA (200 µM) (Figure 
V-3A). A similar residual current was also observed in EAAC1 knockout mice, and 
the peak amplitude was not significantly different from the wild-type littermates 
(EAAC1
-/-:  −5.2 ± 0.7 pA, n = 5; EAAC1
+/+:  −5.5 ± 0.9 pA, n = 3, p = 0.369),  148
suggesting that it is not mediated by EAAC1 either (Figure V-3B). Theses results are 
consistent with the observation that GLT-1 promoter activity was present in CA3 but 
not CA1 pyramidal neurons as revealed in the GLT-1-BAC-eGFP reporter mice 
(Figure V-1B). Thus, expression of eGFP in these mice reflects the activity of the 
GLT-1 protein. 
 
GLT-1 glutamate transporters mediate the photolysis-evoked currents in CA3 
pyramidal neurons.  
The response to photolysis of MNI-D-aspartate (500 µM) was measured in CA3 
pyramidal neurons in the absence and presence of WAY 213613, a newly developed 
selective antagonist of GLT-1 that exhibits more than 40x higher affinity for GLT-1 
than GLAST and EAAC1 (provided by J. Dunlop, Wyeth Research). The peak 
amplitude was reduced by 77.3 ± 2.5 (n = 3) by WAY 213613 (10 µM), suggesting 
that GLT-1 mediates the transporter current in CA3 pyramidal neurons. Furthermore, 
measurements of photolysis-evoked transporter currents in selective glutamate 
transporter knockout mice showed that the current was only absent in GLT-1
-/- mice 
(Figure V-4A) (peak amplitude in GLT-1
+/+: −49.2 ± 5.8 pA, n = 6; GLT-1
-/-: −5.3 ± 
0.5 pA, n = 5, p < 0.001), and the currents in GLAST and EAAC1 knockout mice 
were not significantly different from those of their wild-type littermates (GLAST
+/+: 
−55.1 ± 5.6 pA, n = 5; GLAST
-/-: −55.6 ± 5.9 pA, n = 5, p = 0.475; EAAC1
+/+: −51.2 ± 
5.9 pA, n = 5; EAAC1
-/-: −47.4 ± 5.3 pA, n = 5, p = 0.323) (Figure V-4B). These 
results indicate that the photolysis-evoked glutamate transporter currents in CA3  149
pyramidal neurons are mediated by GLT-1. 
 
Distribution of GLT-1 transporters in CA3 pyramidal neurons. 
The above experiments reveal that glutamate transporter activity is present in the 
soma and proximal dendrites of CA3 pyramidal neurons. To obtain further insights 
about the potential function of GLT-1 in CA3 neurons during synaptic transmission, 
we next examined whether there is preferential regional localization of these 
transporters. CA3 pyramidal neurons receive three main excitatory inputs, which are 
segregated into different layers along the dendritic arbor (Shepherd, 2004). The most 
proximal portion of the apical dendrites of CA3 neurons receive mossy fiber (MF) 
inputs from dentate granule cells; the most distal portion of their apical dendrites 
receives perforant path inputs from the entorinal cortex; and the middle portion of the 
apical dendrites as well as the basal dendrites receive associational/ commissural 
inputs from other CA3 pyramidal neurons (Shepherd, 2004). Using a 60x objective to 
focus the laser UV light onto a ~33 µm spot, we were able to selectively activate 
different portions of the dendritic arbor, and record corresponding glutamate 
transporter currents. To determine the size and position of the uncaging spot in 
relation to the dendritic arbor of the recorded neuron, a CMNB-caged fluorescein was 
included in the superfusing solution (see Methods), and a fluorescent dye Alexa 647 
(red) was included in the recording pipette to reveal the soma and processes. At the 
positions where MNI-D-aspartate is photolyzed, the CMNB-caged fluorescein is also 
photolyzed by the same UV light. The released fluorescein emits green fluorescent  150
light upon excitation with 488 nm light from argon ion laser, and thus reveals the 
uncaging spot. MNI-D-aspartate and the caged fluorescein were applied sequentially 
to avoid potential interference of the two either during photolysis or in activating 
glutamate transporters.   
As shown in Figure V-5A, B, photolysis of MNI-D-aspartate (500 µM) evoked 
transporter currents throughout the apical and basal dendrites, producing the largest 
peak amplitude at the soma. These results suggest that GLT-1 may be most abundant 
in the soma and proximal dendrites of CA3 neurons. However, it was not possible to 
determine whether GLT-1 is also present at more distal parts of CA3 neuron apical 
dendrites or at the axon terminals. This is mainly because K
+-based internal solution 
was used in these recordings to facilitate transporter cycling, which on the other hand 
makes the cell leaky and causes significant spatial filtering of the current signals; 
therefore transporter currents are rapidly attenuated as the current source moves away 
from the recording electrode (soma). Nonetheless, transporter currents evoked from 
the proximal dendrites of CA3 pyramidal neurons indicate that GLT-1 may exist in the 
vicinity of MF and commissural fiber inputs to participate in synaptic clearance.   
 
Discussion 
In this series of experiments we show that photolysis of MNI-D-aspartate elicited 
glutamate transporter currents in hippocampal CA3 but not CA1 pyramidal neurons. 
The photolysis-evoked transporter current was mediated by GLT-1, and could be  151
evoked at the soma as well as the apical and basal dendrites of CA3 pyramidal 
neurons. 
 
Functional GLT-1 expression in hippocampal CA3 pyramidal neurons 
To our knowledge these data represent the first demonstration of functional GLT-1 
expression in neurons in situ. Our ability to detect these rather small currents was 
facilited by the photolysis approach. Compared to other methods for eliciting 
transporter currents, photolysis has the advantage of being able to activate a large 
number of transporters in a highly synchronous manner. In Chapter IV, we showed 
that uncaging of MNI-D-aspartate (125 µM) for the duration of 1 ms could activate 
10.5 x 10
7 transporters on a single astrocyte. When recording from hippocampal 
pyramidal neurons, we further augmented the photolysis capacity by increasing the 
concentration of MNI-D-aspartate to 500 µM and the laser power from ~230 mW to 
~380 mW. Recordings from astrocytes under these conditions revealed that 
transporter currents are greatly potentiated in both peak amplitude and charge transfer 
(data not shown), suggesting that an even larger number of transporters can be 
activated when the concentration of caged compound and the laser power are 
increased. Under these improved conditions, we could isolate the coupled transporter 
currents from CA3 pyramidal neurons and calculate the number of activated 
transporters to be ~ 2.8 x 10
6. The photolysis-evoked currents in CA3 pyramidal 
neurons are much smaller in peak amplitude and charge transfer compared to those 
recorded in astrocytes and Purkinje neurons under similar conditions (Huang et al.,  152
2005). These data are consistent with previous studies showing comparatively low 
levels of GLT-1 immunoreactivity in neurons (for review, see Danbolt, 2001), and the 
observation that in the GLT1-BAC-eGFP reporter mouse, GLT-1 promoter activity, 
although detectable in CA3 neurons, is much lower compared to that in the 
surrounding astrocytes (Figure V-1B). 
When occurrs close to synapses, glutamate uptake by a limited number of 
transporters may still influence the occupancy of receptors during transmission. We 
estimated that ~ 2.8 x 10
6 transporters are activated by photolysis in CA3 pyramidal 
neurons from illuminating the soma and proximal dendrites. If it is assumed that these 
transporters are concentrated at the MF postsynaptic region, and that each CA3 
neuron receives ~ 210 active release sites from MF terminals (Chicurel and Harris, 
1992; von Kitzing et al., 1994), then on average there would be ~ 1.3 x 10
4 
transporters for each MF release site. This is significant compared to ~ 4,000 
glutamate molecules released per vesicle. One other example is shown by neuronal 
transporter EAAC1. Transporter currents mediated by EAAC1 is under the detection 
limit in situ (Figure V-3), and yet inhibition of EAAC1 postsynaptically potentiates 
the activation of extrasynaptic NMDA receptors (Diamond, 2001). Therefore by being 
preferentially positioned at synapses, a limited number of neuronal transporters could 
be effective in regulating the activation of peri- or extrasynaptic receptors during 
transmission. 
 
Putative function of GLT-1 in CA3 pyramidal neurons  153
Compared to EAAT4, the other neuronal glutamate transporter whose activation and 
function at Purkinje neuron synapses have been extensively studied, GLT-1 has (1) a 
lower affinity (Arriza et al., 1994; Fairman et al., 1995), (2) a smaller anion 
conductance (Fairman et al., 1995; Wadiche et al., 1995), and (3) a faster turnover rate 
(Bergles et al., 2002; Otis and Jahr, 1998). Consequently, (1) for a given number of 
transporters, GLT-1 will be a less potent buffer than EAAT4 in reducing the 
concentration of ambient glutamate. (2) EAAT4 transporters have significant anion 
(Cl
-) influx accompanying glutamate transport under physiological conditions, which 
may neutralize charge accumulation at the inside of the membrane and facilitate 
glutamate uptake. In contrast, the anion conductance associated with GLT-1 activity is 
much smaller, which may render GLT-1 less effective in transport glutamate beyond 
the first cycle. (3) But GLT-1 has a faster turnover rate, which presumably will make 
them more responsive than EAAT4 to high-frequency release of glutamate. In 
summary, the characteristic features of GLT-1 indicate that at excitatory synapses, 
GLT-1 may impact transmission very differently than EAAT4. 
CA3 pyramidal neurons receive different excitatory inputs that are segregated 
into layers along the dendritic arbor. Our current studies revealed that GLT-1 mediated 
transporter currents can be evoked at the proximal and middle portions of CA3 
pyramidal neuron apical dendrites as well as the basal dendrites, indicating that GLT-1 
is present where mossy fibers and associational axons terminate. Within the scope of 
synaptic transmission, there are several possibilities to be tested. First, the mossy 
fiber-CA3 synapse is a large complex synapse where the presynaptic expansion is  154
penetrated by large thorny spines of the postsynaptic membrane, forming multiple 
active zones in between (Chicurel and Harris, 1992). The pre- and postsynaptic 
membranes are further joined together by puncta adherentia junctions that are highly 
developed at this synapse (Amaral and Dent, 1981; Commons and Milner, 1995), 
leaving little chance for glial processes to get to the vicinity of release sites. If GLT-1 
is present on the postsynaptic neuronal membrane, it would be the primary 
mechanism to remove synaptic glutamate and thereby influence receptor occupancy 
during transmission. It has been shown at this synapse that excitatory transmission 
can be potentiated if diffusion is compromised in the extracellular space (Min et al., 
1998). These findings suggest that postsynaptic receptors at this synapse are not 
saturated normally, and their activation closely follows the spatial and temporal 
concentration profile of glutamate around the synaptic cleft. In addition to 
postsynaptic receptors, there are high-affinity mGluRs present on mossy fiber 
terminals (Shigemoto et al., 1997), whose activity modulates presynaptic release 
(Manzoni et al., 1995); these receptors are also sensitive to the ambient concentration 
of glutamate (Min et al., 1998), and thus represent another candidate target for GLT-1 
regulation during transmission. Second, CA3 pyramidal neurons are extensively 
interconnected with each other via excitatory synapses formed by re-current 
collaterals (Shepherd, 2004). GLT-1 located at these synapses may regulate the 
recurrent excitation of CA3 neurons and fine-tune the excitability of the local CA3 
network by limiting receptor occupancy at these synapses. Third, if present on CA3 
neuron axon terminals, GLT-1 may also contribute to glutamate clearance at Schaffer  155
collateral synapses. It has been long debated whether GLT-1 exists on the presynaptic 
membrane of excitatory synapses to recycle released glutamate (for review, see 
Danbolt, 2001); and recent studies reveal that full-length GLT-1 is present in a subset 
of nerve terminals in area CA1 that presumably arise from CA3 pyramidal neurons 
(Chen et al., 2004). From our studies it is not conclusive whether GLT-1 is present at 
the axon terminals of CA3 neurons. Generation of neuronal-specific GLT-1 knockout 
mice or mice expressing tagged GLT-1 in CA3 pyramidal neurons selectively may be 
powerful tools to address this question conclusively (see below). 
 
Developing tools for studying GLT-1 function in CA3 pyramidal neurons 
To obtain direct evidence of the existence of GLT-1 on the synaptic membranes of 
CA3 neurons, immuno-EM studies may be necessary. Recent studies using 
peroxidase-enhanced immuno-EM suggest that GLT-1 is present in some axon 
terminals at CA1 radiatum region of the hippocampus. To confirm that GLT-1 is 
located in the Schaffer collateral terminals that originate from CA3 pyramidal neurons, 
it would be informative to examine the axonal expression in CA3-specific GLT-1 
knockout mice. The strategy would be to generate a knock-in mouse line with two 
lox-P sites flanking the endogenous GLT-1 gene; and cross the mouse with a 
transgenic mouse line expressing Cre recombinase selectively in neurons (Hirasawa et 
al., 2001). This approach is currently being developed in our collaborator Dr. Jeffrey 
Rothstein’s laboratory. To overcome the high background of astroglial GLT-1 
immunoreactivity for immuno-EM studies, it is necessary to selectively label GLT-1  156
in CA3 pyramidal neurons. One strategy is to make a knock-in mouse line with 
GLT-1-“tag” fusion protein replacing the endogenous GLT-1, meanwhile having two 
lox-P sites flanking a “stop” codon inserted between GLT-1 and “tag”. When this 
mouse line is crossed with the neuronal-Cre transgenic mouse, GLT-1 but not the 
fusion protein GLT-1-“tag” will be expressed in non-neuronal cells; whereas fusion 
protein will only be expressed in Cre-expressing neurons, presumably CA3 pyramidal 
neurons in the hippocampus. 
Our efforts to understand the putative function of neuronal GLT-1 during 
transmission have been hindered largely by a lack of means to selectively manipulate 
neuronal GLT-1. The currently available GLT-1 selective antagonists dihydrokainate 
(DHK) and WAY 213613 do not distinguish between neuronal and glial GLT-1 
transporters. We have tried to selectively inhibit GLT-1 from the postsynaptic neuron 
by depleting intracellular K
+ to inhibit transporter turn-over; or by including a high 
concentration of glutamate transporter antagonist (TBOA, 10 mM) in the recording 
pipette. However, neither of these manipulations led to the inhibition of glutamate 
transporter currents induced by photolysis of MNI-D-aspartate (data not shown). 
Finally, membrane depolarization to near Na
+ equilibrium potential prohibits Na
+ 
binding; because Na
+ binding is a prerequisite for subsequent glutamate binding, this 
manipulation blocks glutamate transport (Levy et al., 1998). We also observed that the 
transporter current is much reduced at depolarized potentials (Figure V-2B), 
suggesting that membrane depolarization may be a promising approach to inhibit 
transporters. Other than electrophysiology, virus-mediated antisense or RNAi  157
knockdown of neuronal GLT-1, as well as neuronal-specific GLT-1 knockout mice are 
powerful tools to enable single-cell examination of GLT-1 function in CA3 pyramidal 
neurons. These tools are currently being developed in collaboration with the 
laboratory of Dr. Jeffrey Rothstein.  158
Figure V-1.  Hippocampal CA3 pyramidal neurons exhibit GLT-1 promoter 
activity in young adult mice.  A, Saggital sections of the whole brain (top) and the 
hippocampus (bottom) of a BAC-GLT1-eGFP transgenic mouse at the age of 
postnatal day 17. The fluorescence of GLT-1 promoter-driven eGFP was observed 
using wide-field fluorescence microscope. In the hippocampus (bottom), expression 
of eGFP is largely restricted to astroglial cells; CA1 pyramidal cell layer and the 
dentate gyrus granule cell layer are negative for the eGFP signal (asterisks); CA3 
pyramidal cell layer is weakly fluorescent (arrows). Scale bars = 2 mm (top), 200 µm 
(bottom).  B, High magnification confocal images of the CA3 and CA1 regions 
showing eGFP fluorescence and NeuN immunoreactivity. In the CA3 region, eGFP 
fluorescence was detected in astroglial cells (a, arrow head) and pyramidal neurons 
(a&b,  asterisks). Interneurons, as indicated by weak NeuN immunoreactivity (b, 
arrows), do not exhibit eGFP fluorescence (a, arrows). In the CA1 region, eGFP 
fluorescence was detected in astrocytes (c, arrow head) but not pyramidal neurons 
(c&d, asterisks). Scale bars = 20 µm (a−d). This figure was kindly provided by Dr. 
Melissa Regan in the laboratory of Dr. Jeffrey Rothstein.  159
Figure V- 1 
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Figure V-2.  Glutamate transporter-mediated currents can be elicited in CA3 
pyramidal neurons by photolysis of MNI-D-aspartate.  A, A transient inward 
current was elicited in a CA3 pyramidal neuron of an adult rat by a 1 ms flash of UV 
laser light in the presence but not absence of MNI-D-aspartate (MNI-D-Asp, 500 µM) 
(left). The response was inhibited by application of 200 µM TBOA. The trace above 
shows the duration of UV exposure. The neuron was held at −65 mV using a 
KSCN-based internal solution. Right, Summary of the peak amplitude of the evoked 
currents in the absence and presence of TBOA. (*** = p < 0.001). B, Current-Voltage 
(I-V) relationship of the photolysis-evoked responses. The evoked currents were 
recorded at different membrane potentials changing from −80 mV to +40 mV. 
CsNO3-based internal saline was used. Notice that the currents were not reversed at 
+40 mV. Numbers in parentheses indicate the numbers of recordings. All responses 
were recorded in the presence of AMPA, NMDA and GABAA receptor antagonists as 
well as TTX (see Methods).    161
Figure V- 2 
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Figure V-3.  The photolysis-evoked transporter current is absent in CA1 
pyramidal neurons.   A, Response of a CA1 pyramidal neuron in an adult rat 
hippocampus to the same stimulus as previously. The trace above shows the duration 
of UV exposure. The photolysis-evoked response was slightly larger than the 
UV-flash artifact, and was not inhibited by TBOA (200 µM). B, Same recordings 
performed in CA1 pyramidal neurons of an EAAC1
-/- mouse (bottom) and a wild-type 
littermate (top). The photolysis-evoked current in EAAC1
+/+ was not significantly 
larger than that in EAAC1
-/-, suggesting that the residual currents are not mediated by 
the neuronal transporter EAAC1. All neurons were held at −65 mV using 
KSCN-based internal solution. All responses were recorded in the presence of AMPA, 
NMDA and GABAA receptor antagonists as well as TTX (see Methods). 
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Figure V-4.    GLT-1 mediates the photolysis-evoked transporter currents in CA3 
pyramidal neurons.  A, Photolysis-evoked responses recorded from CA3 pyramidal 
neurons in a GLT-1
-/- mouse (right) and a wild-type littermate (left). Traces on the top 
show the duration of UV exposure. B, Summary of the peak amplitude of 
photolysis-evoked transporter currents in CA3 pyramidal neurons recorded from mice 
of different genotypes. The evoked transporter currents were absent in GLT-1
-/- mice 
selectively (*** = p < 0.001; NS = not significant). Numbers in parentheses indicate 
the numbers of recordings. All neurons were held at −65 mV using KSCN-based 
internal solution. All responses were recorded in the presence of AMPA, NMDA and 
GABAA receptor antagonists as well as TTX (see Methods). 
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Figure V-5.  GLT-1 transporters are distributed on the soma and proximal 
dendrites of CA3 pyramidal neurons.  A, A CA3 pyramidal neuron filled with 
Alexa dye 647 was illuminated. The CMNB-caged fluorescein was photolyzed by the 
laser UV light and emitted green fluorescent light upon excitation by 488 nm light. 
The spots of green fluorescent light therefore indicate the location and area that 
photolysis of MNI-D-aspartate occurred to activate transporters. B, Whole-cell 
recordings made from the cell body of the CA3 pyramidal neuron (as in A), showing 
the averaged responses upon photolysis at the four corresponding locations. The trace 
on the top shows the duration of UV exposure (5 ms).  167
Figure V- 5 
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Concluding Remarks 
 
The primary goal of this thesis was to understand the relative contributions of 
neuronal and glial transporters to the clearance of glutamate released at excitatory 
synapses, and to examine their differential impact on transmission. Using whole-cell 
patch-clamp methods, we combined pharmacological tools with genetically altered 
mice to examine transmission at two representative excitatory synapses in the adult 
rodent brain. We found that the neuronal transporter EAAT4 contributes to the uptake 
of ~10% of total released glutamate at the cerebellar climbing fiber-Purkinje cell 
synapse, and that EAAC1 does not contribute to the electrogenic transport of 
glutamate at this synapse. At hippocampal CA1-interneuron synapses, astroglial 
transporters GLAST and GLT-1, but not neuronal transporter EAAC1, contribute to 
the clearance of glutamate at extrasynaptic regions and regulate the activation of 
mGluRs at this synapse. Together, these results suggest that astroglial transporters, 
although positioned outside the synaptic cleft, contribute substantially more than 
neuronal transporters to the uptake of synaptically released glutamate. 
The extreme diversity in synaptic morphology indicates that caution should be 
exercised when generalizing results from a few model synapses. Although less 
numerous, neuronal transporters also have been shown to influence clearance and 
receptor occupancy during transmission, presumably by being localized near receptors. 
At synapses devoid of astroglial processes, and at complex synapses that consist of 
multiple active zones with no intervening astroglia, neuronal glutamate transporters  169
may be of particular importance in terminating glutamate transients and regulating 
receptor occupancy. In addition to EAAC1 and EAAT4 as neuronal transporters, we 
observed in this study that the predominant glial transporter GLT-1 also mediates 
electrogenic glutamate uptake in hippocampal CA3 pyramidal neurons in the adult 
rodent brain. Mossy fiber-CA3 synapses are a typical large, complex synapses that 
have multiple release sites but very little intervening astroglial processes; it is 
therefore a prominent candidate location to study GLT-1 function in neurons during 
transmission. Finally, it is not clear why neurons express different sets of glutamate 
transporters (EAAC1, EAAT4 and GLT-1), which differ in their molecular 
composition as well as affinity for glutamate, conductance for anions, transport 
efficiency and turnover time.  Future studies will test the hypothesis that different 
glutamate transporters expressed by neurons are subject to differential regulation; and 
that the difference in their biophysical properties determines their differential impact 
on synaptic transmission. 
It is likely that synaptic structure and glial ensheathment are not static, even in 
the adult mammalian brain. Astrocyte processes can extend and retract from synapses 
under physiological or pathological conditions and therefore reposition glutamate 
transporters in relation to synapses. Previous studies have shown in the hypothalamus 
during lactation (Oliet et al., 2001) as well as in the cerebellum following selective 
expression of GluR2 in Bergmann glia (Iino et al., 2001), that astroglial cells retract 
their processes from excitatory synapses, which leads to impairment of glutamate 
clearance and alters transmission significantly. These studies suggest that plastic  170
changes in synaptic structure and ensheathment, as well as dynamic regulation of 
glutamate transporter activity in subcellular domains, could represent a widespread 
mechanism for influencing synaptic signaling over a period of seconds, hours, or 
days. 
Although information about the individual roles of different glutamate 
transporters is emerging, the complex and dynamic regulation of synaptic structures 
as well as glutamate transporters themselves suggests that much work still needs to be 
done in order to create a complete picture of glutamate transporter involvement in 
excitatory transmission.  171
References 
 
Aitken, P. G., and Somjen, G. G. (1986). The sources of extracellular potassium 
accumulation in the CA1 region of hippocampal slices. Brain Res 369, 163-167. 
Amaral, D. G., and Dent, J. A. (1981). Development of the mossy fibers of the dentate 
gyrus: I. A light and electron microscopic study of the mossy fibers and their 
expansions. J Comp Neurol 195, 51-86. 
Amit, B., Ben-Efraim, D. A., and Patchornik, A. (1976). LIght-sensitive amides.   
The photosolvolysis of substituted 1-acyl-7-nitroindolines. J Am Chem Soc 98, 
843-844. 
Arnth-Jensen, N., Jabaudon, D., and Scanziani, M. (2002). Cooperation between 
independent hippocampal synapses is controlled by glutamate uptake. Nat 
Neurosci 5, 325-331. 
Arriza, J. L., Eliasof, S., Kavanaugh, M. P., and Amara, S. G. (1997). Excitatory 
amino acid transporter 5, a retinal glutamate transporter coupled to a chloride 
conductance. Proc Natl Acad Sci U S A 94, 4155-4160. 
Arriza, J. L., Fairman, W. A., Wadiche, J. I., Murdoch, G. H., Kavanaugh, M. P., and 
Amara, S. G. (1994). Functional comparisons of three glutamate transporter 
subtypes cloned from human motor cortex. J Neurosci 14, 5559-5569. 
Asztely, F., Erdemli, G., and Kullmann, D. M. (1997). Extrasynaptic glutamate 
spillover in the hippocampus: dependence on temperature and the role of active 
glutamate uptake. Neuron 18, 281-293. 
Attwell, D., and Gibb, A. (2005). Neuroenergetics and the kinetic design of excitatory  172
synapses. Nat Rev Neurosci 6, 841-849. 
Auger, C., and Attwell, D. (2000). Fast removal of synaptic glutamate by postsynaptic 
transporters. Neuron 28, 547-558. 
Balcar, V. J., and Johnston, G. A. (1972). The structural specificity of the high affinity 
uptake of L-glutamate and L-aspartate by rat brain slices. J Neurochem 19, 
2657-2666. 
Barbour, B., Brew, H., and Attwell, D. (1991). Electrogenic uptake of glutamate and 
aspartate into glial cells isolated from the salamander (Ambystoma) retina. J 
Physiol (Lond) 436, 169-193. 
Barbour, B., Keller, B. U., Llano, I., and Marty, A. (1994). Prolonged presence of 
glutamate during excitatory synaptic transmission to cerebellar Purkinje cells. 
Neuron 12, 1331-1343. 
Batchelor, A. M., and Garthwaite, J. (1997). Frequency detection and temporally 
dispersed synaptic signal association through a metabotropic glutamate receptor 
pathway. Nature 385, 74-77. 
Batchelor, A. M., Madge, D. J., and Garthwaite, J. (1994). Synaptic activation of 
metabotropic glutamate receptors in the parallel fibre-Purkinje cell pathway in rat 
cerebellar slices. Neuroscience 63, 911-915. 
Baude, A., Nusser, Z., Roberts, J. D., Mulvihill, E., McIlhinney, R. A., and Somogyi, 
P. (1993). The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at 
perisynaptic membrane of neuronal subpopulations as detected by immunogold 
reaction. Neuron 11, 771-787.  173
Berger, U. V., and Hediger, M. A. (1998). Comparative analysis of glutamate 
transporter expression in rat brain using differential double in situ hybridization. 
Anat Embryol (Berl) 198, 13-30. 
Bergles, D. E., Dzubay, J. A., and Jahr, C. E. (1997). Glutamate transporter currents in 
bergmann glial cells follow the time course of extrasynaptic glutamate. Proc Natl 
Acad Sci U S A 94, 14821-14825. 
Bergles, D. E., and Jahr, C. E. (1997). Synaptic activation of glutamate transporters in 
hippocampal astrocytes. Neuron 19, 1297-1308. 
Bergles, D. E., and Jahr, C. E. (1998). Glial contribution to glutamate uptake at 
Schaffer collateral- commissural synapses in the hippocampus. J Neurosci 18, 
7709-7716. 
Bergles, D. E., Tzingounis, A. V., and Jahr, C. E. (2002). Comparison of coupled and 
uncoupled currents during glutamate uptake by GLT-1 transporters. J Neurosci 22, 
10153-10162. 
Bortolotto, Z. A., Clarke, V. R., Delany, C. M., Parry, M. C., Smolders, I., Vignes, M., 
Ho, K. H., Miu, P., Brinton, B. T., Fantaske, R., et al. (1999). Kainate receptors 
are involved in synaptic plasticity. Nature 402, 297-301. 
Brasnjo, G., and Otis, T. S. (2001). Neuronal glutamate transporters control activation 
of postsynaptic metabotropic glutamate receptors and influence cerebellar 
long-term depression. Neuron 31, 607-616. 
Brasnjo, G., and Otis, T. S. (2004). Isolation of glutamate transport-coupled charge 
flux and estimation of glutamate uptake at the climbing fiber-Purkinje cell  174
synapse. Proc Natl Acad Sci U S A 101, 6273-6278. 
Brickley, S., Swanson, G., Contractor, A., Farrant, M., Sailer, A., Cull-Candy, S., and 
Heinemann, S. (1999). Functional GluR5-containing kainate receptors are 
restricted to extrasynaptic sties in Purkinje cells of the mouse cerebellum. J 
Physiol 521 P, 90P. 
Bureau, I., Dieudonne, S., Coussen, F., and Mulle, C. (2000). Kainate 
receptor-mediated synaptic currents in cerebellar Golgi cells are not shaped by 
diffusion of glutamate. Proc Natl Acad Sci U S A 97, 6838-6843. 
Canepari, M., Nelson, L., Papageorgiou, G., Corrie, J. E., and Ogden, D. (2001). 
Photochemical and pharmacological evaluation of 7-nitroindolinyl-and 
4-methoxy-7-nitroindolinyl-amino acids as novel, fast caged neurotransmitters. J 
Neurosci Methods 112, 29-42. 
Canepari, M., Papageorgiou, G., Corrie, J. E., Watkins, C., and Ogden, D. (2001). The 
conductance underlying the parallel fibre slow EPSP in rat cerebellar Purkinje 
neurones studied with photolytic release of L-glutamate. J Physiol 533, 765-772. 
Chaudhry, F. A., Lehre, K. P., M., v. L. C., Ottersen, O. P., Danbolt, N. C., and J., 
S.-M. (1995). Glutamate Transporters In Glial Plasma Membranes: Highly 
Differentiated Localizations Revealed by Quantitative Ultrastructural 
Immunocytochemistry. Neuron 15, 720. 
Chen, W., Aoki, C., Mahadomrongkul, V., Gruber, C. E., Wang, G. J., Blitzblau, R., 
Irwin, N., and Rosenberg, P. A. (2002). Expression of a variant form of the 
glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in  175
the rat brain. J Neurosci 22, 2142-2152. 
Chen, W., Mahadomrongkul, V., Berger, U. V., Bassan, M., DeSilva, T., Tanaka, K., 
Irwin, N., Aoki, C., and Rosenberg, P. A. (2004). The glutamate transporter 
GLT1α is expressed in excitatory axon terminals of mature hippocampal neurons. 
J Neurosci 24, 1136-1148. 
Chicurel, M. E., and Harris, K. M. (1992). Three-dimensional analysis of the structure 
and composition of CA3 branched dendritic spines and their synaptic relationships 
with mossy fiber boutons in the rat hippocampus. J Comp Neurol 325, 169-182. 
Clark, B. A., and Barbour, B. (1997). Currents evoked in Bergmann glial cells by 
parallel fibre stimulation in rat cerebellar slices. J Physiol (Lond) 502, 335-350. 
Clark, B. A., and Cull-Candy, S. G. (2002). Activity-dependent recruitment of 
extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse. J 
Neurosci 22, 4428-4436. 
Cleveland, D. W., and Rothstein, J. D. (2001). From Charcot to Lou Gehrig: 
deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2, 806-819. 
Commons, K. G., and Milner, T. A. (1995). Ultrastructural heterogeneity of 
enkephalin-containing terminals in the rat hippocampal formation. J Comp Neurol 
358, 324-342. 
Conn, P. J., and Pin, J. P. (1997). Pharmacology and functions of metabotropic 
glutamate receptors. Annu Rev Pharmacol Toxicol 37, 205-237. 
Contractor, A., Swanson, G. T., Sailer, A., O'Gorman, S., and Heinemann, S. F. (2000). 
Identification of the kainate receptor subunits underlying modulation of excitatory  176
synaptic transmission in the CA3 region of the hippocampus. J Neurosci 20, 
8269-8278. 
Cossart, R., Epsztein, J., Tyzio, R., Becq, H., Hirsch, J., Ben-Ari, Y., and Crepel, V. 
(2002). Quantal release of glutamate generates pure kainate and mixed 
AMPA/kainate EPSCs in hippocampal neurons. Neuron 35, 147-159. 
Danbolt, N. C. (2001). Glutamate uptake. Prog Neurobiol 65, 1-105. 
Dehnes, Y., Chaudhry, F. A., Ullensvang, K., Lehre, K. P., Storm-Mathisen, J., and 
Danbolt, N. C. (1998). The glutamate transporter EAAT4 in rat cerebellar Purkinje 
cells: a glutamate-gated chloride channel concentrated near the synapse in parts of 
the dendritic membrane facing astroglia. J Neurosci 18, 3606-3619. 
Diamond, J. S. (2001). Neuronal glutamate transporters limit activation of NMDA 
receptors by neurotransmitter spillover on CA1 pyramidal cells. J Neurosci 21, 
8328-8338. 
Diamond, J. S., and Jahr, C. E. (1997). Transporters buffer synaptically released 
glutamate on a submillisecond time scale. J Neurosci 17, 4672-4687. 
Diamond, J. S., and Jahr, C. E. (2000). Synaptically released glutamate does not 
overwhelm transporters on hippocampal astrocytes during high-frequency 
stimulation. J Neurophysiol 83, 2835-2843. 
Dowd, L. A., Coyle, A. J., Rothstein, J. D., Pritchett, D. B., and Robinson, M. B. 
(1996). Comparison of Na+-dependent glutamate transport activity in 
synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid 
carrier 1 (EAAC1). Mol Pharmacol 49, 465-473.  177
Dowd, L. A., and Robinson, M. B. (1996). Rapid stimulation of EAAC1-mediated 
Na+-dependent L-glutamate transport activity in C6 glioma cells by phorbol ester. 
J Neurochem 67, 508-516. 
Dunlop, J. (2001). Substrate exchange properties of the high-affinity glutamate 
transporter EAAT2. J Neurosci Res 66, 482-486. 
Dunlop, J., Eliasof, S., Stack, G., McIlvain, H. B., Greenfield, A., Kowal, D., Petroski, 
R., and Carrick, T. (2003). WAY-855 
(3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, 
EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake. Br J 
Pharmacol 140, 839-846. 
Dzubay, J. A., and Jahr, C. E. (1999). The concentration of synaptically released 
glutamate outside of the climbing fiber-Purkinje cell synaptic cleft. J Neurosci 19, 
5265-5274. 
Ellis-Davies, G. C., and Kaplan, J. H. (1994). Nitrophenyl-EGTA, a photolabile 
chelator that selectively binds Ca2+ with high affinity and releases it rapidly upon 
photolysis. Proc Natl Acad Sci U S A 91, 187-191. 
Euler, T., and Wassle, H. (1995). Immunocytochemical identification of cone bipolar 
cells in the rat retina. J Comp Neurol 361, 461-478. 
Fairman, W. A., Vandenberg, R. J., Arriza, J. L., Kavanaugh, M. P., and Amara, S. G. 
(1995). An excitatory amino-acid transporter with properties of a ligand-gated 
chloride channel. Nature 375, 599-603. 
Frerking, M., and Ohliger-Frerking, P. (2002). AMPA receptors and kainate receptors  178
encode different features of afferent activity. J Neurosci 22, 7434-7443. 
Freund, T. F., and Buzsáki, G. (1996). Interneurons of the hippocampus. Hippocampus 
6, 347-470. 
Furuta, A., Rothstein, J. D., and Martin, L. J. (1997). Glutamate transporter protein 
subtypes are expressed differentially during rat CNS development. J Neurosci 17, 
8363-8375. 
Gee, C. E., Woodhall, G., and Lacaille, J. C. (2001). Synaptically activated calcium 
responses in dendrites of hippocampal oriens-alveus interneurons. J Neurophysiol 
85, 1603-1613. 
Gee, K. R., Niu, L., Schaper, K., Jayaraman, V., and Hess, G. P. (1999). Synthesis and 
photochemistry of a photolabile precursor of N-methyl-D-aspartate (NMDA) that 
is photolyzed in the microsecond time region and is suitable for chemical kinetic 
investigations of the NMDA receptor. Biochemistry 38, 3140-3147. 
Gegelashvili, G., Danbolt, N. C., and Schousboe, A. (1997). Neuronal soluble factors 
differentially regulate the expression of the GLT1 and GLAST glutamate 
transporters in cultured astroglia. J Neurochem 69, 2612-2615. 
Gonzalez, M. I., and Robinson, M. B. (2004). Neurotransmitter transporters: why 
dance with so many partners? Curr Opin Pharmacol 4, 30-35. 
Grewer, C., Madani Mobarekeh, S. A., Watzke, N., Rauen, T., and Schaper, K. (2001). 
Substrate translocation kinetics of excitatory amino acid carrier 1 probed with 
laser-pulse photolysis of a new photolabile precursor of D-aspartic acid. 
Biochemistry 40, 232-240.  179
Grewer, C., and Rauen, T. (2005). Electrogenic glutamate transporters in the CNS: 
molecular mechanism, pre-steady-state kinetics, and their impact on synaptic 
signaling. J Membr Biol 203, 1-20. 
Grewer, C., Watzke, N., Wiessner, M., and Rauen, T. (2000). Glutamate translocation 
of the neuronal glutamate transporter EAAC1 occurs within milliseconds. Proc 
Natl Acad Sci U S A 97, 9706-9711. 
Hakuba, N., Koga, K., Gyo, K., Usami, S.-i., and Tanaka, K. (2000). Exacerbation of 
Noise-Induced Hearing Loss in Mice Lacking the Glutamate Transporter GLAST. 
J Neurosci 20, 8750-8753. 
Harrison, J., and Jahr, C. E. (2003). Receptor occupancy limits synaptic depression at 
climbing fiber synapses. J Neurosci 23, 377-383. 
Hausser, M., and Roth, A. (1997). Dendritic and somatic glutamate receptor channels 
in rat cerebellar Purkinje cells. J Physiol 501 (Pt 1), 77-95. 
He, Y., Janssen, W. G., Rothstein, J. D., and Morrison, J. H. (2000). Differential 
synaptic localization of the glutamate transporter EAAC1 and glutamate receptor 
subunit GluR2 in the rat hippocampus. J Comp Neurol 418, 255-269. 
Hirasawa, M., Cho, A., Sreenath, T., Sauer, B., Julien, J. P., and Kulkarni, A. B. 
(2001). Neuron-specific expression of Cre recombinase during the late phase of 
brain development. Neurosci Res 40, 125-132. 
Huang, Y. H., and Bergles, D. E. (2004). Glutamate transporters bring competition to 
the synapse. Curr Opin Neurobiol 14, 346-352. 
Huang, Y. H., Dykes-Hoberg, M., Tanaka, K., Rothstein, J. D., and Bergles, D. E.  180
(2004). Climbing fiber activation of EAAT4 transporters and kainate receptors in 
cerebellar Purkinje cells. J Neurosci 24, 103-111. 
Huang, Y. H., Sinha, S. R., Fedoryak, O. D., Ellis-Davies, G. C., and Bergles, D. E. 
(2005). Synthesis and characterization of 4-methoxy-7-nitroindolinyl-D-aspartate, 
a caged compound for selective activation of glutamate transporters and 
N-methyl-D-aspartate receptors in brain tissue. Biochemistry 44, 3316-3326. 
Huang, Y. H., Sinha, S. R., Tanaka, K., Rothstein, J. D., and Bergles, D. E. (2004). 
Astrocyte glutamate transporters regulate metabotropic glutamate 
receptor-mediated excitation of hippocampal interneurons. J Neurosci 24, 
4551-4559. 
Iino, M., Goto, K., Kakegawa, W., Okado, H., Sudo, M., Ishiuchi, S., Miwa, A., 
Takayasu, Y., Saito, I., Tsuzuki, K., and Ozawa, S. (2001). Glia-synapse 
interaction through Ca2+-permeable AMPA receptors in Bergmann glia. Science 
292, 926-929. 
Isaacson, J. S., and Nicoll, R. A. (1993). The uptake inhibitor L-trans-PDC enhances 
responses to glutamate but fails to alter the kinetics of excitatory synaptic currents 
in the hippocampus. J Neurophysiol 70, 2187-2191. 
Jabaudon, D., Shimamoto, K., Yasuda-Kamatani, Y., Scanziani, M., Gahwiler, B. H., 
and Gerber, U. (1999). Inhibition of uptake unmasks rapid extracellular turnover 
of glutamate of nonvesicular origin. Proc Natl Acad Sci U S A 96, 8733-8738. 
Johnston, G. A. R., ed. (1981). Glutamate uptake and its possible role in 
neurotransmitter inactivation (Chichester, UK: Wiley).  181
Jonas, P., and Sakmann, B. (1992). Glutamate receptor channels in isolated patches 
from CA1 and CA3 pyramidal cells of rat hippocampal slices. J Physiol (Lond) 
455, 143-171. 
Kang, J., Jiang, L., Goldman, S. A., and Nedergaard, M. (1998). Astrocyte-mediated 
potentiation of inhibitory synaptic transmission. Nat Neurosci 1, 683-692. 
Kanner, B. I., and Bendahan, A. (1982). Binding order of substrates to the sodium and 
potassium ion coupled L-glutamic acid transporter from rat brain. Biochemistry 
21, 6327-6330. 
Katagiri, H., Tanaka, K., and Manabe, T. (2001). Requirement of appropriate 
glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur 
J Neurosci 14, 547-553. 
Kidd, F. L., and Isaac, J. T. (2001). Kinetics and activation of postsynaptic kainate 
receptors at thalamocortical synapses: role of glutamate clearance. J Neurophysiol 
86, 1139-1148. 
Kim, S. J., Kim, Y. S., Yuan, J. P., Petralia, R. S., Worley, P. F., and Linden, D. J. 
(2003). Activation of the TRPC1 cation channel by metabotropic glutamate 
receptor mGluR1. Nature 426, 285-291. 
Kinney, G. A., Overstreet, L. S., and Slater, N. T. (1997). Prolonged physiological 
entrapment of glutamate in the synaptic cleft of cerebellar unipolar brush cells. J 
Neurophysiol 78, 1320-1333. 
Lehre, K. P., and Danbolt, N. C. (1998). The number of glutamate transporter subtype 
molecules at glutamatergic synapses: chemical and stereological quantification in  182
young adult rat brain. J Neurosci 18, 8751-8757. 
Lehre, K. P., Levy, L. M., Ottersen, O. P., Storm-Mathisen, J., and Danbolt, N. C. 
(1995). Differential expression of two glial glutamate transporters in the rat brain: 
quantitative and immunocytochemical observations. J Neurosci 15, 1835-1853. 
Lehre, K. P., and Rusakov, D. A. (2002). Asymmetry of glia near central synapses 
favors presynaptically directed glutamate escape. Biophys J 83, 125-134. 
Lerma, J. (2003). Roles and rules of kainate receptors in synaptic transmission. Nat 
Rev Neurosci 4, 481-495. 
Lerma, J., Paternain, A. V., Rodriguez-Moreno, A., and Lopez-Garcia, J. C. (2001). 
Molecular physiology of kainate receptors. Physiol Rev 81, 971-998. 
Levy, L. M., Lehre, K. P., Walaas, S. I., Storm-Mathisen, J., and Danbolt, N. C. (1995). 
Down-regulation of glial glutamate transporters after glutamatergic denervation in 
the rat brain. Eur J Neurosci 7, 2036-2041. 
Levy, L. M., Warr, O., and Attwell, D. (1998). Stoichiometry of the glial glutamate 
transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line 
selected for low endogenous Na+-dependent glutamate uptake. J Neurosci 18, 
9620-9628. 
Li, X., Atkinson, R., and King, S. (2001). Preparation and evaluation of new 
-canavanine derivatives as nitric oxide synthase inhibitors. Tetrahedron 57, 
6557-6565. 
Logan, W. J., and Snyder, S. H. (1972). High affinity uptake systems for glycine, 
glutamic and aspaspartic acids in synaptosomes of rat central nervous tissues.  183
Brain Res 42, 413-431. 
Lujan, R., Nusser, Z., Roberts, J. D., Shigemoto, R., and Somogyi, P. (1996). 
Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 
on dendrites and dendritic spines in the rat hippocampus. Eur J Neurosci 8, 
1488-1500. 
Maccaferri, G., and Dingledine, R. (2002). Control of feedforward dendritic inhibition 
by NMDA receptor-dependent spike timing in hippocampal interneurons. J 
Neurosci 22, 5462-5472. 
Maccaferri, G., Roberts, J. D., Szucs, P., Cottingham, C. A., and Somogyi, P. (2000). 
Cell surface domain specific postsynaptic currents evoked by identified 
GABAergic neurones in rat hippocampus in vitro. J Physiol 524 Pt 1, 91-116. 
Manzoni, O. J., Castillo, P. E., and Nicoll, R. A. (1995). Pharmacology of 
metabotropic glutamate receptors at the mossy fiber synapses of the guinea pig 
hippocampus. Neuropharmacology 34, 965-971. 
Martin, L. J., Brambrink, A. M., Lehmann, C., Portera-Cailliau, C., Koehler, R., 
Rothstein, J., and Traystman, R. J. (1997). Hypoxia-ischemia causes abnormalities 
in glutamate transporters and death of astroglia and neurons in newborn striatum.   
42, 335-348. 
Mathews, G. C., and Diamond, J. S. (2003). Neuronal glutamate uptake Contributes to 
GABA synthesis and inhibitory synaptic strength.   23, 2040-2048. 
Matsuzaki, M., Ellis-Davies, G. C., Nemoto, T., Miyashita, Y., Iino, M., and Kasai, H. 
(2001). Dendritic spine geometry is critical for AMPA receptor expression in  184
hippocampal CA1 pyramidal neurons. Nat Neurosci 4, 1086-1092. 
McBain, C. J., DiChiara, T. J., and Kauer, J. A. (1994). Activation of metabotropic 
glutamate receptors differentially affects two classes of hippocampal interneurons 
and potentiates excitatory synaptic transmission. J Neurosci 14, 4433-4445. 
Miles, R., and Poncer, J. C. (1993). Metabotropic glutamate receptors mediate a 
post-tetanic excitation of guinea-pig hippocampal inhibitory neurones. J Physiol 
463, 461-473. 
Min, M. Y., Rusakov, D. A., and Kullmann, D. M. (1998). Activation of AMPA, 
kainate, and metabotropic receptors at hippocampal mossy fiber synapses: role of 
glutamate diffusion. Neuron 21, 561-570. 
Mori, M., and Gerber, U. (2002). Slow feedback inhibition in the CA3 area of the rat 
hippocampus by synergistic synaptic activation of mGluR1 and mGluR5. J 
Physiol 544, 793-799. 
Norman, R. O., and Radda, G. K. (1961). J Chem Soc, 3030-3036. 
Northington, F. J., Traystman, R. J., Koehler, R. C., Rothstein, J. D., and Martin, L. J. 
(1998). Regional and cellular expression of glial (GLT1) and neuronal (EAAC1) 
glutamate transporter proteins in ovine fetal brain. Neuroscience 85, 1183-1194. 
Oliet, S. H., Piet, R., and Poulain, D. A. (2001). Control of glutamate clearance and 
synaptic efficacy by glial coverage of neurons. Science 292, 923-926. 
Olverman, H. J., Jones, A. W., Mewett, K. N., and Watkins, J. C. (1988). 
Structure/activity relations of N-methyl-D-aspartate receptor ligands as studied by 
their inhibition of [3H]D-2-amino-5-phosphonopentanoic acid binding in rat brain  185
membranes. Neuroscience 26, 17-31. 
Otis, T. S., and Jahr, C. E. (1998). Anion currents and predicted glutamate flux 
through a neuronal glutamate transporter. J Neurosci 18, 7099-7110. 
Otis, T. S., and Kavanaugh, M. P. (2000). Isolation of current components and partial 
reaction cycles in the glial glutamate transporter EAAT2. J Neurosci 20, 
2749-2757. 
Otis, T. S., Kavanaugh, M. P., and Jahr, C. E. (1997). Postsynaptic glutamate transport 
at the climbing fiber-Purkinje cell synapse. Science 277, 1515-1518. 
Otis, T. S., Wu, Y. C., and Trussell, L. O. (1996). Delayed clearance of transmitter and 
the role of glutamate transporters at synapses with multiple release sites. J 
Neurosci 16, 1634-1644. 
Ottersen, O. P., Laake, J. H., Reichelt, W., Haug, F. M., and Torp, R. (1996). Ischemic 
disruption of glutamate homeostasis in brain: quantitative immunocytochemical 
analyses. J Chem Neuroanat 12, 1-14. 
Palay, S. L., and Chan-Palay, V. (1974). In Cerebellar Cortex - Cytology and 
Organization (Berlin: Springer). 
Paternain, A. V., Morales, M., and Lerma, J. (1995). Selective antagonism of AMPA 
receptors unmasks kainate receptor-mediated responses in hippocampal neurons. 
Neuron 14, 185-189. 
Patneau, D. K., and Mayer, M. L. (1990). Structure-activity relationships for amino 
acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate 
receptors. J Neurosci 10, 2385-2399.  186
Peghini, P., Janzen, J., and Stoffel, W. (1997). Glutamate transporter 
EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral 
abnormalities but no neurodegeneration. Embo J 16, 3822-3832. 
Perkel, D. J., Hestrin, S., Sah, P., and Nicoll, R. A. (1990). Excitatory synaptic 
currents in Purkinje cells. Proc R Soc Lond B Biol Sci 241, 116-121. 
Pettit, D. L., Wang, S. S., Gee, K. R., and Augustine, G. J. (1997). Chemical 
two-photon uncaging: a novel approach to mapping glutamate receptors. Neuron 
19, 465-471. 
Pin, J. P., and Duvoisin, R. (1995). The metabotropic glutamate receptors: structure 
and functions. Neuropharmacology 34, 1-26. 
Rammes, G., Swandulla, D., Spielmanns, P., and Parsons, C. G. (1998). Interactions of 
GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with 
outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology 37, 
1299-1320. 
Rao, V. L., Baskaya, M. K., Dogan, A., Rothstein, J. D., and Dempsey, R. J. (1998). 
Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and 
GLAST) proteins in rat brain. J Neurochem 70, 2020-2027. 
Rauen, T., and Kanner, B. I. (1994). Localization of the glutamate transporter GLT-1 
in rat and macaque monkey retinae. Neurosci Lett 169, 137-140. 
Rauen, T., Rothstein, J. D., and Wassle, H. (1996). Differential expression of three 
glutamate transporter subtypes in the rat retina. Cell Tissue Res 286, 325-336. 
Reichelt, W., and Knopfel, T. (2002). Glutamate uptake controls expression of a slow  187
postsynaptic current mediated by mGluRs in cerebellar Purkinje cells. J 
Neurophysiol 87, 1974-1980. 
Renden, R., Taschenberger, H., Puente, N., Rusakov, D. A., Duvoisin, R., Wang, L. Y., 
Lehre, K. P., and von Gersdorff, H. (2005). Glutamate transporter studies reveal 
the pruning of metabotropic glutamate receptors and absence of AMPA receptor 
desensitization at mature calyx of held synapses. J Neurosci 25, 8482-8497. 
Rossi, D. J., Oshima, T., and Attwell, D. (2000). Glutamate release in severe brain 
ischaemia is mainly by reversed uptake. Nature 403, 316-321. 
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., 
Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., and Welty, D. F. (1996). 
Knockout of glutamate transporters reveals a major role for astroglial transport in 
excitotoxicity and clearance of glutamate. Neuron 16, 675-686. 
Rothstein, J. D., Martin, L., Levey, A. I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., 
and Kuncl, R. W. (1994). Localization of neuronal and glial glutamate transporters. 
Neuron 13, 713-725. 
Rozas, J. L., Paternain, A. V., and Lerma, J. (2003). Noncanonical signaling by 
ionotropic kainate receptors. Neuron 39, 543-553. 
Saier, M. H., Jr. (1999). Eukaryotic transmembrane solute transport systems. Int Rev 
Cytol 190, 61-136. 
Scanziani, M., Gahwiler, B. H., and Charpak, S. (1998). Target cell-specific 
modulation of transmitter release at terminals from a single axon. Proc Natl Acad 
Sci U S A 95, 12004-12009.  188
Schmitt, A., Asan, E., Puschel, B., Jons, T., and Kugler, P. (1996). Expression of the 
glutamate transporter GLT1 in neural cells of the rat central nervous system: 
non-radioactive in situ hybridization and comparative immunocytochemistry. 
Neuroscience 71, 989-1004. 
Sepkuty, J. P., Cohen, A. S., Eccles, C., Rafiq, A., Behar, K., Ganel, R., Coulter, D. A., 
and Rothstein, J. D. (2002). A neuronal glutamate transporter contributes to 
neurotransmitter GABA synthesis and epilepsy.   22, 6372-6379. 
Shepherd, G. M. (2004). The synaptic organization of the brain, 5th edn (New York: 
Oxford University Press). 
Shigemoto, R., Kinoshita, A., Wada, E., Nomura, S., Ohishi, H., Takada, M., Flor, P. J., 
Neki, A., Abe, T., Nakanishi, S., and Mizuno, N. (1997). Differential presynaptic 
localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J 
Neurosci 17, 7503-7522. 
Shigeri, Y., Shimamoto, K., Yasuda-Kamatani, Y., Seal, R. P., Yumoto, N., Nakajima, 
T., and Amara, S. G. (2001). Effects of threo-beta-hydroxyaspartate derivatives on 
excitatory amino acid transporters (EAAT4 and EAAT5). J Neurochem 79, 
297-302. 
Shimamoto, K., Lebrun, B., Yasuda-Kamatani, Y., Sakaitani, M., Shigeri, Y., Yumoto, 
N., and Nakajima, T. (1998). DL-threo-beta-benzyloxyaspartate, a potent blocker 
of excitatory amino acid transporters. Mol Pharmacol 53, 195-201. 
Shimamoto, K., Shigeri, Y., Yasuda-Kamatani, Y., Lebrun, B., Yumoto, N., and 
Nakajima, T. (2000). Syntheses of optically pure beta-hydroxyaspartate  189
derivatives as glutamate transporter blockers. Bioorg Med Chem Lett 10, 
2407-2410. 
Silver, R. A., Momiyama, A., and Cull-Candy, S. G. (1998). Locus of 
frequency-dependent depression identified with multiple-probability fluctuation 
analysis at rat climbing fibre-Purkinje cell synapses. J Physiol 510 (Pt 3), 
881-902. 
Slotboom, D. J., Konings, W. N., and Lolkema, J. S. (1999). Structural features of the 
glutamate transporter family. Microbiol Mol Biol Rev 63, 293-307. 
Spacek, J. (1980). Non-synaptic membrane specializations on the necks of Purkinje 
cell dentritic spines. J Anat 131, 723-729. 
Spacek, J. (1985). Three-dimensional analysis of dendritic spines. III. Glial sheath. 
Anat Embryol (Berl) 171, 245-252. 
Swanson, G. T., and Heinemann, S. F. (1998). Heterogeneity of homomeric GluR5 
kainate receptor desensitization expressed in HEK293 cells. J Physiol 513 (Pt 3), 
639-646. 
Takahashi, M., Kovalchuk, Y., and Attwell, D. (1995). Pre- and postsynaptic 
determinants of EPSC waveform at cerebellar climbing fiber and parallel fiber to 
Purkinje cell synapses. J Neurosci 15, 5693-5702. 
Takahashi, M., Sarantis, M., and Attwell, D. (1996). Postsynaptic glutamate uptake in 
rat cerebellar Purkinje cells. J Physiol (Lond) 497, 523-530. 
Tamaru, Y., Nomura, S., Mizuno, N., and Shigemoto, R. (2001). Distribution of 
metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location  190
relative to pre- and postsynaptic sites. Neuroscience 106, 481-503. 
Tanaka, J., Ichikawa, R., Watanabe, M., Tanaka, K., and Inoue, Y. (1997). 
Extra-junctional localization of glutamate transporter EAAT4 at excitatory 
Purkinje cell synapses. Neuroreport 8, 2461-2464. 
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, 
H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997). Epilepsy and 
exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. 
Science 276, 1699-1702. 
Tempia, F., Miniaci, M. C., Anchisi, D., and Strata, P. (1998). Postsynaptic current 
mediated by metabotropic glutamate receptors in cerebellar Purkinje cells. J 
Neurophysiol 80, 520-528. 
Theodosis, D. T., and Poulain, D. A. (1993). Activity-dependent neuronal-glial and 
synaptic plasticity in the adult mammalian hypothalamus. Neuroscience 57, 
501-535. 
Thomson, A. M. (2000). Facilitation, augmentation and potentiation at central 
synapses. Trends Neurosci 23, 305-312. 
Tong, G., and Jahr, C. E. (1994). Block of glutamate transporters potentiates 
postsynaptic excitation. Neuron 13, 1195-1203. 
Torp, R., Danbolt, N. C., Babaie, E., Bjoras, M., Seeberg, E., Storm-Mathisen, J., and 
Ottersen, O. P. (1994). Differential expression of two glial glutamate transporters 
in the rat brain: an in situ hybridization study. Eur J Neurosci 6, 936-942. 
Torp, R., Hoover, F., Danbolt, N. C., Storm-Mathisen, J., and Ottersen, O. P. (1997).  191
Differential distribution of the glutamate transporters GLT1 and rEAAC1 in rat 
cerebral cortex and thalamus: an in situ hybridization analysis. Anat Embryol 
(Berl) 195, 317-326. 
Trotti, D., Peng, J. B., Dunlop, J., and Hediger, M. A. (2001). Inhibition of the 
glutamate transporter EAAC1 expressed in Xenopus oocytes by phorbol esters. 
Brain Res 914, 196-203. 
Tsvetkov, E., Shin, R. M., and Bolshakov, V. Y. (2004). Glutamate uptake determines 
pathway specificity of long-term potentiation in the neural circuitry of fear 
conditioning. Neuron 41, 139-151. 
Utsunomiya-Tate, N., Endou, H., and Kanai, Y. (1997). Tissue specific variants of 
glutamate transporter GLT-1. FEBS Lett 416, 312-316. 
Ventura, R., and Harris, K. M. (1999). Three-dimensional relationships between 
hippocampal synapses and astrocytes. J Neurosci 19, 6897-6906. 
von Kitzing, E., Jonas, P., and Sakmann, B. (1994). Quantal analysis of excitatory 
postsynaptic currents at the hippocampal mossy fiber-CA3 pyramidal cell synapse. 
Adv Second Messenger Phosphoprotein Res 29, 235-260. 
Voutsinos-Porche, B., Bonvento, G., Tanaka, K., Steiner, P., Welker, E., Chatton, J. Y., 
Magistretti, P. J., and Pellerin, L. (2003). Glial glutamate transporters mediate a 
functional metabolic crosstalk between neurons and astrocytes in the mouse 
developing cortex. Neuron 37, 275-286. 
Wadiche, J. I., Amara, S. G., and Kavanaugh, M. P. (1995). Ion fluxes associated with 
excitatory amino acid transport. Neuron 15, 721-728.  192
Wadiche, J. I., Arriza, J. L., Amara, S. G., and Kavanaugh, M. P. (1995). Kinetics of a 
human glutamate transporter. Neuron 14, 1019-1027. 
Wadiche, J. I., and Jahr, C. E. (2001). Multivesicular release at climbing 
fiber-Purkinje cell synapses. Neuron 32, 301-313. 
Wadiche, J. I., and Jahr, C. E. (2005). Patterned expression of Purkinje cell glutamate 
transporters controls synaptic plasticity. Nat Neurosci 8, 1329-1334. 
Wadiche, J. I., and Kavanaugh, M. P. (1998). Macroscopic and microscopic properties 
of a cloned glutamate transporter/chloride channel. J Neurosci 18, 7650-7661. 
Watase, K., Hashimoto, K., Kano, M., Yamada, K., Watanabe, M., Inoue, Y., 
Okuyama, S., Sakagawa, T., Ogawa, S., Kawashima, N., et al. (1998). Motor 
discoordination and increased susceptibility to cerebellar injury in GLAST mutant 
mice. Eur J Neurosci 10, 976-988. 
Wisden, W., and Seeburg, P. H. (1993). A complex mosaic of high-affinity kainate 
receptors in rat brain. J Neurosci 13, 3582-3598. 
Wong, M., Ess, K. C., Uhlmann, E. J., Jansen, L. A., Li, W., Crino, P. B., Mennerick, 
S., Yamada, K. A., and Gutmann, D. H. (2003). Impaired glial glutamate transport 
in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54, 251-256. 
Xu-Friedman, M. A., Harris, K. M., and Regehr, W. G. (2001). Three-dimensional 
comparison of ultrastructural characteristics at depressing and facilitating 
synapses onto cerebellar Purkinje cells. J Neurosci 21, 6666-6672. 
Yuzaki, M., Forrest, D., Curran, T., and Connor, J. A. (1996). Selective activation of 
calcium permeability by aspartate in Purkinje cells. Science 273, 1112-1114.  193
Zerangue, N., and Kavanaugh, M. P. (1996). Flux coupling in a neuronal glutamate 
transporter. Nature 383, 634-637. 
Zhang, L., and McBain, C. J. (1995). Potassium conductances underlying 
repolarization and after-hyperpolarization in rat CA1 hippocampal interneurones. 
J Physiol 488 (Pt 3), 661-672. 
 
 
  194
Curriculum Vitae 
 
Name: Yanhua  Huang 
Date of Birth:  April 10, 1978 
Mailing Address:  725 N. Wolfe St., WBSB 914 
Baltimore, MD 21205 
Phone (work): (410)  955-6949 
E-mail:  yhuang@jhmi.edu 
yhhuang@gmail.com 
 
Education: 
Aug. 2000 – Present: 
 
Sept. 1996 – June 2000: 
 
 
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Expecting Ph.D. in Neuroscience by Jan. 2006.   
Beijing University, Beijing, P. R. China 
B.S. in Physiology and Biophysics 
 
Research Experience: 
May 2001 – Present: 
 
 
Aug. 2000 – May 2001: 
 
Sept. 1999 – June 2000: 
 
 
“Glutamate transporter function at excitatory synapses” in 
the laboratory of Dr. Dwight E. Bergles, Johns Hopkins 
University. 
Doing rotations in the laboratories of Drs. Richard L. 
Huganir and David D. Ginty, Johns Hopkins University. 
“Involvement of endogenous opioid systems in the 
modulation of nociception” in the laboratory of Dr. 
Long-Chuan Yu, Beijing University.  195
Publications: 
Peer-Reviewed Journal Articles 
Huang YH, Muralidharan S, Sinha SR, Kao JP, Bergles DE (2005) Ncm-D-aspartate: 
a novel caged D-aspartate suitable for activation of glutamate transporters and 
N-methyl-D-aspartate (NMDA) receptors in brain tissue. Neuropharmacology 
49:831-842. 
Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes 
Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher 
PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate 
transporter expression. Nature 433:73-77. 
Huang YH, Sinha SR, Fedoryak OD, Ellis-Davies GC, Bergles DE (2005) Synthesis 
and characterization of 4-methoxy-7-nitroindolinyl-D-aspartate, a caged 
compound for selective activation of glutamate transporters and 
N-Methyl-D-aspartate (NMDA) receptors in brain tissue. Biochemistry 
44:3316-3326. 
Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE (2004) Astrocyte 
glutamate transporters regulate metabotropic glutamate receptor-mediated 
excitation of hippocampal interneurons. J Neurosci 24:4551-4559. 
Huang YH, Dykes-Hoberg M, Tanaka K, Rothstein JD, Bergles DE (2004) Climbing 
fiber activation of EAAT4 transporters and kainate receptors in cerebellar 
Purkinje cells. J Neurosci 24:103-111. 
Chung HJ, Huang YH, Lau L-F, Huganir RL (2004) Regulation of the NMDA 
receptor complex and trafficking by activity-dependent phosphorylation of the 
NR2B subunit PDZ ligand. J Neurosci 24: 10248-10259 
Lu JT, Huang YH, Palmer PP, Xie GX, Gabriel A, Grond S, Yu LC (2001) Blockade  196
effects of (Nphe1) Nociceptin(1-13)-NH(2) on anti-nociception induced by 
intrathecal administration of nociceptin in rats. Regul Pept 101:81-85. 
Huang Y, Brodda-Jansen G, Lundeberg T, Yu LC (2000) Anti-nociceptive effects of 
calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect 
attenuated by naloxone. Brain Res 873:54-59. 
 
Review paper 
Huang YH, Bergles DE (2004) Glutamate transporters bring competition to the 
synapse. Curr Opin Neurobiol 14:346-352. 
 
Honors and Awards: 
1996 – 1997 
1997 – 1998 
1998 – 1999 
1999 – 2000 
April, 2005 
 
 
Outstanding Student Award, Beijing University. 
Guang Hua Scholarship, Beijing University. 
Guang Cai Scholarship, Beijing University. 
Centennial Elite Scholarship, Beijing University. 
Paul Ehrlich Award (Young Investigator Award) 
Johns Hopkins University School of Medicine. 
 
Membership: 
 
Member of Society for Neuroscience (USA) 
 